📂 Documents Scan

Дата: 2026-04-12 11:07 · Только .md .html .txt · Ничего не перемещено · Ничего не изменено

Показано: 49 папок, 2410 файлов
49
Папок
2410
Файлов
0
Перемещено
0
Изменено

📁 VERONIKA CHATI 1021 → [[Veronika]]

ФайлТипРазмерПуть
pro-summaries-all.mdmd1926KBveronika-health-db/data/pro-summaries-all.md
ALL-CATEGORY-SUMMARIES.mdmd706KBveronika-health-db/public/ALL-CATEGORY-SUMMARIES.md
ALL-CATEGORY-SUMMARIES.mdmd706KBartifacts-database/ALL-CATEGORY-SUMMARIES.md
all-prompts.htmlhtml500KBveronika-health-db/public/all-prompts.html
all-prompts.htmlhtml500KBartifacts-database/all-prompts.html
77_2026-02-01_TMS_treatment_for_Veronika_s_FQAD.txttxt250KBartifacts-database/chat-transcripts/77_2026-02-01_TMS_treatment_for_Veronika_s_FQAD.txt
40_2025-12-03_.txttxt198KBartifacts-database/chat-transcripts/40_2025-12-03_.txt
86_2026-03-10_.txttxt143KBartifacts-database/chat-transcripts/86_2026-03-10_.txt
veronika-complete-site.htmlhtml131KBartifacts-database/compiled-docs/veronika-complete-site.html
index.htmlhtml128KBveronika-health-db/public/index.html
index-v0.htmlhtml108KBveronika-health-db/public/index-v0.html
01_2025-09-21_Insomnia_and_fluoroquinolone_toxicity.txttxt99KBartifacts-database/chat-transcripts/01_2025-09-21_Insomnia_and_fluoroquinolone_toxicity.txt
88_2026-03-11_posmotri_vse_chati_pro_veronik_.txttxt90KBartifacts-database/chat-transcripts/88_2026-03-11_posmotri_vse_chati_pro_veronik_.txt
76_2026-02-01_.txttxt80KBartifacts-database/chat-transcripts/76_2026-02-01_.txt
VERONIKA-MASTER-ANALYSIS-OPUS.mdmd67KBveronika-health-db/public/VERONIKA-MASTER-ANALYSIS-OPUS.md
VERONIKA-MASTER-ANALYSIS-OPUS.mdmd67KBartifacts-database/VERONIKA-MASTER-ANALYSIS-OPUS.md
83_2026-02-14_TMS_.txttxt60KBartifacts-database/chat-transcripts/83_2026-02-14_TMS_.txt
72_2026-01-18_Clonazepam_dosage_and_rumination_side_effects.txttxt58KBartifacts-database/chat-transcripts/72_2026-01-18_Clonazepam_dosage_and_rumination_side_effects.txt
summary-добавки.mdmd58KBveronika-health-db/public/summary-добавки.md
summary-добавки.mdmd58KBartifacts-database/summary-добавки.md
summary-терапия.mdmd56KBveronika-health-db/public/summary-терапия.md
summary-терапия.mdmd56KBartifacts-database/summary-терапия.md
veronika_research.htmlhtml56KBartifacts-database/compiled-docs/veronika_research.html
15.10_Veronikas Complete 90-Day Recovery Protocol Comprehensive Treatment Plan for Com.mdmd54KBartifacts-database/by-tag/документы/15.10_Veronikas Complete 90-Day Recovery Protocol Comprehensive Treatment Plan for Com.md
01_Veronikas Complete 90-Day Recovery Protocol Comprehensive Treatment Plan for Com.mdmd54KBartifacts-database/by-chat/15.10_e039aa18_90-day recovery protocol/01_Veronikas Complete 90-Day Recovery Protocol Comprehensive Treatment Plan for Com.md
39_2025-12-02_Finding_previous_parliament_conversation.txttxt54KBartifacts-database/chat-transcripts/39_2025-12-02_Finding_previous_parliament_conversation.txt
summary-бензо.mdmd53KBveronika-health-db/public/summary-бензо.md
summary-бензо.mdmd53KBartifacts-database/summary-бензо.md
summary-руминация.mdmd53KBveronika-health-db/public/summary-руминация.md
summary-руминация.mdmd53KBartifacts-database/summary-руминация.md
21.02_Литий оротат полное исследование для пациента с FQAD.mdmd50KBartifacts-database/by-tag/лекарства/21.02_Литий оротат полное исследование для пациента с FQAD.md
01_Литий оротат полное исследование для пациента с FQAD.mdmd50KBartifacts-database/by-chat/21.02_ba8f2ee4_Литий оротат (GSK-3β)/01_Литий оротат полное исследование для пациента с FQAD.md
VERONIKA-MASTER-ANALYSIS-PRO.mdmd50KBveronika-health-db/public/VERONIKA-MASTER-ANALYSIS-PRO.md
VERONIKA-MASTER-ANALYSIS-PRO.mdmd50KBartifacts-database/VERONIKA-MASTER-ANALYSIS-PRO.md
04.10_Comprehensive Treatment Plan for Fluoroquinolone Toxicity with Severe Iron Defic.mdmd48KBartifacts-database/by-tag/добавки/04.10_Comprehensive Treatment Plan for Fluoroquinolone Toxicity with Severe Iron Defic.md
01_Comprehensive Treatment Plan for Fluoroquinolone Toxicity with Severe Iron Defic.mdmd48KBartifacts-database/by-chat/04.10_799f0a4d_Comprehensive supplement plan/01_Comprehensive Treatment Plan for Fluoroquinolone Toxicity with Severe Iron Defic.md
19.02_Suppressed Guilt, Secret-Keeping, and the Architecture of Clinical Depression.mdmd45KBartifacts-database/by-tag/терапия/19.02_Suppressed Guilt, Secret-Keeping, and the Architecture of Clinical Depression.md
02_Suppressed Guilt, Secret-Keeping, and the Architecture of Clinical Depression.mdmd45KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/02_Suppressed Guilt, Secret-Keeping, and the Architecture of Clinical Depression.md
veronika_plan_v3.htmlhtml45KBartifacts-database/compiled-docs/veronika_plan_v3.html
VERONIKA-MASTER-ANALYSIS-GEMINI-3.1-PRO.mdmd43KBveronika-health-db/public/VERONIKA-MASTER-ANALYSIS-GEMINI-3.1-PRO.md
VERONIKA-MASTER-ANALYSIS-GEMINI-3.1-PRO.mdmd43KBartifacts-database/VERONIKA-MASTER-ANALYSIS-GEMINI-3.1-PRO.md
010_2025-10-01_IV_Iron_Infusion_Therapy_for_Severe_Iron_Deficiency_Anemia_.mdmd43KBartifacts-database/pre-extracted-artifacts/010_2025-10-01_IV_Iron_Infusion_Therapy_for_Severe_Iron_Deficiency_Anemia_.md
summary-кризисы.mdmd43KBveronika-health-db/public/summary-кризисы.md
summary-кризисы.mdmd43KBartifacts-database/summary-кризисы.md
023_2025-10-04_Comprehensive_Treatment_Plan_for_Medical_Crisis_Iron_Defici.mdmd42KBartifacts-database/pre-extracted-artifacts/023_2025-10-04_Comprehensive_Treatment_Plan_for_Medical_Crisis_Iron_Defici.md
04.10_Comprehensive Treatment Plan for Medical Crisis Iron Deficiency, Sleep Deprivati.mdmd42KBartifacts-database/by-tag/кризисы/04.10_Comprehensive Treatment Plan for Medical Crisis Iron Deficiency, Sleep Deprivati.md
01_Comprehensive Treatment Plan for Medical Crisis Iron Deficiency, Sleep Deprivati.mdmd42KBartifacts-database/by-chat/04.10_b70ca154_Insomnia plan — shes losing her mind/01_Comprehensive Treatment Plan for Medical Crisis Iron Deficiency, Sleep Deprivati.md
summary-клиники.mdmd42KBveronika-health-db/public/summary-клиники.md
summary-клиники.mdmd42KBartifacts-database/summary-клиники.md
013_2025-10-01_Alternative_Iron_Treatments_in_Geneva_Beyond_Ferinject_A_Co.mdmd41KBartifacts-database/pre-extracted-artifacts/013_2025-10-01_Alternative_Iron_Treatments_in_Geneva_Beyond_Ferinject_A_Co.md
09.10_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.mdmd41KBartifacts-database/by-tag/wellness/09.10_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.md
09.10_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.mdmd41KBartifacts-database/by-tag/добавки/09.10_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.md
01_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.mdmd41KBartifacts-database/by-chat/09.10_eab0a8d3_Natural energy boosting/01_Natural Energy-Boosting Protocol for Fluoroquinolone Toxicity and Severe Iron De.md
old-index.htmlhtml40KBveronika-health-db/public/old-index.html
index.htmlhtml40KBartifacts-database/index.html
121_2026-02-06_Post-Fluoroquinolone_Neuropsychiatric_Damage_Diagnostics_T.mdmd40KBartifacts-database/pre-extracted-artifacts/121_2026-02-06_Post-Fluoroquinolone_Neuropsychiatric_Damage_Diagnostics_T.md
07.02_Post-Fluoroquinolone Neuropsychiatric Damage Diagnostics, Treatments, and a Prac.mdmd40KBartifacts-database/by-tag/клиники/07.02_Post-Fluoroquinolone Neuropsychiatric Damage Diagnostics, Treatments, and a Prac.md
06_Post-Fluoroquinolone Neuropsychiatric Damage Diagnostics, Treatments, and a Prac.mdmd40KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/06_Post-Fluoroquinolone Neuropsychiatric Damage Diagnostics, Treatments, and a Prac.md
summary-анализы.mdmd40KBveronika-health-db/public/summary-анализы.md
summary-анализы.mdmd40KBartifacts-database/summary-анализы.md
04.10_PharmaGABA Supplement Safety Analysis High-Risk Profile for Patient with Complex.mdmd40KBartifacts-database/by-tag/добавки/04.10_PharmaGABA Supplement Safety Analysis High-Risk Profile for Patient with Complex.md
01_PharmaGABA Supplement Safety Analysis High-Risk Profile for Patient with Complex.mdmd40KBartifacts-database/by-chat/04.10_fe9c415e_GABA PharmaGABA research/01_PharmaGABA Supplement Safety Analysis High-Risk Profile for Patient with Complex.md
029_2025-10-21_Clonazepam_10-Day_Use_Comprehensive_Safety_Guide_and_Risk_A.mdmd39KBartifacts-database/pre-extracted-artifacts/029_2025-10-21_Clonazepam_10-Day_Use_Comprehensive_Safety_Guide_and_Risk_A.md
21.10_Clonazepam 10-Day Use Comprehensive Safety Guide and Risk Assessment.mdmd39KBartifacts-database/by-tag/бензо/21.10_Clonazepam 10-Day Use Comprehensive Safety Guide and Risk Assessment.md
01_Clonazepam 10-Day Use Comprehensive Safety Guide and Risk Assessment.mdmd39KBartifacts-database/by-chat/21.10_0ec2682d_Clonazepam 2 drops dependency/01_Clonazepam 10-Day Use Comprehensive Safety Guide and Risk Assessment.md
summary-FQAD.mdmd39KBveronika-health-db/public/summary-FQAD.md
summary-FQAD.mdmd39KBartifacts-database/summary-FQAD.md
veronika_full_plan.htmlhtml39KBartifacts-database/compiled-docs/veronika_full_plan.html
veronika-catalog.htmlhtml38KBartifacts-database/compiled-docs/veronika-catalog.html
summary-лекарства.mdmd38KBveronika-health-db/public/summary-лекарства.md
summary-лекарства.mdmd38KBartifacts-database/summary-лекарства.md
summary-wellness.mdmd38KBveronika-health-db/public/summary-wellness.md
summary-wellness.mdmd38KBartifacts-database/summary-wellness.md
summary-печень.mdmd37KBveronika-health-db/public/summary-печень.md
summary-печень.mdmd37KBartifacts-database/summary-печень.md
summary-гормоны.mdmd37KBveronika-health-db/public/summary-гормоны.md
summary-гормоны.mdmd37KBartifacts-database/summary-гормоны.md
60_2026-01-12_.txttxt37KBartifacts-database/chat-transcripts/60_2026-01-12_.txt
67_2026-01-14_.txttxt37KBartifacts-database/chat-transcripts/67_2026-01-14_.txt
23.02_FQAD Medical Compendium Iron, Hormones, Brain Recovery and Treatment Protocol.mdmd36KBartifacts-database/by-tag/документы/23.02_FQAD Medical Compendium Iron, Hormones, Brain Recovery and Treatment Protocol.md
01_FQAD Medical Compendium Iron, Hormones, Brain Recovery and Treatment Protocol.mdmd36KBartifacts-database/by-chat/23.02_a2923288_Fact-checking continued/01_FQAD Medical Compendium Iron, Hormones, Brain Recovery and Treatment Protocol.md
summary-врачи.mdmd36KBveronika-health-db/public/summary-врачи.md
summary-врачи.mdmd36KBartifacts-database/summary-врачи.md
22.01_The Complete Evidence-Based Wellness Catalog What Actually Works.mdmd36KBartifacts-database/by-tag/wellness/22.01_The Complete Evidence-Based Wellness Catalog What Actually Works.md
03_The Complete Evidence-Based Wellness Catalog What Actually Works.mdmd36KBartifacts-database/by-chat/22.01_b85c581d_30-дневный план детокса/03_The Complete Evidence-Based Wellness Catalog What Actually Works.md
015_2025-10-01_The_Insomnia_Treatment_Paradox_Why_Your_Current_Combination.mdmd36KBartifacts-database/pre-extracted-artifacts/015_2025-10-01_The_Insomnia_Treatment_Paradox_Why_Your_Current_Combination.md
01.10_The Insomnia Treatment Paradox Why Your Current Combination May Be Suboptimal.mdmd36KBartifacts-database/by-tag/лекарства/01.10_The Insomnia Treatment Paradox Why Your Current Combination May Be Suboptimal.md
01_The Insomnia Treatment Paradox Why Your Current Combination May Be Suboptimal.mdmd36KBartifacts-database/by-chat/01.10_bbc8f3f2_Cipralex morning Trittico evening/01_The Insomnia Treatment Paradox Why Your Current Combination May Be Suboptimal.md
26.01_Топовые медицинские клиники с комплексным лечением и русскоязычным сервисом.mdmd36KBartifacts-database/by-tag/клиники/26.01_Топовые медицинские клиники с комплексным лечением и русскоязычным сервисом.md
01_Топовые медицинские клиники с комплексным лечением и русскоязычным сервисом.mdmd36KBartifacts-database/by-chat/26.01_4a0572eb_Клиника мировой поиск (SHA, Израиль)/01_Топовые медицинские клиники с комплексным лечением и русскоязычным сервисом.md
VERONIKA-MASTER-ANALYSIS.mdmd36KBveronika-health-db/public/VERONIKA-MASTER-ANALYSIS.md
VERONIKA-MASTER-ANALYSIS.mdmd36KBartifacts-database/VERONIKA-MASTER-ANALYSIS.md
summary-документы.mdmd35KBveronika-health-db/public/summary-документы.md
summary-документы.mdmd35KBartifacts-database/summary-документы.md
07-chat-index.htmlhtml35KBartifacts-database/compiled-docs/07-chat-index.html
summary-TMS.mdmd35KBveronika-health-db/public/summary-TMS.md
summary-TMS.mdmd35KBartifacts-database/summary-TMS.md
028_2025-10-18_Navigating_Cipralex_and_Critically_Low_Hormones_A_Comprehen.mdmd34KBartifacts-database/pre-extracted-artifacts/028_2025-10-18_Navigating_Cipralex_and_Critically_Low_Hormones_A_Comprehen.md
18.10_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.mdmd34KBartifacts-database/by-tag/гормоны/18.10_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.md
18.10_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.mdmd34KBartifacts-database/by-tag/лекарства/18.10_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.md
01_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.mdmd34KBartifacts-database/by-chat/18.10_d6fbc8d3_Cipralex hormones PSSD/01_Navigating Cipralex and Critically Low Hormones A Comprehensive Guide for Couple.md
03.01_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.mdmd34KBartifacts-database/by-tag/бензо/03.01_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.md
03.01_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.mdmd34KBartifacts-database/by-tag/wellness/03.01_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.md
02_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.mdmd34KBartifacts-database/by-chat/03.01_a8d01711_План снижения клоназепама/02_Supportive Therapies During Benzodiazepine Withdrawal with FQAD A Practical Prot.md
08-all-chats-index-v3.htmlhtml33KBartifacts-database/compiled-docs/08-all-chats-index-v3.html
81_2026-02-06_.txttxt33KBartifacts-database/chat-transcripts/81_2026-02-06_.txt
49_2025-12-26_.txttxt33KBartifacts-database/chat-transcripts/49_2025-12-26_.txt
027_2025-10-16_Why_Morning_Anxiety_Disappears_by_Midday_A_Physiological_In.mdmd33KBartifacts-database/pre-extracted-artifacts/027_2025-10-16_Why_Morning_Anxiety_Disappears_by_Midday_A_Physiological_In.md
16.10_Why Morning Anxiety Disappears by Midday A Physiological Investigation.mdmd33KBartifacts-database/by-tag/анализы/16.10_Why Morning Anxiety Disappears by Midday A Physiological Investigation.md
01_Why Morning Anxiety Disappears by Midday A Physiological Investigation.mdmd33KBartifacts-database/by-chat/16.10_f65cec3d_Morning anxiety (cortisolestradiol)/01_Why Morning Anxiety Disappears by Midday A Physiological Investigation.md
summary-железо.mdmd33KBveronika-health-db/public/summary-железо.md
summary-железо.mdmd33KBartifacts-database/summary-железо.md
05.10_Hydroxyzine for Complex Medical Conditions Critical Safety Analysis for Veronika.mdmd32KBartifacts-database/by-tag/лекарства/05.10_Hydroxyzine for Complex Medical Conditions Critical Safety Analysis for Veronika.md
02_Hydroxyzine for Complex Medical Conditions Critical Safety Analysis for Veronika.mdmd32KBartifacts-database/by-chat/05.10_2cad00b0_Cipralex safety for Veronika/02_Hydroxyzine for Complex Medical Conditions Critical Safety Analysis for Veronika.md
27.01_Personal Stories Low Ferritin and Depression from Patient Communities.mdmd31KBartifacts-database/by-tag/гормоны/27.01_Personal Stories Low Ferritin and Depression from Patient Communities.md
27.01_Personal Stories Low Ferritin and Depression from Patient Communities.mdmd31KBartifacts-database/by-tag/железо/27.01_Personal Stories Low Ferritin and Depression from Patient Communities.md
14_Personal Stories Low Ferritin and Depression from Patient Communities.mdmd31KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/14_Personal Stories Low Ferritin and Depression from Patient Communities.md
131_2026-03-11_Veronika_FQAD_Treatment_Plan_Biological_Restoration_and_Tar.mdmd31KBartifacts-database/pre-extracted-artifacts/131_2026-03-11_Veronika_FQAD_Treatment_Plan_Biological_Restoration_and_Tar.md
14.03_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.mdmd31KBartifacts-database/by-tag/клиники/14.03_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.md
14.03_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.mdmd31KBartifacts-database/by-tag/документы/14.03_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.md
01_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.mdmd31KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/01_Veronika FQAD Treatment Plan Biological Restoration and Targeted Intervention St.md
008_2025-09-30_Trazodone_Tolerability_in_Adults_Over_30_Statistical_Eviden.mdmd31KBartifacts-database/pre-extracted-artifacts/008_2025-09-30_Trazodone_Tolerability_in_Adults_Over_30_Statistical_Eviden.md
30.09_Trazodone Tolerability in Adults Over 30 Statistical Evidence and Age-Specific R.mdmd31KBartifacts-database/by-tag/лекарства/30.09_Trazodone Tolerability in Adults Over 30 Statistical Evidence and Age-Specific R.md
02_Trazodone Tolerability in Adults Over 30 Statistical Evidence and Age-Specific R.mdmd31KBartifacts-database/by-chat/30.09_e3364ec3_Trazodone paradoxical depression/02_Trazodone Tolerability in Adults Over 30 Statistical Evidence and Age-Specific R.md
68_2026-01-14_.txttxt31KBartifacts-database/chat-transcripts/68_2026-01-14_.txt
16.01_Iron Deficiency and FQAD Scientific Basis for Neurological Recovery.mdmd31KBartifacts-database/by-tag/лекарства/16.01_Iron Deficiency and FQAD Scientific Basis for Neurological Recovery.md
01_Iron Deficiency and FQAD Scientific Basis for Neurological Recovery.mdmd31KBartifacts-database/by-chat/16.01_ded19d55_Вакцинация и совместимость препаратов/01_Iron Deficiency and FQAD Scientific Basis for Neurological Recovery.md
130_2026-03-11_Triple-Deficiency_Treatment_Plan_for_FQAD_with_Iron_Estroge.mdmd31KBartifacts-database/pre-extracted-artifacts/130_2026-03-11_Triple-Deficiency_Treatment_Plan_for_FQAD_with_Iron_Estroge.md
11.03_Triple-Deficiency Treatment Plan for FQAD with Iron, Estrogen, and GABA System D.mdmd31KBartifacts-database/by-tag/документы/11.03_Triple-Deficiency Treatment Plan for FQAD with Iron, Estrogen, and GABA System D.md
01_Triple-Deficiency Treatment Plan for FQAD with Iron, Estrogen, and GABA System D.mdmd31KBartifacts-database/by-chat/11.03_2cbc9ef9_Triple-deficiency dive reflex/01_Triple-Deficiency Treatment Plan for FQAD with Iron, Estrogen, and GABA System D.md
133_2026-03-11_When_Every_Medication_Has_Been_a_Catastrophe_Pharmacogenomi.mdmd31KBartifacts-database/pre-extracted-artifacts/133_2026-03-11_When_Every_Medication_Has_Been_a_Catastrophe_Pharmacogenomi.md
14.03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.mdmd31KBartifacts-database/by-tag/клиники/14.03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.md
14.03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.mdmd31KBartifacts-database/by-tag/документы/14.03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.md
03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.mdmd31KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/03_When Every Medication Has Been a Catastrophe Pharmacogenomics, Fluvoxamine, and.md
05-research.mdmd30KBartifacts-database/compiled-docs/05-research.md
deep-analysis.htmlhtml30KBveronika-health-db/public/deep-analysis.html
05.10_Cipralex Safety Assessment for Fluoroquinolone Toxicity and Iron Deficiency Crit.mdmd29KBartifacts-database/by-tag/лекарства/05.10_Cipralex Safety Assessment for Fluoroquinolone Toxicity and Iron Deficiency Crit.md
01_Cipralex Safety Assessment for Fluoroquinolone Toxicity and Iron Deficiency Crit.mdmd29KBartifacts-database/by-chat/05.10_2cad00b0_Cipralex safety for Veronika/01_Cipralex Safety Assessment for Fluoroquinolone Toxicity and Iron Deficiency Crit.md
034_2025-12-03_.mdmd29KBartifacts-database/pre-extracted-artifacts/034_2025-12-03_.md
009_2025-10-01_Sleep-Onset_Abdominal_Tension_A_Hyperarousal_Disorder_with_.mdmd29KBartifacts-database/pre-extracted-artifacts/009_2025-10-01_Sleep-Onset_Abdominal_Tension_A_Hyperarousal_Disorder_with_.md
01.10_Sleep-Onset Abdominal Tension A Hyperarousal Disorder with Proven Treatments.mdmd29KBartifacts-database/by-tag/кризисы/01.10_Sleep-Onset Abdominal Tension A Hyperarousal Disorder with Proven Treatments.md
01_Sleep-Onset Abdominal Tension A Hyperarousal Disorder with Proven Treatments.mdmd29KBartifacts-database/by-chat/01.10_13763e4a_Sleep — belly squeezing, hyperarousal/01_Sleep-Onset Abdominal Tension A Hyperarousal Disorder with Proven Treatments.md
80_2026-02-05_.txttxt29KBartifacts-database/chat-transcripts/80_2026-02-05_.txt
117_2026-02-06_Global_Psychiatric_Residential_Clinics_for_Depression_and_Ps.mdmd29KBartifacts-database/pre-extracted-artifacts/117_2026-02-06_Global_Psychiatric_Residential_Clinics_for_Depression_and_Ps.md
07.02_Global Psychiatric Residential Clinics for Depression and Psychosomatic Treatmen.mdmd29KBartifacts-database/by-tag/клиники/07.02_Global Psychiatric Residential Clinics for Depression and Psychosomatic Treatmen.md
02_Global Psychiatric Residential Clinics for Depression and Psychosomatic Treatmen.mdmd29KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/02_Global Psychiatric Residential Clinics for Depression and Psychosomatic Treatmen.md
123_2026-03-08_Asian_Medical_Options_for_FQAD_with_GABA_Damage_Multi-Syste.mdmd29KBartifacts-database/pre-extracted-artifacts/123_2026-03-08_Asian_Medical_Options_for_FQAD_with_GABA_Damage_Multi-Syste.md
74_2026-01-21_TMS_.txttxt28KBartifacts-database/chat-transcripts/74_2026-01-21_TMS_.txt
07.10_LipoCalm Ingredient Analysis Scientific Evidence Review for Sleep and Relaxation.mdmd28KBartifacts-database/by-tag/добавки/07.10_LipoCalm Ingredient Analysis Scientific Evidence Review for Sleep and Relaxation.md
01_LipoCalm Ingredient Analysis Scientific Evidence Review for Sleep and Relaxation.mdmd28KBartifacts-database/by-chat/07.10_9bde6035_Lipocalm ingredient verification/01_LipoCalm Ingredient Analysis Scientific Evidence Review for Sleep and Relaxation.md
024_2025-10-04_Critical_Mental_Health_Risks_in_Triple-Condition_Crisis_Ins.mdmd28KBartifacts-database/pre-extracted-artifacts/024_2025-10-04_Critical_Mental_Health_Risks_in_Triple-Condition_Crisis_Ins.md
04.10_Critical Mental Health Risks in Triple-Condition Crisis Insomnia, Iron Deficienc.mdmd28KBartifacts-database/by-tag/кризисы/04.10_Critical Mental Health Risks in Triple-Condition Crisis Insomnia, Iron Deficienc.md
01_Critical Mental Health Risks in Triple-Condition Crisis Insomnia, Iron Deficienc.mdmd28KBartifacts-database/by-chat/04.10_c029be7a_Mental health crisis — can she become loco/01_Critical Mental Health Risks in Triple-Condition Crisis Insomnia, Iron Deficienc.md
033_2025-12-03_.mdmd28KBartifacts-database/pre-extracted-artifacts/033_2025-12-03_.md
06.12_The Complete Plant-Based 30-Day Detox Reset Evidence-Based Guide for Beginners.mdmd28KBartifacts-database/by-tag/wellness/06.12_The Complete Plant-Based 30-Day Detox Reset Evidence-Based Guide for Beginners.md
01_The Complete Plant-Based 30-Day Detox Reset Evidence-Based Guide for Beginners.mdmd28KBartifacts-database/by-chat/06.12_39b4d8e5_30-day plant-based detox plan/01_The Complete Plant-Based 30-Day Detox Reset Evidence-Based Guide for Beginners.md
20.02_Beyond Flumazenil PET Comprehensive Methods to Assess GABA-A Receptor Function i.mdmd28KBartifacts-database/by-tag/анализы/20.02_Beyond Flumazenil PET Comprehensive Methods to Assess GABA-A Receptor Function i.md
07_Beyond Flumazenil PET Comprehensive Methods to Assess GABA-A Receptor Function i.mdmd28KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/07_Beyond Flumazenil PET Comprehensive Methods to Assess GABA-A Receptor Function i.md
017_2025-10-02_Best_Medications_for_Anxiety_and_Panic_with_Minimal_Side_Eff.mdmd28KBartifacts-database/pre-extracted-artifacts/017_2025-10-02_Best_Medications_for_Anxiety_and_Panic_with_Minimal_Side_Eff.md
71_2026-01-17_.txttxt28KBartifacts-database/chat-transcripts/71_2026-01-17_.txt
08-all-chats-index-v2.htmlhtml27KBartifacts-database/compiled-docs/08-all-chats-index-v2.html
126_2026-03-10_Lateral_Pathways_to_FQAD_Treatment_A_Specialist_and_Clinic_.mdmd27KBartifacts-database/pre-extracted-artifacts/126_2026-03-10_Lateral_Pathways_to_FQAD_Treatment_A_Specialist_and_Clinic_.md
16.03_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.mdmd27KBartifacts-database/by-tag/врачи/16.03_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.md
16.03_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.mdmd27KBartifacts-database/by-tag/документы/16.03_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.md
02_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.mdmd27KBartifacts-database/by-chat/16.03_b76e8115_Müller strategic plan v3/02_Lateral Pathways to FQAD Treatment A Specialist and Clinic Guide.md
15.10_Comprehensive Crisis Action Plan Medication Failures and Root Cause Treatment fo.mdmd27KBartifacts-database/by-tag/кризисы/15.10_Comprehensive Crisis Action Plan Medication Failures and Root Cause Treatment fo.md
01_Comprehensive Crisis Action Plan Medication Failures and Root Cause Treatment fo.mdmd27KBartifacts-database/by-chat/15.10_4b5569da_Atarax crisis — I dont know what to do/01_Comprehensive Crisis Action Plan Medication Failures and Root Cause Treatment fo.md
53_2026-01-05_Natural_alternatives_to_benzodiazepines.txttxt27KBartifacts-database/chat-transcripts/53_2026-01-05_Natural_alternatives_to_benzodiazepines.txt
23.02_Biological Reset FQAD Treatment Document Scientific Fact-Check and Safety Analys.mdmd27KBartifacts-database/by-tag/документы/23.02_Biological Reset FQAD Treatment Document Scientific Fact-Check and Safety Analys.md
01_Biological Reset FQAD Treatment Document Scientific Fact-Check and Safety Analys.mdmd27KBartifacts-database/by-chat/23.02_89c15082_Fact-checking iron-estrogen/01_Biological Reset FQAD Treatment Document Scientific Fact-Check and Safety Analys.md
021_2025-10-04_Trazodone_Safety_in_Fluoroquinolone_Toxicity_and_Severe_Iron.mdmd26KBartifacts-database/pre-extracted-artifacts/021_2025-10-04_Trazodone_Safety_in_Fluoroquinolone_Toxicity_and_Severe_Iron.md
04.10_Trazodone Safety in Fluoroquinolone Toxicity and Severe Iron Deficiency Critical.mdmd26KBartifacts-database/by-tag/лекарства/04.10_Trazodone Safety in Fluoroquinolone Toxicity and Severe Iron Deficiency Critical.md
01_Trazodone Safety in Fluoroquinolone Toxicity and Severe Iron Deficiency Critical.mdmd26KBartifacts-database/by-chat/04.10_95f32ff1_Trazodone worst case/01_Trazodone Safety in Fluoroquinolone Toxicity and Severe Iron Deficiency Critical.md
04.10_Trazodone and Treatment-Resistant Insomnia Addressing Iron Deficiency and Fluoro.mdmd26KBartifacts-database/by-tag/лекарства/04.10_Trazodone and Treatment-Resistant Insomnia Addressing Iron Deficiency and Fluoro.md
01_Trazodone and Treatment-Resistant Insomnia Addressing Iron Deficiency and Fluoro.mdmd26KBartifacts-database/by-chat/04.10_9f5d4a8e_Trazodone cumulative/01_Trazodone and Treatment-Resistant Insomnia Addressing Iron Deficiency and Fluoro.md
041_2025-12-06_Optimal_IV_Iron_Treatment_for_Veronika_Monoferric_Emerges_a.mdmd26KBartifacts-database/pre-extracted-artifacts/041_2025-12-06_Optimal_IV_Iron_Treatment_for_Veronika_Monoferric_Emerges_a.md
06.12_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.mdmd26KBartifacts-database/by-tag/клиники/06.12_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.md
06.12_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.mdmd26KBartifacts-database/by-tag/железо/06.12_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.md
01_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.mdmd26KBartifacts-database/by-chat/06.12_cd3151de_IV iron Germany Monoferric/01_Optimal IV Iron Treatment for Veronika Monoferric Emerges as the Safest Choice.md
30.12_Альтернативы бензодиазепинам при FQAD комплексное руководство.mdmd26KBartifacts-database/by-tag/кризисы/30.12_Альтернативы бензодиазепинам при FQAD комплексное руководство.md
30.12_Альтернативы бензодиазепинам при FQAD комплексное руководство.mdmd26KBartifacts-database/by-tag/лекарства/30.12_Альтернативы бензодиазепинам при FQAD комплексное руководство.md
02_Альтернативы бензодиазепинам при FQAD комплексное руководство.mdmd26KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/02_Альтернативы бензодиазепинам при FQAD комплексное руководство.md
06.10_Scientific Evidence on Spiritual and Energy Healing What the Research Actually S.mdmd26KBartifacts-database/by-tag/терапия/06.10_Scientific Evidence on Spiritual and Energy Healing What the Research Actually S.md
02_Scientific Evidence on Spiritual and Energy Healing What the Research Actually S.mdmd26KBartifacts-database/by-chat/06.10_c785fe1e_Healing through cosmic energy/02_Scientific Evidence on Spiritual and Energy Healing What the Research Actually S.md
08-all-chats-index.htmlhtml26KBartifacts-database/compiled-docs/08-all-chats-index.html
07.10_LipoCalm Safety Profile Real-World Risks and Adverse Effects.mdmd26KBartifacts-database/by-tag/добавки/07.10_LipoCalm Safety Profile Real-World Risks and Adverse Effects.md
02_LipoCalm Safety Profile Real-World Risks and Adverse Effects.mdmd26KBartifacts-database/by-chat/07.10_9bde6035_Lipocalm ingredient verification/02_LipoCalm Safety Profile Real-World Risks and Adverse Effects.md
deep-analysis.htmlhtml25KBartifacts-database/deep-analysis.html
04.10_IV Iron Formulations for Severe Iron Deficiency with Fluoroquinolone Toxicity Co.mdmd25KBartifacts-database/by-tag/железо/04.10_IV Iron Formulations for Severe Iron Deficiency with Fluoroquinolone Toxicity Co.md
02_IV Iron Formulations for Severe Iron Deficiency with Fluoroquinolone Toxicity Co.mdmd25KBartifacts-database/by-chat/04.10_12d66b7c_Liposomal iron research/02_IV Iron Formulations for Severe Iron Deficiency with Fluoroquinolone Toxicity Co.md
006_2025-09-26_Fluoroquinolone_Exposure_and_Subsequent_Benzodiazepine_Use_P.mdmd25KBartifacts-database/pre-extracted-artifacts/006_2025-09-26_Fluoroquinolone_Exposure_and_Subsequent_Benzodiazepine_Use_P.md
26.09_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.mdmd25KBartifacts-database/by-tag/бензо/26.09_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.md
26.09_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.mdmd25KBartifacts-database/by-tag/FQAD/26.09_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.md
02_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.mdmd25KBartifacts-database/by-chat/26.09_f64951c6_FQ benzodiazepine interaction/02_Fluoroquinolone Exposure and Subsequent Benzodiazepine Use Presents Serious, Und.md
116_2026-02-06_Psychiatric_Residential_Clinics_for_Russian-Speaking_Patient.mdmd25KBartifacts-database/pre-extracted-artifacts/116_2026-02-06_Psychiatric_Residential_Clinics_for_Russian-Speaking_Patient.md
07.02_Psychiatric Residential Clinics for Russian-Speaking Patients Across Europe and.mdmd25KBartifacts-database/by-tag/клиники/07.02_Psychiatric Residential Clinics for Russian-Speaking Patients Across Europe and.md
01_Psychiatric Residential Clinics for Russian-Speaking Patients Across Europe and.mdmd25KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/01_Psychiatric Residential Clinics for Russian-Speaking Patients Across Europe and.md
078_2026-01-17_The_Iron-Estrogen-Brain_Axis_A_Unified_Model_for_Treatment-.mdmd25KBartifacts-database/pre-extracted-artifacts/078_2026-01-17_The_Iron-Estrogen-Brain_Axis_A_Unified_Model_for_Treatment-.md
17.01_The Iron-Estrogen-Brain Axis A Unified Model for Treatment-Resistant Depression.mdmd25KBartifacts-database/by-tag/железо/17.01_The Iron-Estrogen-Brain Axis A Unified Model for Treatment-Resistant Depression.md
02_The Iron-Estrogen-Brain Axis A Unified Model for Treatment-Resistant Depression.mdmd25KBartifacts-database/by-chat/17.01_7b5f1fe3_Глубокий анализ ферритина/02_The Iron-Estrogen-Brain Axis A Unified Model for Treatment-Resistant Depression.md
06.10_Investigating Healers Distinguishing Legitimate Traditional Medicine from Faith.mdmd25KBartifacts-database/by-tag/терапия/06.10_Investigating Healers Distinguishing Legitimate Traditional Medicine from Faith.md
01_Investigating Healers Distinguishing Legitimate Traditional Medicine from Faith.mdmd25KBartifacts-database/by-chat/06.10_d1ddd14f_Energy healing origins (Dr Weil)/01_Investigating Healers Distinguishing Legitimate Traditional Medicine from Faith.md
21.12_Evidence-Based Treatment Options for Fluoroquinolone Toxicity Recovery.mdmd25KBartifacts-database/by-tag/wellness/21.12_Evidence-Based Treatment Options for Fluoroquinolone Toxicity Recovery.md
02_Evidence-Based Treatment Options for Fluoroquinolone Toxicity Recovery.mdmd25KBartifacts-database/by-chat/21.12_bbf082cf_Evidence-based wellness (HBOT)/02_Evidence-Based Treatment Options for Fluoroquinolone Toxicity Recovery.md
10.02_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.mdmd25KBartifacts-database/by-tag/TMS/10.02_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.md
10.02_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.mdmd25KBartifacts-database/by-tag/клиники/10.02_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.md
03_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.mdmd25KBartifacts-database/by-chat/10.02_e35d07ff_Oberberg TMS centers worldwide/03_Every Oberberg-Like Psychiatric Clinic in Europe Private Inpatient Psychiatry wi.md
21.02_Methylene Blue 150 Years of Promise, Paradox, and Unresolved Potential.mdmd25KBartifacts-database/by-tag/добавки/21.02_Methylene Blue 150 Years of Promise, Paradox, and Unresolved Potential.md
05_Methylene Blue 150 Years of Promise, Paradox, and Unresolved Potential.mdmd25KBartifacts-database/by-chat/21.02_e520b05b_Methylene blue mitochondria/05_Methylene Blue 150 Years of Promise, Paradox, and Unresolved Potential.md
02-medications.mdmd25KBartifacts-database/compiled-docs/02-medications.md
124_2026-03-08_Advanced_Neuropsychiatric_Treatment_Centers_Across_Asia_for_.mdmd24KBartifacts-database/pre-extracted-artifacts/124_2026-03-08_Advanced_Neuropsychiatric_Treatment_Centers_Across_Asia_for_.md
26.01_Long-Term Rehabilitation Centers with Russian-Language Services Comprehensive Re.mdmd24KBartifacts-database/by-tag/клиники/26.01_Long-Term Rehabilitation Centers with Russian-Language Services Comprehensive Re.md
02_Long-Term Rehabilitation Centers with Russian-Language Services Comprehensive Re.mdmd24KBartifacts-database/by-chat/26.01_4a0572eb_Клиника мировой поиск (SHA, Израиль)/02_Long-Term Rehabilitation Centers with Russian-Language Services Comprehensive Re.md
19.12_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.mdmd24KBartifacts-database/by-tag/FQAD/19.12_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.md
19.12_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.mdmd24KBartifacts-database/by-tag/врачи/19.12_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.md
01_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.mdmd24KBartifacts-database/by-chat/19.12_3fc5edd6_Анализ программы Pieper/01_Comprehensive Treatment Guide for Fluoroquinolone Toxicity Recovery.md
04.02_The Complete Guide to Breaking Free from Cognitive Rumination.mdmd24KBartifacts-database/by-tag/руминация/04.02_The Complete Guide to Breaking Free from Cognitive Rumination.md
01_The Complete Guide to Breaking Free from Cognitive Rumination.mdmd24KBartifacts-database/by-chat/04.02_a348e9f4_Руминация голодание/01_The Complete Guide to Breaking Free from Cognitive Rumination.md
06.10_Healing Through Cosmic Power A Universal Story Across Cultures.mdmd24KBartifacts-database/by-tag/терапия/06.10_Healing Through Cosmic Power A Universal Story Across Cultures.md
01_Healing Through Cosmic Power A Universal Story Across Cultures.mdmd24KBartifacts-database/by-chat/06.10_c785fe1e_Healing through cosmic energy/01_Healing Through Cosmic Power A Universal Story Across Cultures.md
01-timeline-v3.mdmd24KBartifacts-database/compiled-docs/01-timeline-v3.md
summary-CUN.mdmd24KBveronika-health-db/public/summary-CUN.md
summary-CUN.mdmd24KBartifacts-database/summary-CUN.md
21.02_Methylene Blue as an Antidepressant A Uniquely Rational Option for FQAD.mdmd24KBartifacts-database/by-tag/добавки/21.02_Methylene Blue as an Antidepressant A Uniquely Rational Option for FQAD.md
03_Methylene Blue as an Antidepressant A Uniquely Rational Option for FQAD.mdmd24KBartifacts-database/by-chat/21.02_e520b05b_Methylene blue mitochondria/03_Methylene Blue as an Antidepressant A Uniquely Rational Option for FQAD.md
84_2026-02-21_Nicotine_patches_and_treatment_protocol_assessment.txttxt24KBartifacts-database/chat-transcripts/84_2026-02-21_Nicotine_patches_and_treatment_protocol_assessment.txt
082_2026-01-18_Veronika_s_Triple-Hit_Crisis_A_Complete_Treatment_Roadmap_f.mdmd24KBartifacts-database/pre-extracted-artifacts/082_2026-01-18_Veronika_s_Triple-Hit_Crisis_A_Complete_Treatment_Roadmap_f.md
19.01_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.mdmd24KBartifacts-database/by-tag/бензо/19.01_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.md
19.01_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.mdmd24KBartifacts-database/by-tag/руминация/19.01_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.md
03_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.mdmd24KBartifacts-database/by-chat/19.01_f67d5678_Clonazepam rumination/03_Veronikas Triple-Hit Crisis A Complete Treatment Roadmap for FQAD, Kindling, and.md
06.10_Severe Iron Deficiency Drives Rumination Through Neurotransmitter Collapse.mdmd24KBartifacts-database/by-tag/железо/06.10_Severe Iron Deficiency Drives Rumination Through Neurotransmitter Collapse.md
01_Severe Iron Deficiency Drives Rumination Through Neurotransmitter Collapse.mdmd24KBartifacts-database/by-chat/06.10_0eb1cb19_Iron supplementation summary/01_Severe Iron Deficiency Drives Rumination Through Neurotransmitter Collapse.md
04-doctors-clinics.mdmd23KBartifacts-database/compiled-docs/04-doctors-clinics.md
138_2026-03-11_Private_Psychiatric_Inpatient_Clinics_Across_Asia_for_Depres.mdmd23KBartifacts-database/pre-extracted-artifacts/138_2026-03-11_Private_Psychiatric_Inpatient_Clinics_Across_Asia_for_Depres.md
14.03_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.mdmd23KBartifacts-database/by-tag/клиники/14.03_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.md
14.03_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.mdmd23KBartifacts-database/by-tag/документы/14.03_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.md
08_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.mdmd23KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/08_Private Psychiatric Inpatient Clinics Across Asia for Depression Treatment Facil.md
26.01_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.mdmd23KBartifacts-database/by-tag/гормоны/26.01_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.md
26.01_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.mdmd23KBartifacts-database/by-tag/врачи/26.01_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.md
02_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.mdmd23KBartifacts-database/by-chat/26.01_f89e1470_Finding functional gynecologist/02_Functional and Integrative Gynecologists Across Europe for Complex FQAD Cases.md
098_2026-02-01_Emergency_Protocols_for_TMS_Treatment_in_Complex_FQAD_Patien.mdmd23KBartifacts-database/pre-extracted-artifacts/098_2026-02-01_Emergency_Protocols_for_TMS_Treatment_in_Complex_FQAD_Patien.md
05.02_Emergency Protocols for TMS Treatment in Complex FQAD Patient with Paradoxical D.mdmd23KBartifacts-database/by-tag/TMS/05.02_Emergency Protocols for TMS Treatment in Complex FQAD Patient with Paradoxical D.md
03_Emergency Protocols for TMS Treatment in Complex FQAD Patient with Paradoxical D.mdmd23KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/03_Emergency Protocols for TMS Treatment in Complex FQAD Patient with Paradoxical D.md
69_2026-01-16_.txttxt23KBartifacts-database/chat-transcripts/69_2026-01-16_.txt
28_2025-10-08_Veronika_s_medication_research.txttxt23KBartifacts-database/chat-transcripts/28_2025-10-08_Veronika_s_medication_research.txt
22.02_Global Integrative Healing Centers for FQAD Recovery A Strategic Analysis of Tre.mdmd23KBartifacts-database/by-tag/клиники/22.02_Global Integrative Healing Centers for FQAD Recovery A Strategic Analysis of Tre.md
01_Global Integrative Healing Centers for FQAD Recovery A Strategic Analysis of Tre.mdmd23KBartifacts-database/by-chat/22.02_4df1ce6f_Detox mitochondria centers/01_Global Integrative Healing Centers for FQAD Recovery A Strategic Analysis of Tre.md
022_2025-10-04_Trazodone_100mg_Daily_No_Cumulative_Buildup_Over_Two_Weeks_.mdmd23KBartifacts-database/pre-extracted-artifacts/022_2025-10-04_Trazodone_100mg_Daily_No_Cumulative_Buildup_Over_Two_Weeks_.md
08.10_Glutathione Safety Assessment Critical Concerns for Veronikas Profile.mdmd23KBartifacts-database/by-tag/добавки/08.10_Glutathione Safety Assessment Critical Concerns for Veronikas Profile.md
04.10_Trazodone 100mg Daily No Cumulative Buildup Over Two Weeks of Continuous Use.mdmd23KBartifacts-database/by-tag/лекарства/04.10_Trazodone 100mg Daily No Cumulative Buildup Over Two Weeks of Continuous Use.md
02_Trazodone 100mg Daily No Cumulative Buildup Over Two Weeks of Continuous Use.mdmd23KBartifacts-database/by-chat/04.10_95f32ff1_Trazodone worst case/02_Trazodone 100mg Daily No Cumulative Buildup Over Two Weeks of Continuous Use.md
01_Glutathione Safety Assessment Critical Concerns for Veronikas Profile.mdmd23KBartifacts-database/by-chat/08.10_6e260a52_Liposomal glutathione risks/01_Glutathione Safety Assessment Critical Concerns for Veronikas Profile.md
091_2026-02-01_Rumination_Neurobiology_Treatment_Landscape_and_Clinical_.mdmd23KBartifacts-database/pre-extracted-artifacts/091_2026-02-01_Rumination_Neurobiology_Treatment_Landscape_and_Clinical_.md
01.02_Rumination Neurobiology, Treatment Landscape, and Clinical Decision-Making.mdmd23KBartifacts-database/by-tag/бензо/01.02_Rumination Neurobiology, Treatment Landscape, and Clinical Decision-Making.md
02_Rumination Neurobiology, Treatment Landscape, and Clinical Decision-Making.mdmd23KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/02_Rumination Neurobiology, Treatment Landscape, and Clinical Decision-Making.md
077_2026-01-17_Iron_Deficiency_at_Ferritin_9.98_ng_mL_Explains_Psychiatric_.mdmd22KBartifacts-database/pre-extracted-artifacts/077_2026-01-17_Iron_Deficiency_at_Ferritin_9.98_ng_mL_Explains_Psychiatric_.md
17.01_Iron Deficiency at Ferritin 9.98 ngmL Explains Psychiatric Symptoms Through Impa.mdmd22KBartifacts-database/by-tag/железо/17.01_Iron Deficiency at Ferritin 9.98 ngmL Explains Psychiatric Symptoms Through Impa.md
01_Iron Deficiency at Ferritin 9.98 ngmL Explains Psychiatric Symptoms Through Impa.mdmd22KBartifacts-database/by-chat/17.01_7b5f1fe3_Глубокий анализ ферритина/01_Iron Deficiency at Ferritin 9.98 ngmL Explains Psychiatric Symptoms Through Impa.md
038_2025-12-03_GABA_Receptor_Recovery_After_Fluoroquinolone_and_Benzodiazep.mdmd22KBartifacts-database/pre-extracted-artifacts/038_2025-12-03_GABA_Receptor_Recovery_After_Fluoroquinolone_and_Benzodiazep.md
04.01_ZEM Wellness Clinic Safety Evaluation for Complex FQAD Patient with Iron Deficie.mdmd22KBartifacts-database/by-tag/wellness/04.01_ZEM Wellness Clinic Safety Evaluation for Complex FQAD Patient with Iron Deficie.md
01_ZEM Wellness Clinic Safety Evaluation for Complex FQAD Patient with Iron Deficie.mdmd22KBartifacts-database/by-chat/04.01_8e697473_Анализ процедур для здоровья/01_ZEM Wellness Clinic Safety Evaluation for Complex FQAD Patient with Iron Deficie.md
17.10_Rivotril Safety Assessment Critical Risks for Patient with Fluoroquinolone Toxic.mdmd22KBartifacts-database/by-tag/бензо/17.10_Rivotril Safety Assessment Critical Risks for Patient with Fluoroquinolone Toxic.md
01_Rivotril Safety Assessment Critical Risks for Patient with Fluoroquinolone Toxic.mdmd22KBartifacts-database/by-chat/17.10_c8857647_Rivotril 2 drops (0.2mg)/01_Rivotril Safety Assessment Critical Risks for Patient with Fluoroquinolone Toxic.md
DEEP-RESEARCH-PLAN.mdmd22KBveronika-health-db/public/DEEP-RESEARCH-PLAN.md
MARKET-RESEARCH.mdmd22KBMARKET-RESEARCH.md
MARKET-RESEARCH.mdmd22KBveronika-health-db/public/MARKET-RESEARCH.md
032_2025-12-02_The_Cascade_Effect_How_Seven_Interconnected_Conditions_Crea.mdmd22KBartifacts-database/pre-extracted-artifacts/032_2025-12-02_The_Cascade_Effect_How_Seven_Interconnected_Conditions_Crea.md
03.12_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.mdmd22KBartifacts-database/by-tag/FQAD/03.12_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.md
03.12_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.mdmd22KBartifacts-database/by-tag/железо/03.12_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.md
01_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.mdmd22KBartifacts-database/by-chat/03.12_840e1cb1_GABA dopamine iron triple problem/01_The Cascade Effect How Seven Interconnected Conditions Create Treatment-Resistan.md
026_2025-10-15_Finding_the_Safest_Antidepressant_After_Mirtazapine_Paradox_.mdmd22KBartifacts-database/pre-extracted-artifacts/026_2025-10-15_Finding_the_Safest_Antidepressant_After_Mirtazapine_Paradox_.md
15.10_Finding the Safest Antidepressant After Mirtazapine Paradox Iron, Estradiol, and.mdmd22KBartifacts-database/by-tag/лекарства/15.10_Finding the Safest Antidepressant After Mirtazapine Paradox Iron, Estradiol, and.md
01_Finding the Safest Antidepressant After Mirtazapine Paradox Iron, Estradiol, and.mdmd22KBartifacts-database/by-chat/15.10_f473c9b3_Mirtazapine reaction review/01_Finding the Safest Antidepressant After Mirtazapine Paradox Iron, Estradiol, and.md
26.01_Evidence-Based Methods to Eliminate Ruminating Thoughts in FQAD Recovery.mdmd22KBartifacts-database/by-tag/руминация/26.01_Evidence-Based Methods to Eliminate Ruminating Thoughts in FQAD Recovery.md
01_Evidence-Based Methods to Eliminate Ruminating Thoughts in FQAD Recovery.mdmd22KBartifacts-database/by-chat/26.01_da6be039_Non-medication anti-rumination/01_Evidence-Based Methods to Eliminate Ruminating Thoughts in FQAD Recovery.md
063_2026-01-13_Healing_Beyond_the_Prescription_Real_Stories_of_Mental_Heal.mdmd22KBartifacts-database/pre-extracted-artifacts/063_2026-01-13_Healing_Beyond_the_Prescription_Real_Stories_of_Mental_Heal.md
13.01_Healing Beyond the Prescription Real Stories of Mental Health Recovery Through S.mdmd22KBartifacts-database/by-tag/документы/13.01_Healing Beyond the Prescription Real Stories of Mental Health Recovery Through S.md
01_Healing Beyond the Prescription Real Stories of Mental Health Recovery Through S.mdmd22KBartifacts-database/by-chat/13.01_11abe4b0_Перевод спонтанное исцеление/01_Healing Beyond the Prescription Real Stories of Mental Health Recovery Through S.md
043_2025-12-20_Recovery_from_FQAD_and_Safe_Benzodiazepine_Tapering_An_Evid.mdmd22KBartifacts-database/pre-extracted-artifacts/043_2025-12-20_Recovery_from_FQAD_and_Safe_Benzodiazepine_Tapering_An_Evid.md
20.12_Recovery from FQAD and Safe Benzodiazepine Tapering An Evidence-Based Guide.mdmd22KBartifacts-database/by-tag/документы/20.12_Recovery from FQAD and Safe Benzodiazepine Tapering An Evidence-Based Guide.md
01_Recovery from FQAD and Safe Benzodiazepine Tapering An Evidence-Based Guide.mdmd22KBartifacts-database/by-chat/20.12_dce7e843_Comprehensive history plan/01_Recovery from FQAD and Safe Benzodiazepine Tapering An Evidence-Based Guide.md
051_2026-01-05_Natural_Alternatives_to_Benzodiazepines_for_FQAD_Patients_S.mdmd22KBartifacts-database/pre-extracted-artifacts/051_2026-01-05_Natural_Alternatives_to_Benzodiazepines_for_FQAD_Patients_S.md
05.01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.mdmd22KBartifacts-database/by-tag/бензо/05.01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.md
05.01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.mdmd22KBartifacts-database/by-tag/добавки/05.01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.md
01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.mdmd22KBartifacts-database/by-chat/05.01_d7b4a21a_Natural alternatives to benzos/01_Natural Alternatives to Benzodiazepines for FQAD Patients Safety and Evidence An.md
014_2025-10-01_Ferinject_Safety_Profile_Hypophosphatemia_Emerges_as_Primar.mdmd21KBartifacts-database/pre-extracted-artifacts/014_2025-10-01_Ferinject_Safety_Profile_Hypophosphatemia_Emerges_as_Primar.md
04.10_Liposomal Iron for Severe Deficiency with Fluoroquinolone Toxicity Clinical Evid.mdmd21KBartifacts-database/by-tag/железо/04.10_Liposomal Iron for Severe Deficiency with Fluoroquinolone Toxicity Clinical Evid.md
01_Liposomal Iron for Severe Deficiency with Fluoroquinolone Toxicity Clinical Evid.mdmd21KBartifacts-database/by-chat/04.10_12d66b7c_Liposomal iron research/01_Liposomal Iron for Severe Deficiency with Fluoroquinolone Toxicity Clinical Evid.md
025_2025-10-05_Lorazepam_vs_Alprazolam_for_Fluoroquinolone_Toxicity_Patient.mdmd21KBartifacts-database/pre-extracted-artifacts/025_2025-10-05_Lorazepam_vs_Alprazolam_for_Fluoroquinolone_Toxicity_Patient.md
05.10_Lorazepam vs Alprazolam for Fluoroquinolone Toxicity Patient Safety Analysis and.mdmd21KBartifacts-database/by-tag/лекарства/05.10_Lorazepam vs Alprazolam for Fluoroquinolone Toxicity Patient Safety Analysis and.md
01_Lorazepam vs Alprazolam for Fluoroquinolone Toxicity Patient Safety Analysis and.mdmd21KBartifacts-database/by-chat/05.10_62eb16e9_Lorazepam vs Xanax comparison/01_Lorazepam vs Alprazolam for Fluoroquinolone Toxicity Patient Safety Analysis and.md
08.10_Urgent Post-Glutathione Management Guide for Veronika Safety Protocol and 24-Hou.mdmd21KBartifacts-database/by-tag/добавки/08.10_Urgent Post-Glutathione Management Guide for Veronika Safety Protocol and 24-Hou.md
02_Urgent Post-Glutathione Management Guide for Veronika Safety Protocol and 24-Hou.mdmd21KBartifacts-database/by-chat/08.10_6e260a52_Liposomal glutathione risks/02_Urgent Post-Glutathione Management Guide for Veronika Safety Protocol and 24-Hou.md
22.01_The Complete 30-Day Regeneration Protocol Integrating Gut Health, Breathwork, Co.mdmd21KBartifacts-database/by-tag/wellness/22.01_The Complete 30-Day Regeneration Protocol Integrating Gut Health, Breathwork, Co.md
01_The Complete 30-Day Regeneration Protocol Integrating Gut Health, Breathwork, Co.mdmd21KBartifacts-database/by-chat/22.01_b85c581d_30-дневный план детокса/01_The Complete 30-Day Regeneration Protocol Integrating Gut Health, Breathwork, Co.md
34_2025-10-21_Checking_previous_chat_details.txttxt21KBartifacts-database/chat-transcripts/34_2025-10-21_Checking_previous_chat_details.txt
10.02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.mdmd21KBartifacts-database/by-tag/TMS/10.02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.md
10.02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.mdmd21KBartifacts-database/by-tag/клиники/10.02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.md
02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.mdmd21KBartifacts-database/by-chat/10.02_e35d07ff_Oberberg TMS centers worldwide/02_Beyond the Usual Names 30 Psychiatric Facilities Worldwide for Treatment-Resista.md
21.02_The Most Remarkable Molecule Youve Never Heard Of Methylene Blues 149-Year Journ.mdmd21KBartifacts-database/by-tag/добавки/21.02_The Most Remarkable Molecule Youve Never Heard Of Methylene Blues 149-Year Journ.md
04_The Most Remarkable Molecule Youve Never Heard Of Methylene Blues 149-Year Journ.mdmd21KBartifacts-database/by-chat/21.02_e520b05b_Methylene blue mitochondria/04_The Most Remarkable Molecule Youve Never Heard Of Methylene Blues 149-Year Journ.md
16.12_Europes Best Medical Centers for Complex Fluoroquinolone Toxicity.mdmd21KBartifacts-database/by-tag/клиники/16.12_Europes Best Medical Centers for Complex Fluoroquinolone Toxicity.md
01_Europes Best Medical Centers for Complex Fluoroquinolone Toxicity.mdmd21KBartifacts-database/by-chat/16.12_3b138973_Центры check-up Берлин/01_Europes Best Medical Centers for Complex Fluoroquinolone Toxicity.md
20.02_Pharmacogenomic Testing The Science, the Options, and Why Your DNA Isnt Like a F.mdmd21KBartifacts-database/by-tag/анализы/20.02_Pharmacogenomic Testing The Science, the Options, and Why Your DNA Isnt Like a F.md
04_Pharmacogenomic Testing The Science, the Options, and Why Your DNA Isnt Like a F.mdmd21KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/04_Pharmacogenomic Testing The Science, the Options, and Why Your DNA Isnt Like a F.md
19.02_Why Estradiol Replacement Is Medically Urgent Evidence for Transdermal HRT in Pr.mdmd21KBartifacts-database/by-tag/терапия/19.02_Why Estradiol Replacement Is Medically Urgent Evidence for Transdermal HRT in Pr.md
06_Why Estradiol Replacement Is Medically Urgent Evidence for Transdermal HRT in Pr.mdmd21KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/06_Why Estradiol Replacement Is Medically Urgent Evidence for Transdermal HRT in Pr.md
18.12_Veronikas FQAD Recovery Plan A Complete Psychiatric and Medication-Sensitivity P.mdmd20KBartifacts-database/by-tag/лекарства/18.12_Veronikas FQAD Recovery Plan A Complete Psychiatric and Medication-Sensitivity P.md
04_Veronikas FQAD Recovery Plan A Complete Psychiatric and Medication-Sensitivity P.mdmd20KBartifacts-database/by-chat/18.12_a53ea027_Кветиапин альтернатива/04_Veronikas FQAD Recovery Plan A Complete Psychiatric and Medication-Sensitivity P.md
30.12_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.mdmd20KBartifacts-database/by-tag/кризисы/30.12_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.md
30.12_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.mdmd20KBartifacts-database/by-tag/лекарства/30.12_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.md
01_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.mdmd20KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/01_Два кризиса одновременно отмена клоназепама и реакция на кветиапин.md
01-timeline.mdmd20KBartifacts-database/compiled-docs/01-timeline.md
17.01_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.mdmd20KBartifacts-database/by-tag/добавки/17.01_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.md
17.01_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.mdmd20KBartifacts-database/by-tag/документы/17.01_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.md
02_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.mdmd20KBartifacts-database/by-chat/17.01_ec7ced03_Расписание таблеток (DOCX)/02_Clinical Evidence for Probiotics in Depression and Anxiety Garden of Life Mood v.md
15.10_Is Cipralex Right for Veronika Mitochondrial and Safety Concerns in Fluoroquinol.mdmd20KBartifacts-database/by-tag/лекарства/15.10_Is Cipralex Right for Veronika Mitochondrial and Safety Concerns in Fluoroquinol.md
02_Is Cipralex Right for Veronika Mitochondrial and Safety Concerns in Fluoroquinol.mdmd20KBartifacts-database/by-chat/15.10_f18d4b2c_Quetiapine suitability/02_Is Cipralex Right for Veronika Mitochondrial and Safety Concerns in Fluoroquinol.md
SYSTEM-DESCRIPTION.mdmd20KBveronika-health-db/SYSTEM-DESCRIPTION.md
09.10_Lorazepam Redosing Safety After 1 Hour Critical Medical Analysis.mdmd20KBartifacts-database/by-tag/лекарства/09.10_Lorazepam Redosing Safety After 1 Hour Critical Medical Analysis.md
02_Lorazepam Redosing Safety After 1 Hour Critical Medical Analysis.mdmd20KBartifacts-database/by-chat/09.10_96e139bb_Medication interaction lorazepamatarax 12hr/02_Lorazepam Redosing Safety After 1 Hour Critical Medical Analysis.md
17.02_Premium Psychiatric Clinics in Spain for Supervised Antidepressant Initiation A.mdmd20KBartifacts-database/by-tag/клиники/17.02_Premium Psychiatric Clinics in Spain for Supervised Antidepressant Initiation A.md
02_Premium Psychiatric Clinics in Spain for Supervised Antidepressant Initiation A.mdmd20KBartifacts-database/by-chat/17.02_f4cbdd26_Mental health treatment Spain/02_Premium Psychiatric Clinics in Spain for Supervised Antidepressant Initiation A.md
RESEARCH-patient-controlled-health-records.mdmd20KBRESEARCH-patient-controlled-health-records.md
097_2026-02-01_TMS_for_FQAD_A_High-Stakes_Decision_Requiring_Careful_Prepa.mdmd20KBartifacts-database/pre-extracted-artifacts/097_2026-02-01_TMS_for_FQAD_A_High-Stakes_Decision_Requiring_Careful_Prepa.md
05.02_TMS for FQAD A High-Stakes Decision Requiring Careful Preparation.mdmd20KBartifacts-database/by-tag/TMS/05.02_TMS for FQAD A High-Stakes Decision Requiring Careful Preparation.md
02_TMS for FQAD A High-Stakes Decision Requiring Careful Preparation.mdmd20KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/02_TMS for FQAD A High-Stakes Decision Requiring Careful Preparation.md
062_2026-01-12_Complete_FQAD_Supplement_Protocol_Safety_Interactions_and.mdmd20KBartifacts-database/pre-extracted-artifacts/062_2026-01-12_Complete_FQAD_Supplement_Protocol_Safety_Interactions_and.md
12.01_Complete FQAD Supplement Protocol Safety, Interactions, and Timing Guide for Clo.mdmd20KBartifacts-database/by-tag/добавки/12.01_Complete FQAD Supplement Protocol Safety, Interactions, and Timing Guide for Clo.md
02_Complete FQAD Supplement Protocol Safety, Interactions, and Timing Guide for Clo.mdmd20KBartifacts-database/by-chat/12.01_47896ca1_План добавок клоназепам/02_Complete FQAD Supplement Protocol Safety, Interactions, and Timing Guide for Clo.md
19.02_The Weight of What We Hide How Secrets and Guilt Damage Mind and Body.mdmd20KBartifacts-database/by-tag/терапия/19.02_The Weight of What We Hide How Secrets and Guilt Damage Mind and Body.md
01_The Weight of What We Hide How Secrets and Guilt Damage Mind and Body.mdmd20KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/01_The Weight of What We Hide How Secrets and Guilt Damage Mind and Body.md
18.02_MRS for GABA Measurement in Barcelona Diagnostic Limitations and Alternatives fo.mdmd20KBartifacts-database/by-tag/клиники/18.02_MRS for GABA Measurement in Barcelona Diagnostic Limitations and Alternatives fo.md
04_MRS for GABA Measurement in Barcelona Diagnostic Limitations and Alternatives fo.mdmd20KBartifacts-database/by-chat/18.02_95993d55_Top brain clinics Spain/04_MRS for GABA Measurement in Barcelona Diagnostic Limitations and Alternatives fo.md
135_2026-03-11_Residential_Psychiatric_Care_Options_for_Treatment-Resistant.mdmd20KBartifacts-database/pre-extracted-artifacts/135_2026-03-11_Residential_Psychiatric_Care_Options_for_Treatment-Resistant.md
14.03_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.mdmd20KBartifacts-database/by-tag/клиники/14.03_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.md
14.03_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.mdmd20KBartifacts-database/by-tag/документы/14.03_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.md
05_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.mdmd20KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/05_Residential Psychiatric Care Options for Treatment-Resistant Depression Across E.md
136_2026-03-11_Psychiatric_Residential_Clinics_in_Europe_for_Supervised_Ant.mdmd20KBartifacts-database/pre-extracted-artifacts/136_2026-03-11_Psychiatric_Residential_Clinics_in_Europe_for_Supervised_Ant.md
14.03_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.mdmd20KBartifacts-database/by-tag/клиники/14.03_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.md
14.03_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.mdmd20KBartifacts-database/by-tag/документы/14.03_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.md
06_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.mdmd20KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/06_Psychiatric Residential Clinics in Europe for Supervised Antidepressant Initiati.md
18.02_Spains Top Brain Research and Diagnostic Centers A Complete Guide for FQAD Patie.mdmd19KBartifacts-database/by-tag/клиники/18.02_Spains Top Brain Research and Diagnostic Centers A Complete Guide for FQAD Patie.md
01_Spains Top Brain Research and Diagnostic Centers A Complete Guide for FQAD Patie.mdmd19KBartifacts-database/by-chat/18.02_95993d55_Top brain clinics Spain/01_Spains Top Brain Research and Diagnostic Centers A Complete Guide for FQAD Patie.md
118_2026-02-06_The_Definitive_Guide_to_Comprehensive_Brain_Diagnostics_for_.mdmd19KBartifacts-database/pre-extracted-artifacts/118_2026-02-06_The_Definitive_Guide_to_Comprehensive_Brain_Diagnostics_for_.md
07.02_The Definitive Guide to Comprehensive Brain Diagnostics for Post-Fluoroquinolone.mdmd19KBartifacts-database/by-tag/клиники/07.02_The Definitive Guide to Comprehensive Brain Diagnostics for Post-Fluoroquinolone.md
03_The Definitive Guide to Comprehensive Brain Diagnostics for Post-Fluoroquinolone.mdmd19KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/03_The Definitive Guide to Comprehensive Brain Diagnostics for Post-Fluoroquinolone.md
20.02_Everything CUN Madrid Can Offer Veronikas Case Comprehensive Capabilities and St.mdmd19KBartifacts-database/by-tag/анализы/20.02_Everything CUN Madrid Can Offer Veronikas Case Comprehensive Capabilities and St.md
02_Everything CUN Madrid Can Offer Veronikas Case Comprehensive Capabilities and St.mdmd19KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/02_Everything CUN Madrid Can Offer Veronikas Case Comprehensive Capabilities and St.md
21.12_Evidence-Based Recovery Treatments for Fluoroquinolone Toxicity A Clinical Evalu.mdmd19KBartifacts-database/by-tag/wellness/21.12_Evidence-Based Recovery Treatments for Fluoroquinolone Toxicity A Clinical Evalu.md
01_Evidence-Based Recovery Treatments for Fluoroquinolone Toxicity A Clinical Evalu.mdmd19KBartifacts-database/by-chat/21.12_bbf082cf_Evidence-based wellness (HBOT)/01_Evidence-Based Recovery Treatments for Fluoroquinolone Toxicity A Clinical Evalu.md
55_2026-01-06_ZEM_Altea_employee_reviews_and_background_check.txttxt19KBartifacts-database/chat-transcripts/55_2026-01-06_ZEM_Altea_employee_reviews_and_background_check.txt
15.10_Lorazepam and Hydroxyzine Understanding the Risks of Concurrent Use.mdmd19KBartifacts-database/by-tag/лекарства/15.10_Lorazepam and Hydroxyzine Understanding the Risks of Concurrent Use.md
01_Lorazepam and Hydroxyzine Understanding the Risks of Concurrent Use.mdmd19KBartifacts-database/by-chat/15.10_df5a3639_Lorazepam Atarax interactions/01_Lorazepam and Hydroxyzine Understanding the Risks of Concurrent Use.md
122_2026-02-14_A_Triple_Neurochemical_Crisis_With_a_Clear_Path_Forward_FQA.mdmd19KBartifacts-database/pre-extracted-artifacts/122_2026-02-14_A_Triple_Neurochemical_Crisis_With_a_Clear_Path_Forward_FQA.md
14.02_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.mdmd19KBartifacts-database/by-tag/TMS/14.02_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.md
14.02_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.mdmd19KBartifacts-database/by-tag/железо/14.02_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.md
01_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.mdmd19KBartifacts-database/by-chat/14.02_fcf4a767_TMS и дефицит железа/01_A Triple Neurochemical Crisis With a Clear Path Forward FQAD, Iron Deficiency, a.md
19.02_How to Help Someone Confess What Feels Unforgivable Evidence-Based Strategies fo.mdmd19KBartifacts-database/by-tag/терапия/19.02_How to Help Someone Confess What Feels Unforgivable Evidence-Based Strategies fo.md
04_How to Help Someone Confess What Feels Unforgivable Evidence-Based Strategies fo.mdmd19KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/04_How to Help Someone Confess What Feels Unforgivable Evidence-Based Strategies fo.md
63_2026-01-13_.txttxt19KBartifacts-database/chat-transcripts/63_2026-01-13_.txt
090_2026-02-01_Benzodiazepine_Kindling_After_Cold-Turkey_Withdrawal_Why_Cl.mdmd19KBartifacts-database/pre-extracted-artifacts/090_2026-02-01_Benzodiazepine_Kindling_After_Cold-Turkey_Withdrawal_Why_Cl.md
01.02_Benzodiazepine Kindling After Cold-Turkey Withdrawal Why Clonazepam Stops Workin.mdmd19KBartifacts-database/by-tag/бензо/01.02_Benzodiazepine Kindling After Cold-Turkey Withdrawal Why Clonazepam Stops Workin.md
01_Benzodiazepine Kindling After Cold-Turkey Withdrawal Why Clonazepam Stops Workin.mdmd19KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/01_Benzodiazepine Kindling After Cold-Turkey Withdrawal Why Clonazepam Stops Workin.md
23.01_Transdermal Estradiol Patches for Functional Hypothalamic Amenorrhea Complete Cl.mdmd19KBartifacts-database/by-tag/гормоны/23.01_Transdermal Estradiol Patches for Functional Hypothalamic Amenorrhea Complete Cl.md
01_Transdermal Estradiol Patches for Functional Hypothalamic Amenorrhea Complete Cl.mdmd19KBartifacts-database/by-chat/23.01_0991ac6a_Estrogen patches deep research/01_Transdermal Estradiol Patches for Functional Hypothalamic Amenorrhea Complete Cl.md
061_2026-01-12_Complete_Supplement_Analysis_for_FQAD_Patient_with_Paradoxic.mdmd19KBartifacts-database/pre-extracted-artifacts/061_2026-01-12_Complete_Supplement_Analysis_for_FQAD_Patient_with_Paradoxic.md
12.01_Complete Supplement Analysis for FQAD Patient with Paradoxical Reactions.mdmd19KBartifacts-database/by-tag/добавки/12.01_Complete Supplement Analysis for FQAD Patient with Paradoxical Reactions.md
01_Complete Supplement Analysis for FQAD Patient with Paradoxical Reactions.mdmd19KBartifacts-database/by-chat/12.01_47896ca1_План добавок клоназепам/01_Complete Supplement Analysis for FQAD Patient with Paradoxical Reactions.md
04.02_Fasting and Mental Health A Comprehensive Evidence Review.mdmd19KBartifacts-database/by-tag/руминация/04.02_Fasting and Mental Health A Comprehensive Evidence Review.md
02_Fasting and Mental Health A Comprehensive Evidence Review.mdmd19KBartifacts-database/by-chat/04.02_a348e9f4_Руминация голодание/02_Fasting and Mental Health A Comprehensive Evidence Review.md
20.02_Advanced Neurodiagnostic Testing for FQAD Across Spain Facility Analysis and Str.mdmd18KBartifacts-database/by-tag/анализы/20.02_Advanced Neurodiagnostic Testing for FQAD Across Spain Facility Analysis and Str.md
01_Advanced Neurodiagnostic Testing for FQAD Across Spain Facility Analysis and Str.mdmd18KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/01_Advanced Neurodiagnostic Testing for FQAD Across Spain Facility Analysis and Str.md
19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.mdmd18KBartifacts-database/by-tag/FQAD/19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.md
19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.mdmd18KBartifacts-database/by-tag/клиники/19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.md
19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.mdmd18KBartifacts-database/by-tag/железо/19.12_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.md
01_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.mdmd18KBartifacts-database/by-chat/19.12_baba89e6_План лечения ФХ токсичности ZEM iron/01_Ferritin and Psychiatric Symptoms Why 20-50 ngmL Is Not Normal for Brain Functio.md
08.10_Iron Supplementation for Severe Deficiency with Fluoroquinolone Toxicity Treatme.mdmd18KBartifacts-database/by-tag/железо/08.10_Iron Supplementation for Severe Deficiency with Fluoroquinolone Toxicity Treatme.md
01_Iron Supplementation for Severe Deficiency with Fluoroquinolone Toxicity Treatme.mdmd18KBartifacts-database/by-chat/08.10_20f3621a_Iron after GABA side effects/01_Iron Supplementation for Severe Deficiency with Fluoroquinolone Toxicity Treatme.md
120_2026-02-06_European_Clinics_for_Post-Fluoroquinolone_Neuropsychiatric_E.mdmd18KBartifacts-database/pre-extracted-artifacts/120_2026-02-06_European_Clinics_for_Post-Fluoroquinolone_Neuropsychiatric_E.md
07.02_European Clinics for Post-Fluoroquinolone Neuropsychiatric Evaluation Diagnostic.mdmd18KBartifacts-database/by-tag/клиники/07.02_European Clinics for Post-Fluoroquinolone Neuropsychiatric Evaluation Diagnostic.md
05_European Clinics for Post-Fluoroquinolone Neuropsychiatric Evaluation Diagnostic.mdmd18KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/05_European Clinics for Post-Fluoroquinolone Neuropsychiatric Evaluation Diagnostic.md
17.02_Urgent Psychiatric Care Options in Spain for an FQAD Patient Treatment Strategy.mdmd18KBartifacts-database/by-tag/клиники/17.02_Urgent Psychiatric Care Options in Spain for an FQAD Patient Treatment Strategy.md
01_Urgent Psychiatric Care Options in Spain for an FQAD Patient Treatment Strategy.mdmd18KBartifacts-database/by-chat/17.02_f4cbdd26_Mental health treatment Spain/01_Urgent Psychiatric Care Options in Spain for an FQAD Patient Treatment Strategy.md
30.12_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.mdmd18KBartifacts-database/by-tag/кризисы/30.12_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.md
30.12_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.mdmd18KBartifacts-database/by-tag/лекарства/30.12_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.md
05_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.mdmd18KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/05_Benzodiazepine Withdrawal After PRN Use Kindling Risk and Clinical Management Pr.md
040_2025-12-03_Advanced_Detoxification_Protocols_for_Fluoroquinolone_Toxici.mdmd18KBartifacts-database/pre-extracted-artifacts/040_2025-12-03_Advanced_Detoxification_Protocols_for_Fluoroquinolone_Toxici.md
03.01_Hyperbaric Oxygen Therapy for Depression A Comprehensive Evidence Review.mdmd18KBartifacts-database/by-tag/wellness/03.01_Hyperbaric Oxygen Therapy for Depression A Comprehensive Evidence Review.md
01_Hyperbaric Oxygen Therapy for Depression A Comprehensive Evidence Review.mdmd18KBartifacts-database/by-chat/03.01_cd2bc4b8_HBOT and depression research/01_Hyperbaric Oxygen Therapy for Depression A Comprehensive Evidence Review.md
052_2026-01-05_Replacing_Clonazepam_With_Natural_Alternatives_After_Fluoroq.mdmd18KBartifacts-database/pre-extracted-artifacts/052_2026-01-05_Replacing_Clonazepam_With_Natural_Alternatives_After_Fluoroq.md
05.01_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.mdmd18KBartifacts-database/by-tag/бензо/05.01_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.md
05.01_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.mdmd18KBartifacts-database/by-tag/добавки/05.01_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.md
02_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.mdmd18KBartifacts-database/by-chat/05.01_d7b4a21a_Natural alternatives to benzos/02_Replacing Clonazepam With Natural Alternatives After Fluoroquinolone Toxicity.md
15.10_Mirtazapine and Hydroxyzine Safety The 12-Hour Spacing Question.mdmd18KBartifacts-database/by-tag/лекарства/15.10_Mirtazapine and Hydroxyzine Safety The 12-Hour Spacing Question.md
01_Mirtazapine and Hydroxyzine Safety The 12-Hour Spacing Question.mdmd18KBartifacts-database/by-chat/15.10_fe29b000_Mirtazapine Atarax timing/01_Mirtazapine and Hydroxyzine Safety The 12-Hour Spacing Question.md
129_2026-03-10_Her_Depression_Is_Not_What_Psychiatry_Thinks_It_Is_Fluoroqu.mdmd18KBartifacts-database/pre-extracted-artifacts/129_2026-03-10_Her_Depression_Is_Not_What_Psychiatry_Thinks_It_Is_Fluoroqu.md
16.03_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.mdmd18KBartifacts-database/by-tag/врачи/16.03_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.md
16.03_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.mdmd18KBartifacts-database/by-tag/документы/16.03_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.md
05_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.mdmd18KBartifacts-database/by-chat/16.03_b76e8115_Müller strategic plan v3/05_Her Depression Is Not What Psychiatry Thinks It Is Fluoroquinolone-Induced Syste.md
20.02_Assessing GABA-A Receptor Damage in FQAD A Practical European Guide.mdmd18KBartifacts-database/by-tag/анализы/20.02_Assessing GABA-A Receptor Damage in FQAD A Practical European Guide.md
06_Assessing GABA-A Receptor Damage in FQAD A Practical European Guide.mdmd18KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/06_Assessing GABA-A Receptor Damage in FQAD A Practical European Guide.md
61_2026-01-13_.txttxt18KBartifacts-database/chat-transcripts/61_2026-01-13_.txt
059_2026-01-06_ZEM_Wellness_Clinic_Altea_Staff_Verification_and_Critical_O.mdmd18KBartifacts-database/pre-extracted-artifacts/059_2026-01-06_ZEM_Wellness_Clinic_Altea_Staff_Verification_and_Critical_O.md
06.01_ZEM Wellness Clinic Altea Staff Verification and Critical Ownership Red Flags.mdmd18KBartifacts-database/by-tag/клиники/06.01_ZEM Wellness Clinic Altea Staff Verification and Critical Ownership Red Flags.md
02_ZEM Wellness Clinic Altea Staff Verification and Critical Ownership Red Flags.mdmd18KBartifacts-database/by-chat/06.01_54fb3b56_ZEM SHA procedures/02_ZEM Wellness Clinic Altea Staff Verification and Critical Ownership Red Flags.md
17.01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.mdmd18KBartifacts-database/by-tag/добавки/17.01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.md
17.01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.mdmd18KBartifacts-database/by-tag/документы/17.01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.md
01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.mdmd18KBartifacts-database/by-chat/17.01_ec7ced03_Расписание таблеток (DOCX)/01_Curcumin for Rheumatoid Arthritis and Pulmonary Fibrosis Clinical Evidence Revie.md
119_2026-02-06_HUG_Geneva_Brain_and_Mental_Health_Clinic_A_Complete_Guide_.mdmd18KBartifacts-database/pre-extracted-artifacts/119_2026-02-06_HUG_Geneva_Brain_and_Mental_Health_Clinic_A_Complete_Guide_.md
07.02_HUG Geneva Brain and Mental Health Clinic A Complete Guide to Diagnostics, Acces.mdmd18KBartifacts-database/by-tag/клиники/07.02_HUG Geneva Brain and Mental Health Clinic A Complete Guide to Diagnostics, Acces.md
04_HUG Geneva Brain and Mental Health Clinic A Complete Guide to Diagnostics, Acces.mdmd18KBartifacts-database/by-chat/07.02_c0aff939_Клиники для психотерапии/04_HUG Geneva Brain and Mental Health Clinic A Complete Guide to Diagnostics, Acces.md
41_2025-12-06_Cipralex_side_effects_timeline_and_relief.txttxt18KBartifacts-database/chat-transcripts/41_2025-12-06_Cipralex_side_effects_timeline_and_relief.txt
127_2026-03-10_Gadolinium_Contrast_Safety_in_Fluoroquinolone-Associated_Neu.mdmd17KBartifacts-database/pre-extracted-artifacts/127_2026-03-10_Gadolinium_Contrast_Safety_in_Fluoroquinolone-Associated_Neu.md
16.03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.mdmd17KBartifacts-database/by-tag/врачи/16.03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.md
16.03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.mdmd17KBartifacts-database/by-tag/документы/16.03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.md
03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.mdmd17KBartifacts-database/by-chat/16.03_b76e8115_Müller strategic plan v3/03_Gadolinium Contrast Safety in Fluoroquinolone-Associated Neurological Damage Ris.md
03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity Evidence Review and Treat.mdmd17KBartifacts-database/by-tag/wellness/03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity Evidence Review and Treat.md
02_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity Evidence Review and Treat.mdmd17KBartifacts-database/by-chat/03.01_cd2bc4b8_HBOT and depression research/02_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity Evidence Review and Treat.md
19.02_Depression Manufactures Guilt The Neuroscience of False Moral Confession.mdmd17KBartifacts-database/by-tag/терапия/19.02_Depression Manufactures Guilt The Neuroscience of False Moral Confession.md
05_Depression Manufactures Guilt The Neuroscience of False Moral Confession.mdmd17KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/05_Depression Manufactures Guilt The Neuroscience of False Moral Confession.md
24.01_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.mdmd17KBartifacts-database/by-tag/терапия/24.01_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.md
24.01_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.mdmd17KBartifacts-database/by-tag/лекарства/24.01_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.md
07_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.mdmd17KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/07_Treating Severe Rumination in FQAD A Comprehensive Treatment Roadmap.md
04.01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.mdmd17KBartifacts-database/by-tag/wellness/04.01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.md
04.01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.mdmd17KBartifacts-database/by-tag/клиники/04.01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.md
01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.mdmd17KBartifacts-database/by-chat/04.01_868ed355_Wellness procedures research trip/01_ZEM Clinic Procedures Evidence-Based Analysis for FQAD Patient.md
chat.htmlhtml17KBartifacts-database/chat.html
060_2026-01-06_SHA_vs_ZEM_Wellness_Clinics_Complete_Comparison_for_FQAD_Re.mdmd17KBartifacts-database/pre-extracted-artifacts/060_2026-01-06_SHA_vs_ZEM_Wellness_Clinics_Complete_Comparison_for_FQAD_Re.md
07.01_SHA vs ZEM Wellness Clinics Complete Comparison for FQAD Recovery.mdmd17KBartifacts-database/by-tag/клиники/07.01_SHA vs ZEM Wellness Clinics Complete Comparison for FQAD Recovery.md
01_SHA vs ZEM Wellness Clinics Complete Comparison for FQAD Recovery.mdmd17KBartifacts-database/by-chat/07.01_4604bad0_SHA vs ZEM comparison/01_SHA vs ZEM Wellness Clinics Complete Comparison for FQAD Recovery.md
79_2026-02-05_Pregabalina_dlya_Veroniki.txttxt17KBartifacts-database/chat-transcripts/79_2026-02-05_Pregabalina_dlya_Veroniki.txt
020_2025-10-04_Trazodone_Safety_Analysis_Critical_Concerns_for_Patient_wit.mdmd17KBartifacts-database/pre-extracted-artifacts/020_2025-10-04_Trazodone_Safety_Analysis_Critical_Concerns_for_Patient_wit.md
04.10_Trazodone Safety Analysis Critical Concerns for Patient with Fluoroquinolone Tox.mdmd17KBartifacts-database/by-tag/лекарства/04.10_Trazodone Safety Analysis Critical Concerns for Patient with Fluoroquinolone Tox.md
01_Trazodone Safety Analysis Critical Concerns for Patient with Fluoroquinolone Tox.mdmd17KBartifacts-database/by-chat/04.10_638da230_Trazodone FQiron safety/01_Trazodone Safety Analysis Critical Concerns for Patient with Fluoroquinolone Tox.md
139_2026-03-11_A_Global_Guide_to_Comfortable_Residential_Depression_Treatme.mdmd17KBartifacts-database/pre-extracted-artifacts/139_2026-03-11_A_Global_Guide_to_Comfortable_Residential_Depression_Treatme.md
14.03_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.mdmd17KBartifacts-database/by-tag/клиники/14.03_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.md
14.03_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.mdmd17KBartifacts-database/by-tag/документы/14.03_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.md
09_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.mdmd17KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/09_A Global Guide to Comfortable Residential Depression Treatment Facilities, Costs.md
27.01_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.mdmd17KBartifacts-database/by-tag/гормоны/27.01_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.md
27.01_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.mdmd17KBartifacts-database/by-tag/железо/27.01_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.md
15_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.mdmd17KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/15_Personal Stories Amenorrhea, Low Estrogen, and the Path to Recovery.md
134_2026-03-11_Esketamine_and_Ketamine_for_Depression_A_Complete_Adverse_E.mdmd17KBartifacts-database/pre-extracted-artifacts/134_2026-03-11_Esketamine_and_Ketamine_for_Depression_A_Complete_Adverse_E.md
14.03_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.mdmd17KBartifacts-database/by-tag/клиники/14.03_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.md
14.03_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.mdmd17KBartifacts-database/by-tag/документы/14.03_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.md
04_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.mdmd17KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/04_Esketamine and Ketamine for Depression A Complete Adverse Event Dossier.md
16.12_Complex Psychiatric Presentation Following Escitalopram A Multi-Factor Analysis.mdmd17KBartifacts-database/by-tag/лекарства/16.12_Complex Psychiatric Presentation Following Escitalopram A Multi-Factor Analysis.md
01_Complex Psychiatric Presentation Following Escitalopram A Multi-Factor Analysis.mdmd17KBartifacts-database/by-chat/16.12_654829d5_Диагностика после отмены (кветиапин)/01_Complex Psychiatric Presentation Following Escitalopram A Multi-Factor Analysis.md
011_2025-10-01_Morning_Cipralex_and_Evening_Trittico_The_Clinical_Rational.mdmd17KBartifacts-database/pre-extracted-artifacts/011_2025-10-01_Morning_Cipralex_and_Evening_Trittico_The_Clinical_Rational.md
01-timeline-v2.mdmd16KBartifacts-database/compiled-docs/01-timeline-v2.md
10.02_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.mdmd16KBartifacts-database/by-tag/TMS/10.02_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.md
10.02_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.mdmd16KBartifacts-database/by-tag/клиники/10.02_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.md
01_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.mdmd16KBartifacts-database/by-chat/10.02_e35d07ff_Oberberg TMS centers worldwide/01_Oberberg Fachklinik Berlin Brandenburg Comprehensive Guide for Prospective Patie.md
03.01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.mdmd16KBartifacts-database/by-tag/wellness/03.01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.md
03.01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.mdmd16KBartifacts-database/by-tag/клиники/03.01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.md
01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.mdmd16KBartifacts-database/by-chat/03.01_af67cc8b_Научный анализ процедур ZEM/01_Scientific Evidence for Spa Treatments in Fluoroquinolone Toxicity and Related C.md
112_2026-02-01_TMS_Brain_Injury_Claims_and_Adverse_Patient_Experiences_A_C.mdmd16KBartifacts-database/pre-extracted-artifacts/112_2026-02-01_TMS_Brain_Injury_Claims_and_Adverse_Patient_Experiences_A_C.md
05.02_TMS Brain Injury Claims and Adverse Patient Experiences A Comprehensive Document.mdmd16KBartifacts-database/by-tag/TMS/05.02_TMS Brain Injury Claims and Adverse Patient Experiences A Comprehensive Document.md
17_TMS Brain Injury Claims and Adverse Patient Experiences A Comprehensive Document.mdmd16KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/17_TMS Brain Injury Claims and Adverse Patient Experiences A Comprehensive Document.md
07.01_Treatment Options for Rumination in FQAD A Personalized Clinical Guide.mdmd16KBartifacts-database/by-tag/добавки/07.01_Treatment Options for Rumination in FQAD A Personalized Clinical Guide.md
01_Treatment Options for Rumination in FQAD A Personalized Clinical Guide.mdmd16KBartifacts-database/by-chat/07.01_db62e77a_Ancient herbs GABA mitochondria/01_Treatment Options for Rumination in FQAD A Personalized Clinical Guide.md
019_2025-10-04_Trazodone_for_Anxiety-Related_Insomnia_Comprehensive_Treatm.mdmd16KBartifacts-database/pre-extracted-artifacts/019_2025-10-04_Trazodone_for_Anxiety-Related_Insomnia_Comprehensive_Treatm.md
04.10_Trazodone for Anxiety-Related Insomnia Comprehensive Treatment Evaluation.mdmd16KBartifacts-database/by-tag/лекарства/04.10_Trazodone for Anxiety-Related Insomnia Comprehensive Treatment Evaluation.md
01_Trazodone for Anxiety-Related Insomnia Comprehensive Treatment Evaluation.mdmd16KBartifacts-database/by-chat/04.10_6e4b7ec3_Trazodone cumulative effect/01_Trazodone for Anxiety-Related Insomnia Comprehensive Treatment Evaluation.md
050_2026-01-04_Complete_Vegetable_and_Fruit_Guide_for_Veronika_s_Medical_Pr.mdmd16KBartifacts-database/pre-extracted-artifacts/050_2026-01-04_Complete_Vegetable_and_Fruit_Guide_for_Veronika_s_Medical_Pr.md
069_2026-01-14_Managing_Paradoxical_Benzodiazepine_Reactions_in_FQAD_with_K.mdmd16KBartifacts-database/pre-extracted-artifacts/069_2026-01-14_Managing_Paradoxical_Benzodiazepine_Reactions_in_FQAD_with_K.md
14.01_Managing Paradoxical Benzodiazepine Reactions in FQAD with Kindling Clinical Pro.mdmd16KBartifacts-database/by-tag/бензо/14.01_Managing Paradoxical Benzodiazepine Reactions in FQAD with Kindling Clinical Pro.md
01_Managing Paradoxical Benzodiazepine Reactions in FQAD with Kindling Clinical Pro.mdmd16KBartifacts-database/by-chat/14.01_5bb989d1_Clonazepam paradox (0.6mg WORSE)/01_Managing Paradoxical Benzodiazepine Reactions in FQAD with Kindling Clinical Pro.md
055_2026-01-05_Benzodiazepine_Kindling_Complete_Guide_for_FQAD_Patients.mdmd16KBartifacts-database/pre-extracted-artifacts/055_2026-01-05_Benzodiazepine_Kindling_Complete_Guide_for_FQAD_Patients.md
05.01_Benzodiazepine Kindling Complete Guide for FQAD Patients.mdmd16KBartifacts-database/by-tag/бензо/05.01_Benzodiazepine Kindling Complete Guide for FQAD Patients.md
05.01_Benzodiazepine Kindling Complete Guide for FQAD Patients.mdmd16KBartifacts-database/by-tag/добавки/05.01_Benzodiazepine Kindling Complete Guide for FQAD Patients.md
05_Benzodiazepine Kindling Complete Guide for FQAD Patients.mdmd16KBartifacts-database/by-chat/05.01_d7b4a21a_Natural alternatives to benzos/05_Benzodiazepine Kindling Complete Guide for FQAD Patients.md
132_2026-03-11_The_Diagnosis_Everyone_Is_Likely_Missing_Excited_Catatonia_.mdmd16KBartifacts-database/pre-extracted-artifacts/132_2026-03-11_The_Diagnosis_Everyone_Is_Likely_Missing_Excited_Catatonia_.md
14.03_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.mdmd16KBartifacts-database/by-tag/клиники/14.03_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.md
14.03_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.mdmd16KBartifacts-database/by-tag/документы/14.03_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.md
02_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.mdmd16KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/02_The Diagnosis Everyone Is Likely Missing Excited Catatonia, Autoimmune Encephali.md
15.01_Medication Strategy for Rumination Treatment and Clonazepam Tapering in FQAD.mdmd16KBartifacts-database/by-tag/лекарства/15.01_Medication Strategy for Rumination Treatment and Clonazepam Tapering in FQAD.md
03_Medication Strategy for Rumination Treatment and Clonazepam Tapering in FQAD.mdmd16KBartifacts-database/by-chat/15.01_6221b8ed_Anafranil Brintellix safety/03_Medication Strategy for Rumination Treatment and Clonazepam Tapering in FQAD.md
054_2026-01-05_Permanent_GABA_Receptor_and_CNS_Damage_from_Benzodiazepines_.mdmd16KBartifacts-database/pre-extracted-artifacts/054_2026-01-05_Permanent_GABA_Receptor_and_CNS_Damage_from_Benzodiazepines_.md
05.01_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.mdmd16KBartifacts-database/by-tag/бензо/05.01_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.md
05.01_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.mdmd16KBartifacts-database/by-tag/добавки/05.01_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.md
04_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.mdmd16KBartifacts-database/by-chat/05.01_d7b4a21a_Natural alternatives to benzos/04_Permanent GABA Receptor and CNS Damage from Benzodiazepines and Fluoroquinolones.md
18.12_Quetiapine vs Clonazepam for Medication-Sensitive Patient with SSRI-Induced Live.mdmd16KBartifacts-database/by-tag/лекарства/18.12_Quetiapine vs Clonazepam for Medication-Sensitive Patient with SSRI-Induced Live.md
01_Quetiapine vs Clonazepam for Medication-Sensitive Patient with SSRI-Induced Live.mdmd16KBartifacts-database/by-chat/18.12_a53ea027_Кветиапин альтернатива/01_Quetiapine vs Clonazepam for Medication-Sensitive Patient with SSRI-Induced Live.md
18.12_Worlds Leading FQAD Specialists and Treatment Centers 2025 Guide for Barcelona-B.mdmd16KBartifacts-database/by-tag/лекарства/18.12_Worlds Leading FQAD Specialists and Treatment Centers 2025 Guide for Barcelona-B.md
03_Worlds Leading FQAD Specialists and Treatment Centers 2025 Guide for Barcelona-B.mdmd16KBartifacts-database/by-chat/18.12_a53ea027_Кветиапин альтернатива/03_Worlds Leading FQAD Specialists and Treatment Centers 2025 Guide for Barcelona-B.md
08.10_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.mdmd16KBartifacts-database/by-tag/добавки/08.10_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.md
08.10_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.mdmd16KBartifacts-database/by-tag/FQAD/08.10_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.md
01_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.mdmd16KBartifacts-database/by-chat/08.10_3600d484_Lipocalm paradoxical reaction/01_Sleep Supplement Paradoxical Reaction Fluoroquinolone Toxicity and GABA System I.md
03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.mdmd16KBartifacts-database/by-tag/wellness/03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.md
03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.mdmd16KBartifacts-database/by-tag/клиники/03.01_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.md
02_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.mdmd16KBartifacts-database/by-chat/03.01_af67cc8b_Научный анализ процедур ZEM/02_Hyperbaric Oxygen Therapy for Fluoroquinolone Toxicity A Complex Case Analysis.md
SYSTEM-ARCHITECTURE.mdmd16KBveronika-health-db/public/SYSTEM-ARCHITECTURE.md
065_2026-01-13_IV_Iron_Infusion_Clinics_and_Services_Across_Spain_Urgent_T.mdmd16KBartifacts-database/pre-extracted-artifacts/065_2026-01-13_IV_Iron_Infusion_Clinics_and_Services_Across_Spain_Urgent_T.md
14.01_IV Iron Infusion Clinics and Services Across Spain Urgent Treatment Options.mdmd16KBartifacts-database/by-tag/железо/14.01_IV Iron Infusion Clinics and Services Across Spain Urgent Treatment Options.md
01_IV Iron Infusion Clinics and Services Across Spain Urgent Treatment Options.mdmd16KBartifacts-database/by-chat/14.01_77f07fb7_IV iron Spain (Feriv)/01_IV Iron Infusion Clinics and Services Across Spain Urgent Treatment Options.md
056_2026-01-06_IV_Antioxidant_Therapies_for_FQAD_Recovery_Evidence_and_Pra.mdmd16KBartifacts-database/pre-extracted-artifacts/056_2026-01-06_IV_Antioxidant_Therapies_for_FQAD_Recovery_Evidence_and_Pra.md
071_2026-01-14_Clomipramine_Safety_Assessment_High-Risk_Profile_for_FQAD_P.mdmd15KBartifacts-database/pre-extracted-artifacts/071_2026-01-14_Clomipramine_Safety_Assessment_High-Risk_Profile_for_FQAD_P.md
14.01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.mdmd15KBartifacts-database/by-tag/документы/14.01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.md
14.01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.mdmd15KBartifacts-database/by-tag/терапия/14.01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.md
01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.mdmd15KBartifacts-database/by-chat/14.01_55d3f95d_История на русском (ОКР vs руминация)/01_Clomipramine Safety Assessment High-Risk Profile for FQAD Patient.md
18.02_FQAD at a Turning Point Molecular Breakthroughs, ICD Codes, and the Long Road to.mdmd15KBartifacts-database/by-tag/клиники/18.02_FQAD at a Turning Point Molecular Breakthroughs, ICD Codes, and the Long Road to.md
03_FQAD at a Turning Point Molecular Breakthroughs, ICD Codes, and the Long Road to.mdmd15KBartifacts-database/by-chat/18.02_95993d55_Top brain clinics Spain/03_FQAD at a Turning Point Molecular Breakthroughs, ICD Codes, and the Long Road to.md
04_2025-09-23_Veronika_s_sleep_medication_changes.txttxt15KBartifacts-database/chat-transcripts/04_2025-09-23_Veronika_s_sleep_medication_changes.txt
30.12_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.mdmd15KBartifacts-database/by-tag/кризисы/30.12_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.md
30.12_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.mdmd15KBartifacts-database/by-tag/лекарства/30.12_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.md
06_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.mdmd15KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/06_Cerebellar Ataxia in Benzodiazepine Withdrawal and FQAD Mechanisms and Treatment.md
15.10_Quetiapine Safety Assessment for Complex Medical Profile with Fluoroquinolone Hi.mdmd15KBartifacts-database/by-tag/лекарства/15.10_Quetiapine Safety Assessment for Complex Medical Profile with Fluoroquinolone Hi.md
01_Quetiapine Safety Assessment for Complex Medical Profile with Fluoroquinolone Hi.mdmd15KBartifacts-database/by-chat/15.10_f18d4b2c_Quetiapine suitability/01_Quetiapine Safety Assessment for Complex Medical Profile with Fluoroquinolone Hi.md
03.01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.mdmd15KBartifacts-database/by-tag/бензо/03.01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.md
03.01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.mdmd15KBartifacts-database/by-tag/wellness/03.01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.md
01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.mdmd15KBartifacts-database/by-chat/03.01_a8d01711_План снижения клоназепама/01_Безопасный план отмены клоназепама при повышенной чувствительности к препаратам.md
093_2026-02-01_Breaking_the_Loop_What_Actually_Works_for_Severe_Rumination.mdmd15KBartifacts-database/pre-extracted-artifacts/093_2026-02-01_Breaking_the_Loop_What_Actually_Works_for_Severe_Rumination.md
01.02_Breaking the Loop What Actually Works for Severe Rumination.mdmd15KBartifacts-database/by-tag/бензо/01.02_Breaking the Loop What Actually Works for Severe Rumination.md
04_Breaking the Loop What Actually Works for Severe Rumination.mdmd15KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/04_Breaking the Loop What Actually Works for Severe Rumination.md
099_2026-02-01_TMS_for_FQAD-Related_Depression_Evidence_Review_and_Treatme.mdmd15KBartifacts-database/pre-extracted-artifacts/099_2026-02-01_TMS_for_FQAD-Related_Depression_Evidence_Review_and_Treatme.md
05.02_TMS for FQAD-Related Depression Evidence Review and Treatment Preparation Guide.mdmd15KBartifacts-database/by-tag/TMS/05.02_TMS for FQAD-Related Depression Evidence Review and Treatment Preparation Guide.md
04_TMS for FQAD-Related Depression Evidence Review and Treatment Preparation Guide.mdmd15KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/04_TMS for FQAD-Related Depression Evidence Review and Treatment Preparation Guide.md
22.01_Evidence-Based 30-Day Health Optimization Protocol What Science Actually Support.mdmd15KBartifacts-database/by-tag/wellness/22.01_Evidence-Based 30-Day Health Optimization Protocol What Science Actually Support.md
02_Evidence-Based 30-Day Health Optimization Protocol What Science Actually Support.mdmd15KBartifacts-database/by-chat/22.01_b85c581d_30-дневный план детокса/02_Evidence-Based 30-Day Health Optimization Protocol What Science Actually Support.md
09.10_Taking Lorazepam After Atarax Elevated Safety Concerns for Patients with Fluoroq.mdmd15KBartifacts-database/by-tag/лекарства/09.10_Taking Lorazepam After Atarax Elevated Safety Concerns for Patients with Fluoroq.md
01_Taking Lorazepam After Atarax Elevated Safety Concerns for Patients with Fluoroq.mdmd15KBartifacts-database/by-chat/09.10_96e139bb_Medication interaction lorazepamatarax 12hr/01_Taking Lorazepam After Atarax Elevated Safety Concerns for Patients with Fluoroq.md
44_2025-12-10_Managing_Cipralex_discontinuation_symptoms.txttxt15KBartifacts-database/chat-transcripts/44_2025-12-10_Managing_Cipralex_discontinuation_symptoms.txt
007_2025-09-30_When_Sleep_Medicine_Turns_Dark_Trazodone_s_Paradoxical_Depr.mdmd15KBartifacts-database/pre-extracted-artifacts/007_2025-09-30_When_Sleep_Medicine_Turns_Dark_Trazodone_s_Paradoxical_Depr.md
30.09_When Sleep Medicine Turns Dark Trazodones Paradoxical Depression Effects in Vuln.mdmd15KBartifacts-database/by-tag/лекарства/30.09_When Sleep Medicine Turns Dark Trazodones Paradoxical Depression Effects in Vuln.md
01_When Sleep Medicine Turns Dark Trazodones Paradoxical Depression Effects in Vuln.mdmd15KBartifacts-database/by-chat/30.09_e3364ec3_Trazodone paradoxical depression/01_When Sleep Medicine Turns Dark Trazodones Paradoxical Depression Effects in Vuln.md
PROJECT-LOG.mdmd15KBveronika-health-db/PROJECT-LOG.md
24.01_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.mdmd15KBartifacts-database/by-tag/терапия/24.01_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.md
24.01_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.mdmd15KBartifacts-database/by-tag/лекарства/24.01_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.md
02_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.mdmd15KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/02_Medication Safety Analysis for FQAD Patient Lamotrigine, Aripiprazole, and Bupro.md
053_2026-01-05_FQAD_Patients_and_Benzodiazepine_Tapers_Scientific_Mechanis.mdmd15KBartifacts-database/pre-extracted-artifacts/053_2026-01-05_FQAD_Patients_and_Benzodiazepine_Tapers_Scientific_Mechanis.md
05.01_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.mdmd15KBartifacts-database/by-tag/бензо/05.01_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.md
05.01_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.mdmd15KBartifacts-database/by-tag/добавки/05.01_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.md
03_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.mdmd15KBartifacts-database/by-chat/05.01_d7b4a21a_Natural alternatives to benzos/03_FQAD Patients and Benzodiazepine Tapers Scientific Mechanisms, Patient Experienc.md
083_2026-01-18_Evidence-Based_Resources_Against_Abrupt_Benzodiazepine_Disco.mdmd15KBartifacts-database/pre-extracted-artifacts/083_2026-01-18_Evidence-Based_Resources_Against_Abrupt_Benzodiazepine_Disco.md
19.01_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.mdmd15KBartifacts-database/by-tag/бензо/19.01_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.md
19.01_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.mdmd15KBartifacts-database/by-tag/руминация/19.01_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.md
04_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.mdmd15KBartifacts-database/by-chat/19.01_f67d5678_Clonazepam rumination/04_Evidence-Based Resources Against Abrupt Benzodiazepine Discontinuation Clinical.md
27.01_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.mdmd15KBartifacts-database/by-tag/гормоны/27.01_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.md
27.01_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.mdmd15KBartifacts-database/by-tag/железо/27.01_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.md
11_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.mdmd15KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/11_Iron Deficiency and Neuropsychiatric Symptoms Fact-Check Analysis.md
03.01_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.mdmd15KBartifacts-database/by-tag/wellness/03.01_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.md
03.01_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.mdmd15KBartifacts-database/by-tag/добавки/03.01_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.md
02_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.mdmd15KBartifacts-database/by-chat/03.01_bccbd47e_Релаксация Джейкобсона PBM research/02_Near-Infrared Photobiomodulation for Fluoroquinolone Toxicity A Comprehensive Ev.md
23.01_Transdermal Estradiol for Functional Hypothalamic Amenorrhea Long-Term Effects a.mdmd15KBartifacts-database/by-tag/гормоны/23.01_Transdermal Estradiol for Functional Hypothalamic Amenorrhea Long-Term Effects a.md
01_Transdermal Estradiol for Functional Hypothalamic Amenorrhea Long-Term Effects a.mdmd15KBartifacts-database/by-chat/23.01_a9dae63c_Эстрогеновые пластыри effects/01_Transdermal Estradiol for Functional Hypothalamic Amenorrhea Long-Term Effects a.md
03.01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.mdmd15KBartifacts-database/by-tag/wellness/03.01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.md
03.01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.mdmd15KBartifacts-database/by-tag/добавки/03.01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.md
01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.mdmd15KBartifacts-database/by-chat/03.01_bccbd47e_Релаксация Джейкобсона PBM research/01_Scientific Evidence for Progressive Muscle Relaxation Meta-Analyses and Clinical.md
037_2025-12-03_Blood_Test_Analysis_Hidden_Concerns_Beneath_Normal_Results_.mdmd15KBartifacts-database/pre-extracted-artifacts/037_2025-12-03_Blood_Test_Analysis_Hidden_Concerns_Beneath_Normal_Results_.md
02.12_Escitalopram-Induced Liver Injury Clinical Assessment and Management.mdmd15KBartifacts-database/by-tag/печень/02.12_Escitalopram-Induced Liver Injury Clinical Assessment and Management.md
02.12_Escitalopram-Induced Liver Injury Clinical Assessment and Management.mdmd15KBartifacts-database/by-tag/лекарства/02.12_Escitalopram-Induced Liver Injury Clinical Assessment and Management.md
01_Escitalopram-Induced Liver Injury Clinical Assessment and Management.mdmd15KBartifacts-database/by-chat/02.12_ecf0a91f_Liver damage ALT 173/01_Escitalopram-Induced Liver Injury Clinical Assessment and Management.md
042_2025-12-06_German_Integrative_Medicine_Clinics_for_Complex_Chronic_Cond.mdmd15KBartifacts-database/pre-extracted-artifacts/042_2025-12-06_German_Integrative_Medicine_Clinics_for_Complex_Chronic_Cond.md
018_2025-10-02_Sequential_Use_of_Lorazepam_and_Trazodone_Safety_Profile_an.mdmd14KBartifacts-database/pre-extracted-artifacts/018_2025-10-02_Sequential_Use_of_Lorazepam_and_Trazodone_Safety_Profile_an.md
24.01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.mdmd14KBartifacts-database/by-tag/терапия/24.01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.md
24.01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.mdmd14KBartifacts-database/by-tag/лекарства/24.01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.md
01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.mdmd14KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/01_Chronic Rumination and Depression Clinical Assessment and Treatment Recommendati.md
24.01_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.mdmd14KBartifacts-database/by-tag/терапия/24.01_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.md
24.01_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.mdmd14KBartifacts-database/by-tag/лекарства/24.01_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.md
03_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.mdmd14KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/03_Medication Ranking for Depressive Rumination in FQAD Treatment Analysis and Reco.md
048_2025-12-27_Clonazepam_Discontinuation_and_Rebound_Insomnia_Clinical_Ev.mdmd14KBartifacts-database/pre-extracted-artifacts/048_2025-12-27_Clonazepam_Discontinuation_and_Rebound_Insomnia_Clinical_Ev.md
079_2026-01-17_Why_Doctors_Hesitate_to_Prescribe_Estrogen_for_Functional_Hy.mdmd14KBartifacts-database/pre-extracted-artifacts/079_2026-01-17_Why_Doctors_Hesitate_to_Prescribe_Estrogen_for_Functional_Hy.md
17.01_Why Doctors Hesitate to Prescribe Estrogen for Functional Hypothalamic Amenorrhe.mdmd14KBartifacts-database/by-tag/железо/17.01_Why Doctors Hesitate to Prescribe Estrogen for Functional Hypothalamic Amenorrhe.md
03_Why Doctors Hesitate to Prescribe Estrogen for Functional Hypothalamic Amenorrhe.mdmd14KBartifacts-database/by-chat/17.01_7b5f1fe3_Глубокий анализ ферритина/03_Why Doctors Hesitate to Prescribe Estrogen for Functional Hypothalamic Amenorrhe.md
04.01_ZEM Wellness Clinic Altea Evidence Verification Report.mdmd14KBartifacts-database/by-tag/клиники/04.01_ZEM Wellness Clinic Altea Evidence Verification Report.md
01_ZEM Wellness Clinic Altea Evidence Verification Report.mdmd14KBartifacts-database/by-chat/04.01_576fb70a_ZEM Wellness analysis doc/01_ZEM Wellness Clinic Altea Evidence Verification Report.md
03.01_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.mdmd14KBartifacts-database/by-tag/wellness/03.01_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.md
03.01_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.mdmd14KBartifacts-database/by-tag/клиники/03.01_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.md
03_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.mdmd14KBartifacts-database/by-chat/03.01_af67cc8b_Научный анализ процедур ZEM/03_Vibroacoustic Therapy and RLX SATORI Device Evidence Review for Fluoroquinolone.md
22.12_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.mdmd14KBartifacts-database/by-tag/FQAD/22.12_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.md
22.12_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.mdmd14KBartifacts-database/by-tag/лекарства/22.12_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.md
01_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.mdmd14KBartifacts-database/by-chat/22.12_bed63ef4_Никотиновые пластыри кветиапин/01_Medication Safety Analysis for FQAD Patient Nicotine Patches and Quetiapine Risk.md
ACTION-PLAN-2-MONTHS.mdmd14KBveronika-health-db/public/ACTION-PLAN-2-MONTHS.md
109_2026-02-01_Severe_Adverse_Effects_from_TMS_Documented_Cases_and_Real_R.mdmd14KBartifacts-database/pre-extracted-artifacts/109_2026-02-01_Severe_Adverse_Effects_from_TMS_Documented_Cases_and_Real_R.md
05.02_Severe Adverse Effects from TMS Documented Cases and Real Risks.mdmd14KBartifacts-database/by-tag/TMS/05.02_Severe Adverse Effects from TMS Documented Cases and Real Risks.md
14_Severe Adverse Effects from TMS Documented Cases and Real Risks.mdmd14KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/14_Severe Adverse Effects from TMS Documented Cases and Real Risks.md
21.02_Methylene Blue for FQAD Mitochondrial Recovery A Complete Evidence Review.mdmd14KBartifacts-database/by-tag/добавки/21.02_Methylene Blue for FQAD Mitochondrial Recovery A Complete Evidence Review.md
01_Methylene Blue for FQAD Mitochondrial Recovery A Complete Evidence Review.mdmd14KBartifacts-database/by-chat/21.02_e520b05b_Methylene blue mitochondria/01_Methylene Blue for FQAD Mitochondrial Recovery A Complete Evidence Review.md
049_2026-01-04_.mdmd14KBartifacts-database/pre-extracted-artifacts/049_2026-01-04_.md
137_2026-03-11_English-Speaking_Psychiatric_Inpatient_Clinics_Across_Europe.mdmd14KBartifacts-database/pre-extracted-artifacts/137_2026-03-11_English-Speaking_Psychiatric_Inpatient_Clinics_Across_Europe.md
14.03_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.mdmd14KBartifacts-database/by-tag/клиники/14.03_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.md
14.03_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.mdmd14KBartifacts-database/by-tag/документы/14.03_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.md
07_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.mdmd14KBartifacts-database/by-chat/14.03_de6e1014_40 клиник strategic plan/07_English-Speaking Psychiatric Inpatient Clinics Across Europe A Comparative Analy.md
47_2025-12-20_Veronika_s_comprehensive_medical_history_and_treatment_plan.txttxt14KBartifacts-database/chat-transcripts/47_2025-12-20_Veronika_s_comprehensive_medical_history_and_treatment_plan.txt
28.12_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.mdmd14KBartifacts-database/by-tag/кризисы/28.12_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.md
28.12_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.mdmd14KBartifacts-database/by-tag/лекарства/28.12_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.md
02_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.mdmd14KBartifacts-database/by-chat/28.12_4a45246e_Ночной террор кветиапин/02_Emergency Differential Diagnosis Quetiapine, FQAD, and Low Ferritin Convergence.md
095_2026-02-01_Evidence-Based_Treatment_Analysis_for_FQAD_with_Iron_Deficie.mdmd14KBartifacts-database/pre-extracted-artifacts/095_2026-02-01_Evidence-Based_Treatment_Analysis_for_FQAD_with_Iron_Deficie.md
01.02_Evidence-Based Treatment Analysis for FQAD with Iron Deficiency and Psychiatric.mdmd14KBartifacts-database/by-tag/бензо/01.02_Evidence-Based Treatment Analysis for FQAD with Iron Deficiency and Psychiatric.md
06_Evidence-Based Treatment Analysis for FQAD with Iron Deficiency and Psychiatric.mdmd14KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/06_Evidence-Based Treatment Analysis for FQAD with Iron Deficiency and Psychiatric.md
096_2026-02-01_TMS_for_FQAD_with_GABA_Damage_A_Clinical_Decision_Guide.mdmd14KBartifacts-database/pre-extracted-artifacts/096_2026-02-01_TMS_for_FQAD_with_GABA_Damage_A_Clinical_Decision_Guide.md
05.02_TMS for FQAD with GABA Damage A Clinical Decision Guide.mdmd14KBartifacts-database/by-tag/TMS/05.02_TMS for FQAD with GABA Damage A Clinical Decision Guide.md
01_TMS for FQAD with GABA Damage A Clinical Decision Guide.mdmd14KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/01_TMS for FQAD with GABA Damage A Clinical Decision Guide.md
23.01_Estrogen Therapy for Depression in Young Hypoestrogenic Women What the Science S.mdmd14KBartifacts-database/by-tag/гормоны/23.01_Estrogen Therapy for Depression in Young Hypoestrogenic Women What the Science S.md
05_Estrogen Therapy for Depression in Young Hypoestrogenic Women What the Science S.mdmd14KBartifacts-database/by-chat/23.01_a9dae63c_Эстрогеновые пластыри effects/05_Estrogen Therapy for Depression in Young Hypoestrogenic Women What the Science S.md
08.01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.mdmd14KBartifacts-database/by-tag/бензо/08.01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.md
08.01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.mdmd14KBartifacts-database/by-tag/кризисы/08.01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.md
01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.mdmd14KBartifacts-database/by-chat/08.01_efa5ef9b_Тревожность tolerance withdrawal/01_Benzodiazepine Tolerance in FQAD Urgent Management Guide.md
26.01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.mdmd14KBartifacts-database/by-tag/гормоны/26.01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.md
26.01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.mdmd14KBartifacts-database/by-tag/врачи/26.01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.md
01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.mdmd14KBartifacts-database/by-chat/26.01_f89e1470_Finding functional gynecologist/01_Integrative Gynecologists for Complex FQAD Recovery in Catalonia and Beyond.md
18.12_Quetiapine in FQAD Patients Safety Concerns and Safer Alternatives for Sleep and.mdmd14KBartifacts-database/by-tag/лекарства/18.12_Quetiapine in FQAD Patients Safety Concerns and Safer Alternatives for Sleep and.md
02_Quetiapine in FQAD Patients Safety Concerns and Safer Alternatives for Sleep and.mdmd14KBartifacts-database/by-chat/18.12_a53ea027_Кветиапин альтернатива/02_Quetiapine in FQAD Patients Safety Concerns and Safer Alternatives for Sleep and.md
094_2026-02-01_TMS_Safety_Research_Risks_Permanent_Damage_and_the_Unchar.mdmd14KBartifacts-database/pre-extracted-artifacts/094_2026-02-01_TMS_Safety_Research_Risks_Permanent_Damage_and_the_Unchar.md
01.02_TMS Safety Research Risks, Permanent Damage, and the Uncharted Territory of FQAD.mdmd14KBartifacts-database/by-tag/бензо/01.02_TMS Safety Research Risks, Permanent Damage, and the Uncharted Territory of FQAD.md
05_TMS Safety Research Risks, Permanent Damage, and the Uncharted Territory of FQAD.mdmd14KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/05_TMS Safety Research Risks, Permanent Damage, and the Uncharted Territory of FQAD.md
24.01_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.mdmd13KBartifacts-database/by-tag/терапия/24.01_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.md
24.01_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.mdmd13KBartifacts-database/by-tag/лекарства/24.01_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.md
05_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.mdmd13KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/05_Breaking Severe Rumination A Crisis Intervention Guide for Caregivers.md
15.10_Can You Take Cipralex with Atarax Safely Cardiac Risks and Clinical Guidelines.mdmd13KBartifacts-database/by-tag/лекарства/15.10_Can You Take Cipralex with Atarax Safely Cardiac Risks and Clinical Guidelines.md
02_Can You Take Cipralex with Atarax Safely Cardiac Risks and Clinical Guidelines.mdmd13KBartifacts-database/by-chat/15.10_df5a3639_Lorazepam Atarax interactions/02_Can You Take Cipralex with Atarax Safely Cardiac Risks and Clinical Guidelines.md
2026-01-14_Treatment_Plan_Veronika_Pogrebova_13.01.26.docx.txttxt13KBartifacts-database/chat-uploaded-files/2026-01-14_Treatment_Plan_Veronika_Pogrebova_13.01.26.docx.txt
2025-12-23_2_Treatment_Plan_Veronika_Pogrebova_11.11.25.docx.txttxt13KBartifacts-database/chat-uploaded-files/2025-12-23_2_Treatment_Plan_Veronika_Pogrebova_11.11.25.docx.txt
78_2026-02-04_.txttxt13KBartifacts-database/chat-transcripts/78_2026-02-04_.txt
06-decisions-actions.mdmd13KBartifacts-database/compiled-docs/06-decisions-actions.md
06_2025-09-26_Fluoroquinolone_antibiotics_risks.txttxt13KBartifacts-database/chat-transcripts/06_2025-09-26_Fluoroquinolone_antibiotics_risks.txt
03.01_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.mdmd13KBartifacts-database/by-tag/wellness/03.01_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.md
03.01_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.mdmd13KBartifacts-database/by-tag/добавки/03.01_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.md
03_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.mdmd13KBartifacts-database/by-chat/03.01_bccbd47e_Релаксация Джейкобсона PBM research/03_Vielight Photobiomodulation Promising Signals, Preliminary Evidence.md
56_2026-01-06_posmotri_prediduwii_chat_i_sde_.txttxt13KBartifacts-database/chat-transcripts/56_2026-01-06_posmotri_prediduwii_chat_i_sde_.txt
26.01_SHA Wellness Clinic Лучший реабилитационный центр для восстановления после FQAD.mdmd13KBartifacts-database/by-tag/клиники/26.01_SHA Wellness Clinic Лучший реабилитационный центр для восстановления после FQAD.md
03_SHA Wellness Clinic Лучший реабилитационный центр для восстановления после FQAD.mdmd13KBartifacts-database/by-chat/26.01_4a0572eb_Клиника мировой поиск (SHA, Израиль)/03_SHA Wellness Clinic Лучший реабилитационный центр для восстановления после FQAD.md
070_2026-01-14_IV_Treatments_for_Fluoroquinolone_Toxicity_A_Patient_Experi.mdmd13KBartifacts-database/pre-extracted-artifacts/070_2026-01-14_IV_Treatments_for_Fluoroquinolone_Toxicity_A_Patient_Experi.md
14.01_IV Treatments for Fluoroquinolone Toxicity A Patient Experience Analysis.mdmd13KBartifacts-database/by-tag/FQAD/14.01_IV Treatments for Fluoroquinolone Toxicity A Patient Experience Analysis.md
01_IV Treatments for Fluoroquinolone Toxicity A Patient Experience Analysis.mdmd13KBartifacts-database/by-chat/14.01_c7f9787f_FloxieHope IVs/01_IV Treatments for Fluoroquinolone Toxicity A Patient Experience Analysis.md
111_2026-02-01_Accelerated_iTBS_Safety_Assessment_Critical_Review_for_Trea.mdmd13KBartifacts-database/pre-extracted-artifacts/111_2026-02-01_Accelerated_iTBS_Safety_Assessment_Critical_Review_for_Trea.md
05.02_Accelerated iTBS Safety Assessment Critical Review for Treatment-Resistant Depre.mdmd13KBartifacts-database/by-tag/TMS/05.02_Accelerated iTBS Safety Assessment Critical Review for Treatment-Resistant Depre.md
16_Accelerated iTBS Safety Assessment Critical Review for Treatment-Resistant Depre.mdmd13KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/16_Accelerated iTBS Safety Assessment Critical Review for Treatment-Resistant Depre.md
15.01_Antidepressants and Iron Deficiency Evidence-Based Guidance for FQAD Recovery.mdmd13KBartifacts-database/by-tag/лекарства/15.01_Antidepressants and Iron Deficiency Evidence-Based Guidance for FQAD Recovery.md
02_Antidepressants and Iron Deficiency Evidence-Based Guidance for FQAD Recovery.mdmd13KBartifacts-database/by-chat/15.01_6221b8ed_Anafranil Brintellix safety/02_Antidepressants and Iron Deficiency Evidence-Based Guidance for FQAD Recovery.md
30.12_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.mdmd13KBartifacts-database/by-tag/кризисы/30.12_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.md
30.12_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.mdmd13KBartifacts-database/by-tag/лекарства/30.12_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.md
03_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.mdmd13KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/03_PRN Benzodiazepines During Withdrawal Scientific Consensus Against Intermittent.md
005_2025-09-26_Critical_Safety_Concerns_for_Lorazepam_Use_After_Fluoroquino.mdmd13KBartifacts-database/pre-extracted-artifacts/005_2025-09-26_Critical_Safety_Concerns_for_Lorazepam_Use_After_Fluoroquino.md
26.09_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.mdmd13KBartifacts-database/by-tag/бензо/26.09_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.md
26.09_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.mdmd13KBartifacts-database/by-tag/FQAD/26.09_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.md
01_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.mdmd13KBartifacts-database/by-chat/26.09_f64951c6_FQ benzodiazepine interaction/01_Critical Safety Concerns for Lorazepam Use After Fluoroquinolone Exposure.md
16.01_IV Iron Safety Assessment for Patient with FQAD and Multiple Drug Sensitivities.mdmd13KBartifacts-database/by-tag/железо/16.01_IV Iron Safety Assessment for Patient with FQAD and Multiple Drug Sensitivities.md
02_IV Iron Safety Assessment for Patient with FQAD and Multiple Drug Sensitivities.mdmd13KBartifacts-database/by-chat/16.01_07d686e7_IV железо безопасность/02_IV Iron Safety Assessment for Patient with FQAD and Multiple Drug Sensitivities.md
27.01_Complete Diagnostic Analysis Veronikas Multifactorial Illness.mdmd13KBartifacts-database/by-tag/гормоны/27.01_Complete Diagnostic Analysis Veronikas Multifactorial Illness.md
27.01_Complete Diagnostic Analysis Veronikas Multifactorial Illness.mdmd13KBartifacts-database/by-tag/железо/27.01_Complete Diagnostic Analysis Veronikas Multifactorial Illness.md
08_Complete Diagnostic Analysis Veronikas Multifactorial Illness.mdmd13KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/08_Complete Diagnostic Analysis Veronikas Multifactorial Illness.md
62_2026-01-13_NAD_.txttxt13KBartifacts-database/chat-transcripts/62_2026-01-13_NAD_.txt
088_2026-01-21_How_TMS_Rewires_the_Brain_Mechanisms_Durability_and_the_Q.mdmd13KBartifacts-database/pre-extracted-artifacts/088_2026-01-21_How_TMS_Rewires_the_Brain_Mechanisms_Durability_and_the_Q.md
21.01_How TMS Rewires the Brain Mechanisms, Durability, and the Question of Permanence.mdmd13KBartifacts-database/by-tag/TMS/21.01_How TMS Rewires the Brain Mechanisms, Durability, and the Question of Permanence.md
04_How TMS Rewires the Brain Mechanisms, Durability, and the Question of Permanence.mdmd13KBartifacts-database/by-chat/21.01_6dcb4cc8_TMS подготовка побочные/04_How TMS Rewires the Brain Mechanisms, Durability, and the Question of Permanence.md
19.12_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.mdmd13KBartifacts-database/by-tag/FQAD/19.12_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.md
19.12_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.mdmd13KBartifacts-database/by-tag/врачи/19.12_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.md
03_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.mdmd13KBartifacts-database/by-chat/19.12_3fc5edd6_Анализ программы Pieper/03_Nicotine Patch Safety for FQAD A Complex Risk-Benefit Analysis.md
110_2026-02-01_TMS_Harm_Reports_What_Clinics_Don_t_Tell_Patients.mdmd13KBartifacts-database/pre-extracted-artifacts/110_2026-02-01_TMS_Harm_Reports_What_Clinics_Don_t_Tell_Patients.md
05.02_TMS Harm Reports What Clinics Dont Tell Patients.mdmd13KBartifacts-database/by-tag/TMS/05.02_TMS Harm Reports What Clinics Dont Tell Patients.md
15_TMS Harm Reports What Clinics Dont Tell Patients.mdmd13KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/15_TMS Harm Reports What Clinics Dont Tell Patients.md
24.01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.mdmd13KBartifacts-database/by-tag/руминация/24.01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.md
24.01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.mdmd13KBartifacts-database/by-tag/терапия/24.01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.md
01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.mdmd13KBartifacts-database/by-chat/24.01_e924eae1_Руминация TMS RFCBT/01_TMS Shows Promise for Rumination but Evidence Remains Incomplete.md
2026-01-12_Treatment_Plan_Veronika_Pogrebova_16.12.25.docx.txttxt13KBartifacts-database/chat-uploaded-files/2026-01-12_Treatment_Plan_Veronika_Pogrebova_16.12.25.docx.txt
001_2025-09-21_Magnesium_Forms_for_Sleep_Brain_Bioavailability_and_Clinica.mdmd12KBartifacts-database/pre-extracted-artifacts/001_2025-09-21_Magnesium_Forms_for_Sleep_Brain_Bioavailability_and_Clinica.md
22.09_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.mdmd12KBartifacts-database/by-tag/FQAD/22.09_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.md
22.09_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.mdmd12KBartifacts-database/by-tag/кризисы/22.09_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.md
01_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.mdmd12KBartifacts-database/by-chat/22.09_e5d50070_Insomnia crisis start — FQAD relapse/01_Magnesium Forms for Sleep Brain Bioavailability and Clinical Effectiveness Analy.md
128_2026-03-10_MRS_GABA_Measurement_Will_Not_Guide_Treatment_Decisions_Cli.mdmd12KBartifacts-database/pre-extracted-artifacts/128_2026-03-10_MRS_GABA_Measurement_Will_Not_Guide_Treatment_Decisions_Cli.md
16.03_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.mdmd12KBartifacts-database/by-tag/врачи/16.03_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.md
16.03_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.mdmd12KBartifacts-database/by-tag/документы/16.03_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.md
04_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.mdmd12KBartifacts-database/by-chat/16.03_b76e8115_Müller strategic plan v3/04_MRS GABA Measurement Will Not Guide Treatment Decisions Clinical Utility Analysi.md
103_2026-02-01_Anhedonia_and_Amenorrhea_Evidence-Based_Mechanisms_and_Shar.mdmd12KBartifacts-database/pre-extracted-artifacts/103_2026-02-01_Anhedonia_and_Amenorrhea_Evidence-Based_Mechanisms_and_Shar.md
05.02_Anhedonia and Amenorrhea Evidence-Based Mechanisms and Shared Pathways in HPA Ax.mdmd12KBartifacts-database/by-tag/TMS/05.02_Anhedonia and Amenorrhea Evidence-Based Mechanisms and Shared Pathways in HPA Ax.md
08_Anhedonia and Amenorrhea Evidence-Based Mechanisms and Shared Pathways in HPA Ax.mdmd12KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/08_Anhedonia and Amenorrhea Evidence-Based Mechanisms and Shared Pathways in HPA Ax.md
16.01_IV Iron Infusion Safety for Patients with Complex Medical Histories.mdmd12KBartifacts-database/by-tag/железо/16.01_IV Iron Infusion Safety for Patients with Complex Medical Histories.md
01_IV Iron Infusion Safety for Patients with Complex Medical Histories.mdmd12KBartifacts-database/by-chat/16.01_07d686e7_IV железо безопасность/01_IV Iron Infusion Safety for Patients with Complex Medical Histories.md
089_2026-01-21_TMS_Four_Decades_of_Safety_Data_Reveal_Excellent_Profile_wi.mdmd12KBartifacts-database/pre-extracted-artifacts/089_2026-01-21_TMS_Four_Decades_of_Safety_Data_Reveal_Excellent_Profile_wi.md
21.01_TMS Four Decades of Safety Data Reveal Excellent Profile with Notable Research G.mdmd12KBartifacts-database/by-tag/TMS/21.01_TMS Four Decades of Safety Data Reveal Excellent Profile with Notable Research G.md
05_TMS Four Decades of Safety Data Reveal Excellent Profile with Notable Research G.mdmd12KBartifacts-database/by-chat/21.01_6dcb4cc8_TMS подготовка побочные/05_TMS Four Decades of Safety Data Reveal Excellent Profile with Notable Research G.md
27.01_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.mdmd12KBartifacts-database/by-tag/гормоны/27.01_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.md
27.01_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.mdmd12KBartifacts-database/by-tag/железо/27.01_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.md
10_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.mdmd12KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/10_Iron Deficiency and Neuropsychiatric Symptoms A Rigorous Fact-Check.md
15.01_Quetiapine Safety Risks Evidence Review of Low-Dose Use and Clinical Guidelines.mdmd12KBartifacts-database/by-tag/лекарства/15.01_Quetiapine Safety Risks Evidence Review of Low-Dose Use and Clinical Guidelines.md
04_Quetiapine Safety Risks Evidence Review of Low-Dose Use and Clinical Guidelines.mdmd12KBartifacts-database/by-chat/15.01_6221b8ed_Anafranil Brintellix safety/04_Quetiapine Safety Risks Evidence Review of Low-Dose Use and Clinical Guidelines.md
30.12_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.mdmd12KBartifacts-database/by-tag/кризисы/30.12_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.md
30.12_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.mdmd12KBartifacts-database/by-tag/лекарства/30.12_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.md
04_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.mdmd12KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/04_PRN-приём бензодиазепинов научный обзор рисков и рекомендаций после отмены.md
23.01_Transdermal Estradiol for Hypothalamic Amenorrhea Comprehensive Risk Profile for.mdmd12KBartifacts-database/by-tag/гормоны/23.01_Transdermal Estradiol for Hypothalamic Amenorrhea Comprehensive Risk Profile for.md
02_Transdermal Estradiol for Hypothalamic Amenorrhea Comprehensive Risk Profile for.mdmd12KBartifacts-database/by-chat/23.01_a9dae63c_Эстрогеновые пластыри effects/02_Transdermal Estradiol for Hypothalamic Amenorrhea Comprehensive Risk Profile for.md
125_2026-03-10_Prof._Dr._Thomas_M_ller_A_Parkinson_s_Expert_with_Untapped_.mdmd12KBartifacts-database/pre-extracted-artifacts/125_2026-03-10_Prof._Dr._Thomas_M_ller_A_Parkinson_s_Expert_with_Untapped_.md
16.03_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.mdmd12KBartifacts-database/by-tag/врачи/16.03_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.md
16.03_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.mdmd12KBartifacts-database/by-tag/документы/16.03_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.md
01_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.mdmd12KBartifacts-database/by-chat/16.03_b76e8115_Müller strategic plan v3/01_Prof. Dr. Thomas Müller A Parkinsons Expert with Untapped Relevance to FQAD.md
27.01_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.mdmd12KBartifacts-database/by-tag/гормоны/27.01_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.md
27.01_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.mdmd12KBartifacts-database/by-tag/железо/27.01_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.md
07_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.mdmd12KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/07_Honest Reassessment Evidence for Iron Deficiency, FQAD, and Depression Treatment.md
06.03_CUN Pamplona Complaint Contacts and Escalation Directory.mdmd12KBartifacts-database/by-tag/CUN/06.03_CUN Pamplona Complaint Contacts and Escalation Directory.md
06.03_CUN Pamplona Complaint Contacts and Escalation Directory.mdmd12KBartifacts-database/by-tag/кризисы/06.03_CUN Pamplona Complaint Contacts and Escalation Directory.md
01_CUN Pamplona Complaint Contacts and Escalation Directory.mdmd12KBartifacts-database/by-chat/06.03_349efdab_CUN complaint психиатрия/01_CUN Pamplona Complaint Contacts and Escalation Directory.md
19.02_The Science of Confession How Disclosure Improves Health, Relationships, and Wel.mdmd12KBartifacts-database/by-tag/терапия/19.02_The Science of Confession How Disclosure Improves Health, Relationships, and Wel.md
03_The Science of Confession How Disclosure Improves Health, Relationships, and Wel.mdmd12KBartifacts-database/by-chat/19.02_f1594b90_Pennebaker — секреты здоровье/03_The Science of Confession How Disclosure Improves Health, Relationships, and Wel.md
28.12_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.mdmd12KBartifacts-database/by-tag/кризисы/28.12_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.md
28.12_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.mdmd12KBartifacts-database/by-tag/лекарства/28.12_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.md
03_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.mdmd12KBartifacts-database/by-chat/28.12_4a45246e_Ночной террор кветиапин/03_Multi-factorial Crisis in FQAD When GABA Systems Fail Simultaneously.md
085_2026-01-21_TMS_for_FQAD_Complete_Clinical_Guide_and_Evidence_Review.mdmd12KBartifacts-database/pre-extracted-artifacts/085_2026-01-21_TMS_for_FQAD_Complete_Clinical_Guide_and_Evidence_Review.md
21.01_TMS for FQAD Complete Clinical Guide and Evidence Review.mdmd12KBartifacts-database/by-tag/TMS/21.01_TMS for FQAD Complete Clinical Guide and Evidence Review.md
01_TMS for FQAD Complete Clinical Guide and Evidence Review.mdmd12KBartifacts-database/by-chat/21.01_6dcb4cc8_TMS подготовка побочные/01_TMS for FQAD Complete Clinical Guide and Evidence Review.md
22.12_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.mdmd12KBartifacts-database/by-tag/FQAD/22.12_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.md
22.12_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.mdmd12KBartifacts-database/by-tag/лекарства/22.12_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.md
02_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.mdmd12KBartifacts-database/by-chat/22.12_bed63ef4_Никотиновые пластыри кветиапин/02_Hydroxyzine-Clonazepam Combination Evidence-Based Safety Guide for FQAD.md
039_2025-12-03_GABA_Recovery_Protocol_for_Fluoroquinolone_Toxicity_with_Con.mdmd12KBartifacts-database/pre-extracted-artifacts/039_2025-12-03_GABA_Recovery_Protocol_for_Fluoroquinolone_Toxicity_with_Con.md
064_2026-01-13_NAD_Therapy_for_FQAD_Recovery_What_the_Science_Actually_Sh.mdmd12KBartifacts-database/pre-extracted-artifacts/064_2026-01-13_NAD_Therapy_for_FQAD_Recovery_What_the_Science_Actually_Sh.md
13.01_NAD Therapy for FQAD Recovery What the Science Actually Shows.mdmd12KBartifacts-database/by-tag/добавки/13.01_NAD Therapy for FQAD Recovery What the Science Actually Shows.md
01_NAD Therapy for FQAD Recovery What the Science Actually Shows.mdmd12KBartifacts-database/by-chat/13.01_3f094537_NAD therapy (NR IV)/01_NAD Therapy for FQAD Recovery What the Science Actually Shows.md
100_2026-02-01_Scientific_Evidence_Links_SSRI_and_Benzodiazepine_Withdrawal.mdmd12KBartifacts-database/pre-extracted-artifacts/100_2026-02-01_Scientific_Evidence_Links_SSRI_and_Benzodiazepine_Withdrawal.md
05.02_Scientific Evidence Links SSRI and Benzodiazepine Withdrawal to Rumination.mdmd12KBartifacts-database/by-tag/TMS/05.02_Scientific Evidence Links SSRI and Benzodiazepine Withdrawal to Rumination.md
05_Scientific Evidence Links SSRI and Benzodiazepine Withdrawal to Rumination.mdmd12KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/05_Scientific Evidence Links SSRI and Benzodiazepine Withdrawal to Rumination.md
081_2026-01-18_Veronika_s_Psychiatric_Crisis_Triple-Hit_Syndrome_of_Iron_D.mdmd12KBartifacts-database/pre-extracted-artifacts/081_2026-01-18_Veronika_s_Psychiatric_Crisis_Triple-Hit_Syndrome_of_Iron_D.md
19.01_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.mdmd12KBartifacts-database/by-tag/бензо/19.01_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.md
19.01_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.mdmd12KBartifacts-database/by-tag/руминация/19.01_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.md
02_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.mdmd12KBartifacts-database/by-chat/19.01_f67d5678_Clonazepam rumination/02_Veronikas Psychiatric Crisis Triple-Hit Syndrome of Iron Deficiency, Benzodiazep.md
004_2025-09-26_Benzodiazepine_Use_After_Fluoroquinolone_Exposure_Effects_.mdmd12KBartifacts-database/pre-extracted-artifacts/004_2025-09-26_Benzodiazepine_Use_After_Fluoroquinolone_Exposure_Effects_.md
26.09_Benzodiazepine Use After Fluoroquinolone Exposure Effects, Recovery, and Treatme.mdmd12KBartifacts-database/by-tag/FQAD/26.09_Benzodiazepine Use After Fluoroquinolone Exposure Effects, Recovery, and Treatme.md
01_Benzodiazepine Use After Fluoroquinolone Exposure Effects, Recovery, and Treatme.mdmd12KBartifacts-database/by-chat/26.09_22e62a7f_Benzoinfo — GABA receptor antagonism/01_Benzodiazepine Use After Fluoroquinolone Exposure Effects, Recovery, and Treatme.md
02-medications-v2.mdmd12KBartifacts-database/compiled-docs/02-medications-v2.md
27.01_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.mdmd12KBartifacts-database/by-tag/гормоны/27.01_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.md
27.01_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.mdmd12KBartifacts-database/by-tag/железо/27.01_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.md
03_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.mdmd12KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/03_The Iron-Neurotransmitter Paradox Why Biochemistry Doesnt Equal Clinical Outcome.md
092_2026-02-01_Fresh_Diagnostic_Perspectives_for_a_Complex_Post-Infectious_.mdmd12KBartifacts-database/pre-extracted-artifacts/092_2026-02-01_Fresh_Diagnostic_Perspectives_for_a_Complex_Post-Infectious_.md
01.02_Fresh Diagnostic Perspectives for a Complex Post-Infectious Psychiatric Presenta.mdmd12KBartifacts-database/by-tag/бензо/01.02_Fresh Diagnostic Perspectives for a Complex Post-Infectious Psychiatric Presenta.md
03_Fresh Diagnostic Perspectives for a Complex Post-Infectious Psychiatric Presenta.mdmd12KBartifacts-database/by-chat/01.02_bf1749c5_Бензо киндлинг (Ashton)/03_Fresh Diagnostic Perspectives for a Complex Post-Infectious Psychiatric Presenta.md
115_2026-02-05_Pregabalin_Safety_for_FQAD_Patient_Tapering_Clonazepam_Mech.mdmd12KBartifacts-database/pre-extracted-artifacts/115_2026-02-05_Pregabalin_Safety_for_FQAD_Patient_Tapering_Clonazepam_Mech.md
016_2025-10-02_Lavender_and_Lorazepam_Lower_Interaction_Risk_Than_Expected.mdmd12KBartifacts-database/pre-extracted-artifacts/016_2025-10-02_Lavender_and_Lorazepam_Lower_Interaction_Risk_Than_Expected.md
30.12_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.mdmd11KBartifacts-database/by-tag/кризисы/30.12_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.md
30.12_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.mdmd11KBartifacts-database/by-tag/лекарства/30.12_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.md
07_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.mdmd11KBartifacts-database/by-chat/30.12_15651f5d_Бензо при ФХ токсичности (госпиталь)/07_Quetiapine Movement Disorders and Clonazepam Tapering Schedule Assessment.md
03.01_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.mdmd11KBartifacts-database/by-tag/wellness/03.01_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.md
03.01_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.mdmd11KBartifacts-database/by-tag/добавки/03.01_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.md
04_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.mdmd11KBartifacts-database/by-chat/03.01_bccbd47e_Релаксация Джейкобсона PBM research/04_Red and Near-Infrared LED Light Therapy A Comprehensive Safety Assessment.md
28.12_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.mdmd11KBartifacts-database/by-tag/кризисы/28.12_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.md
28.12_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.mdmd11KBartifacts-database/by-tag/лекарства/28.12_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.md
01_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.mdmd11KBartifacts-database/by-chat/28.12_4a45246e_Ночной террор кветиапин/01_Acute Movement Disorders from Low-Dose Quetiapine Emergency Guidance.md
27.01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.mdmd11KBartifacts-database/by-tag/гормоны/27.01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.md
27.01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.mdmd11KBartifacts-database/by-tag/железо/27.01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.md
01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.mdmd11KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/01_IV Iron and Mood Timeline, Mechanisms, and Clinical Evidence for Neuropsychiatri.md
21.12_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.mdmd11KBartifacts-database/by-tag/печень/21.12_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.md
21.12_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.mdmd11KBartifacts-database/by-tag/лекарства/21.12_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.md
01_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.mdmd11KBartifacts-database/by-chat/21.12_6f1b7a75_Cymbalta печень (duloxetine)/01_Cymbalta (Duloxetine) Safety Assessment High-Risk Patient Profile.md
15.10_Lorazepam and Hydroxyzine Safety Evaluating the 12-Hour Spacing Question.mdmd11KBartifacts-database/by-tag/лекарства/15.10_Lorazepam and Hydroxyzine Safety Evaluating the 12-Hour Spacing Question.md
01_Lorazepam and Hydroxyzine Safety Evaluating the 12-Hour Spacing Question.mdmd11KBartifacts-database/by-chat/15.10_29fc1289_Lorazepam Atarax 12hr timing/01_Lorazepam and Hydroxyzine Safety Evaluating the 12-Hour Spacing Question.md
076_2026-01-16_IV_Iron_Sucrose_Ferritin_and_Symptom_Recovery_Timelines.mdmd11KBartifacts-database/pre-extracted-artifacts/076_2026-01-16_IV_Iron_Sucrose_Ferritin_and_Symptom_Recovery_Timelines.md
16.01_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.mdmd11KBartifacts-database/by-tag/wellness/16.01_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.md
16.01_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.mdmd11KBartifacts-database/by-tag/железо/16.01_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.md
03_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.mdmd11KBartifacts-database/by-chat/16.01_c0bfc771_Капельница глутатион/03_IV Iron Sucrose Ferritin and Symptom Recovery Timelines.md
03.01_Metawell Treatments Scientific Evaluation for FQAD Patients.mdmd11KBartifacts-database/by-tag/wellness/03.01_Metawell Treatments Scientific Evaluation for FQAD Patients.md
01_Metawell Treatments Scientific Evaluation for FQAD Patients.mdmd11KBartifacts-database/by-chat/03.01_e460ab06_Welnamis MLX Quartz evidence/01_Metawell Treatments Scientific Evaluation for FQAD Patients.md
003_2025-09-26_Lorazepam_1mg_for_Four_Days_What_to_Expect.mdmd11KBartifacts-database/pre-extracted-artifacts/003_2025-09-26_Lorazepam_1mg_for_Four_Days_What_to_Expect.md
26.09_Lorazepam 1mg for Four Days What to Expect.mdmd11KBartifacts-database/by-tag/лекарства/26.09_Lorazepam 1mg for Four Days What to Expect.md
02_Lorazepam 1mg for Four Days What to Expect.mdmd11KBartifacts-database/by-chat/26.09_54d6279f_Lorazepam safety research/02_Lorazepam 1mg for Four Days What to Expect.md
27.01_What to Expect from IV Iron with Ferritin at 9.98 ngmL.mdmd11KBartifacts-database/by-tag/гормоны/27.01_What to Expect from IV Iron with Ferritin at 9.98 ngmL.md
27.01_What to Expect from IV Iron with Ferritin at 9.98 ngmL.mdmd11KBartifacts-database/by-tag/железо/27.01_What to Expect from IV Iron with Ferritin at 9.98 ngmL.md
13_What to Expect from IV Iron with Ferritin at 9.98 ngmL.mdmd11KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/13_What to Expect from IV Iron with Ferritin at 9.98 ngmL.md
002_2025-09-26_Lorazepam_for_Insomnia_Benefits_Risks_and_Clinical_Realit.mdmd11KBartifacts-database/pre-extracted-artifacts/002_2025-09-26_Lorazepam_for_Insomnia_Benefits_Risks_and_Clinical_Realit.md
26.09_Lorazepam for Insomnia Benefits, Risks, and Clinical Realities.mdmd11KBartifacts-database/by-tag/лекарства/26.09_Lorazepam for Insomnia Benefits, Risks, and Clinical Realities.md
01_Lorazepam for Insomnia Benefits, Risks, and Clinical Realities.mdmd11KBartifacts-database/by-chat/26.09_54d6279f_Lorazepam safety research/01_Lorazepam for Insomnia Benefits, Risks, and Clinical Realities.md
64_2026-01-13_.txttxt11KBartifacts-database/chat-transcripts/64_2026-01-13_.txt
07-notion-content-v2.mdmd11KBartifacts-database/compiled-docs/07-notion-content-v2.md
27_2025-10-06_Energy_healing_for_veronika.txttxt11KBartifacts-database/chat-transcripts/27_2025-10-06_Energy_healing_for_veronika.txt
19.01_L-Theanine for FQAD and Depression A Comprehensive Risk-Benefit Analysis.mdmd11KBartifacts-database/by-tag/добавки/19.01_L-Theanine for FQAD and Depression A Comprehensive Risk-Benefit Analysis.md
01_L-Theanine for FQAD and Depression A Comprehensive Risk-Benefit Analysis.mdmd11KBartifacts-database/by-chat/19.01_35039c02_L-theanine deep research/01_L-Theanine for FQAD and Depression A Comprehensive Risk-Benefit Analysis.md
058_2026-01-06_ZEM_Wellness_Clinic_Altea_Critical_Review_Authenticity_Anal.mdmd11KBartifacts-database/pre-extracted-artifacts/058_2026-01-06_ZEM_Wellness_Clinic_Altea_Critical_Review_Authenticity_Anal.md
06.01_ZEM Wellness Clinic Altea Critical Review Authenticity Analysis.mdmd11KBartifacts-database/by-tag/клиники/06.01_ZEM Wellness Clinic Altea Critical Review Authenticity Analysis.md
01_ZEM Wellness Clinic Altea Critical Review Authenticity Analysis.mdmd11KBartifacts-database/by-chat/06.01_54fb3b56_ZEM SHA procedures/01_ZEM Wellness Clinic Altea Critical Review Authenticity Analysis.md
084_2026-01-18_Scientific_Evidence_Benzodiazepine_Withdrawal_Risk_from_Sho.mdmd11KBartifacts-database/pre-extracted-artifacts/084_2026-01-18_Scientific_Evidence_Benzodiazepine_Withdrawal_Risk_from_Sho.md
19.01_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.mdmd11KBartifacts-database/by-tag/бензо/19.01_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.md
19.01_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.mdmd11KBartifacts-database/by-tag/руминация/19.01_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.md
05_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.mdmd11KBartifacts-database/by-chat/19.01_f67d5678_Clonazepam rumination/05_Scientific Evidence Benzodiazepine Withdrawal Risk from Short-Term and Low-Dose.md
046_2025-12-26_European_Integrative_Medicine_Price_Comparison_ZEM_Altea_vs.mdmd11KBartifacts-database/pre-extracted-artifacts/046_2025-12-26_European_Integrative_Medicine_Price_Comparison_ZEM_Altea_vs.md
27.12_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.mdmd11KBartifacts-database/by-tag/клиники/27.12_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.md
27.12_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.mdmd11KBartifacts-database/by-tag/документы/27.12_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.md
03_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.mdmd11KBartifacts-database/by-chat/27.12_dfac065a_Программа восстановления EU/03_European Integrative Medicine Price Comparison ZEM Altea vs. Competitors.md
012_2025-10-01_Ferinject_Iron_Infusion_Treatment_in_Geneva_Access_Provide.mdmd11KBartifacts-database/pre-extracted-artifacts/012_2025-10-01_Ferinject_Iron_Infusion_Treatment_in_Geneva_Access_Provide.md
045_2025-12-26_Quetiapine_25mg_Safety_Assessment_for_FQAD_Patient_with_Live.mdmd11KBartifacts-database/pre-extracted-artifacts/045_2025-12-26_Quetiapine_25mg_Safety_Assessment_for_FQAD_Patient_with_Live.md
27.12_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.mdmd11KBartifacts-database/by-tag/клиники/27.12_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.md
27.12_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.mdmd11KBartifacts-database/by-tag/документы/27.12_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.md
02_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.mdmd11KBartifacts-database/by-chat/27.12_dfac065a_Программа восстановления EU/02_Quetiapine 25mg Safety Assessment for FQAD Patient with Liver Damage.md
02.12_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.mdmd11KBartifacts-database/by-tag/печень/02.12_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.md
02.12_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.mdmd11KBartifacts-database/by-tag/лекарства/02.12_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.md
02_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.mdmd11KBartifacts-database/by-chat/02.12_ecf0a91f_Liver damage ALT 173/02_SSRI Activation Syndrome When Escitalopram Causes Paradoxical Agitation.md
2026-01-14_Treatment_Plan_Veronika_Pogrebova_30.04.24.docx.txttxt11KBartifacts-database/chat-uploaded-files/2026-01-14_Treatment_Plan_Veronika_Pogrebova_30.04.24.docx.txt
101_2026-02-01_TMS_Timing_with_SSRI_Withdrawal_and_Benzodiazepine_Kindling_.mdmd11KBartifacts-database/pre-extracted-artifacts/101_2026-02-01_TMS_Timing_with_SSRI_Withdrawal_and_Benzodiazepine_Kindling_.md
05.02_TMS Timing with SSRI Withdrawal and Benzodiazepine Kindling A Clinical Decision.mdmd11KBartifacts-database/by-tag/TMS/05.02_TMS Timing with SSRI Withdrawal and Benzodiazepine Kindling A Clinical Decision.md
06_TMS Timing with SSRI Withdrawal and Benzodiazepine Kindling A Clinical Decision.mdmd11KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/06_TMS Timing with SSRI Withdrawal and Benzodiazepine Kindling A Clinical Decision.md
ROADMAP.mdmd11KBveronika-health-db/ROADMAP.md
ROADMAP.mdmd11KBveronika-health-db/public/ROADMAP.md
24.01_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.mdmd11KBartifacts-database/by-tag/терапия/24.01_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.md
24.01_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.mdmd11KBartifacts-database/by-tag/лекарства/24.01_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.md
06_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.mdmd11KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/06_Psychiatric Hospitalization Options in Spain for Severe Depression Crisis.md
10_2025-10-01_Iv_iron_injection_safety_concerns.txttxt11KBartifacts-database/chat-transcripts/10_2025-10-01_Iv_iron_injection_safety_concerns.txt
15.01_Vortioxetine Safety Assessment for FQAD Patient with Iron Deficiency.mdmd11KBartifacts-database/by-tag/лекарства/15.01_Vortioxetine Safety Assessment for FQAD Patient with Iron Deficiency.md
01_Vortioxetine Safety Assessment for FQAD Patient with Iron Deficiency.mdmd11KBartifacts-database/by-chat/15.01_6221b8ed_Anafranil Brintellix safety/01_Vortioxetine Safety Assessment for FQAD Patient with Iron Deficiency.md
73_2026-01-21_.txttxt11KBartifacts-database/chat-transcripts/73_2026-01-21_.txt
24.01_RFCBT and Rumination-Focused Therapy Options in Spain.mdmd10KBartifacts-database/by-tag/терапия/24.01_RFCBT and Rumination-Focused Therapy Options in Spain.md
02_RFCBT and Rumination-Focused Therapy Options in Spain.mdmd10KBartifacts-database/by-chat/24.01_75a64249_RFCBT специалисты/02_RFCBT and Rumination-Focused Therapy Options in Spain.md
23.01_IV Iron Comparison Ferinject vs Venofer Clinical and Market Analysis.mdmd10KBartifacts-database/by-tag/лекарства/23.01_IV Iron Comparison Ferinject vs Venofer Clinical and Market Analysis.md
01_IV Iron Comparison Ferinject vs Venofer Clinical and Market Analysis.mdmd10KBartifacts-database/by-chat/23.01_3f9865eb_Успокаивающие пластыри/01_IV Iron Comparison Ferinject vs Venofer Clinical and Market Analysis.md
07-notion-data.mdmd10KBartifacts-database/compiled-docs/07-notion-data.md
074_2026-01-16_IV_Therapy_Clinics_in_Barcelona_for_Therapeutic_Infusions_an.mdmd10KBartifacts-database/pre-extracted-artifacts/074_2026-01-16_IV_Therapy_Clinics_in_Barcelona_for_Therapeutic_Infusions_an.md
16.01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.mdmd10KBartifacts-database/by-tag/wellness/16.01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.md
16.01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.mdmd10KBartifacts-database/by-tag/железо/16.01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.md
01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.mdmd10KBartifacts-database/by-chat/16.01_c0bfc771_Капельница глутатион/01_IV Therapy Clinics in Barcelona for Therapeutic Infusions and FQAD Recovery.md
04.10_Critical Safety Concerns Supplement Use with Multiple Medical Conditions.mdmd10KBartifacts-database/by-tag/добавки/04.10_Critical Safety Concerns Supplement Use with Multiple Medical Conditions.md
01_Critical Safety Concerns Supplement Use with Multiple Medical Conditions.mdmd10KBartifacts-database/by-chat/04.10_a606c68a_Supplement check (NAD, PQQ, quercetin)/01_Critical Safety Concerns Supplement Use with Multiple Medical Conditions.md
24.01_RFCBT Specialists From Developer Ed Watkins to Russian-Speaking Practitioners.mdmd10KBartifacts-database/by-tag/терапия/24.01_RFCBT Specialists From Developer Ed Watkins to Russian-Speaking Practitioners.md
01_RFCBT Specialists From Developer Ed Watkins to Russian-Speaking Practitioners.mdmd10KBartifacts-database/by-chat/24.01_75a64249_RFCBT специалисты/01_RFCBT Specialists From Developer Ed Watkins to Russian-Speaking Practitioners.md
066_2026-01-13_Venofer_IV_Iron_Infusion_Providers_in_Spain_Facility_Guide_.mdmd10KBartifacts-database/pre-extracted-artifacts/066_2026-01-13_Venofer_IV_Iron_Infusion_Providers_in_Spain_Facility_Guide_.md
14.01_Venofer IV Iron Infusion Providers in Spain Facility Guide and Access Options.mdmd10KBartifacts-database/by-tag/железо/14.01_Venofer IV Iron Infusion Providers in Spain Facility Guide and Access Options.md
02_Venofer IV Iron Infusion Providers in Spain Facility Guide and Access Options.mdmd10KBartifacts-database/by-chat/14.01_77f07fb7_IV iron Spain (Feriv)/02_Venofer IV Iron Infusion Providers in Spain Facility Guide and Access Options.md
102_2026-02-01_Multiple_Converging_Factors_Explain_Anhedonia_Symptoms_Horm.mdmd10KBartifacts-database/pre-extracted-artifacts/102_2026-02-01_Multiple_Converging_Factors_Explain_Anhedonia_Symptoms_Horm.md
05.02_Multiple Converging Factors Explain Anhedonia Symptoms Hormonal and Iron Deficie.mdmd10KBartifacts-database/by-tag/TMS/05.02_Multiple Converging Factors Explain Anhedonia Symptoms Hormonal and Iron Deficie.md
07_Multiple Converging Factors Explain Anhedonia Symptoms Hormonal and Iron Deficie.mdmd10KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/07_Multiple Converging Factors Explain Anhedonia Symptoms Hormonal and Iron Deficie.md
16.12_Quetiapine for SSRI-Induced Activation Syndrome Risk-Benefit Analysis with Activ.mdmd10KBartifacts-database/by-tag/лекарства/16.12_Quetiapine for SSRI-Induced Activation Syndrome Risk-Benefit Analysis with Activ.md
02_Quetiapine for SSRI-Induced Activation Syndrome Risk-Benefit Analysis with Activ.mdmd10KBartifacts-database/by-chat/16.12_654829d5_Диагностика после отмены (кветиапин)/02_Quetiapine for SSRI-Induced Activation Syndrome Risk-Benefit Analysis with Activ.md
06.03_Every CUN Escalation Contact and Complaint Channel Uncovered.mdmd10KBartifacts-database/by-tag/CUN/06.03_Every CUN Escalation Contact and Complaint Channel Uncovered.md
06.03_Every CUN Escalation Contact and Complaint Channel Uncovered.mdmd10KBartifacts-database/by-tag/кризисы/06.03_Every CUN Escalation Contact and Complaint Channel Uncovered.md
02_Every CUN Escalation Contact and Complaint Channel Uncovered.mdmd10KBartifacts-database/by-chat/06.03_349efdab_CUN complaint психиатрия/02_Every CUN Escalation Contact and Complaint Channel Uncovered.md
27.01_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.mdmd10KBartifacts-database/by-tag/гормоны/27.01_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.md
27.01_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.mdmd10KBartifacts-database/by-tag/железо/27.01_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.md
02_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.mdmd10KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/02_The Honest Evidence IV Iron Treats Fatigue Convincingly But Depression Remains U.md
75_2026-01-23_TMS_treatment_questions_for_MyBrain_clinic.txttxt10KBartifacts-database/chat-transcripts/75_2026-01-23_TMS_treatment_questions_for_MyBrain_clinic.txt
113_2026-02-01_TMS-Induced_Akathisia_in_PSSD_and_FQAD_Patient_Differential.mdmd10KBartifacts-database/pre-extracted-artifacts/113_2026-02-01_TMS-Induced_Akathisia_in_PSSD_and_FQAD_Patient_Differential.md
05.02_TMS-Induced Akathisia in PSSD and FQAD Patient Differential Diagnosis and Clinic.mdmd10KBartifacts-database/by-tag/TMS/05.02_TMS-Induced Akathisia in PSSD and FQAD Patient Differential Diagnosis and Clinic.md
18_TMS-Induced Akathisia in PSSD and FQAD Patient Differential Diagnosis and Clinic.mdmd10KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/18_TMS-Induced Akathisia in PSSD and FQAD Patient Differential Diagnosis and Clinic.md
075_2026-01-16_Feriv_100mg_5ml_Complete_Analysis_of_Spain_s_Iron_Sucrose_I.mdmd10KBartifacts-database/pre-extracted-artifacts/075_2026-01-16_Feriv_100mg_5ml_Complete_Analysis_of_Spain_s_Iron_Sucrose_I.md
16.01_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.mdmd10KBartifacts-database/by-tag/wellness/16.01_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.md
16.01_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.mdmd10KBartifacts-database/by-tag/железо/16.01_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.md
02_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.mdmd10KBartifacts-database/by-chat/16.01_c0bfc771_Капельница глутатион/02_Feriv 100mg5ml Complete Analysis of Spains Iron Sucrose IV Formulation.md
intranet.htmlhtml10KBveronika-health-db/public/intranet.html
21.02_Methylene Blue for Seizures Promising in Rats, Unproven in Humans.mdmd10KBartifacts-database/by-tag/добавки/21.02_Methylene Blue for Seizures Promising in Rats, Unproven in Humans.md
02_Methylene Blue for Seizures Promising in Rats, Unproven in Humans.mdmd10KBartifacts-database/by-chat/21.02_e520b05b_Methylene blue mitochondria/02_Methylene Blue for Seizures Promising in Rats, Unproven in Humans.md
05-research-v2.mdmd10KBartifacts-database/compiled-docs/05-research-v2.md
104_2026-02-01_SSRI-Induced_Emotional_Blunting_and_PSSD_Critical_Evidence_.mdmd10KBartifacts-database/pre-extracted-artifacts/104_2026-02-01_SSRI-Induced_Emotional_Blunting_and_PSSD_Critical_Evidence_.md
05.02_SSRI-Induced Emotional Blunting and PSSD Critical Evidence for Causation Assessm.mdmd10KBartifacts-database/by-tag/TMS/05.02_SSRI-Induced Emotional Blunting and PSSD Critical Evidence for Causation Assessm.md
09_SSRI-Induced Emotional Blunting and PSSD Critical Evidence for Causation Assessm.mdmd10KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/09_SSRI-Induced Emotional Blunting and PSSD Critical Evidence for Causation Assessm.md
067_2026-01-13_Venofer_vs_Ferinject_Iron_Sucrose_Is_the_Safer_Choice_for_F.mdmd10KBartifacts-database/pre-extracted-artifacts/067_2026-01-13_Venofer_vs_Ferinject_Iron_Sucrose_Is_the_Safer_Choice_for_F.md
14.01_Venofer vs Ferinject Iron Sucrose Is the Safer Choice for FQAD Patients.mdmd10KBartifacts-database/by-tag/железо/14.01_Venofer vs Ferinject Iron Sucrose Is the Safer Choice for FQAD Patients.md
03_Venofer vs Ferinject Iron Sucrose Is the Safer Choice for FQAD Patients.mdmd10KBartifacts-database/by-chat/14.01_77f07fb7_IV iron Spain (Feriv)/03_Venofer vs Ferinject Iron Sucrose Is the Safer Choice for FQAD Patients.md
27.01_Fact-Check Ferritin and Depression Claims.mdmd10KBartifacts-database/by-tag/гормоны/27.01_Fact-Check Ferritin and Depression Claims.md
27.01_Fact-Check Ferritin and Depression Claims.mdmd10KBartifacts-database/by-tag/железо/27.01_Fact-Check Ferritin and Depression Claims.md
05_Fact-Check Ferritin and Depression Claims.mdmd10KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/05_Fact-Check Ferritin and Depression Claims.md
035_2025-12-03_Ferinject_IV_Iron_Therapy_Safety_Dosing_and_Clinical_Guid.mdmd10KBartifacts-database/pre-extracted-artifacts/035_2025-12-03_Ferinject_IV_Iron_Therapy_Safety_Dosing_and_Clinical_Guid.md
16.01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.mdmd10KBartifacts-database/by-tag/добавки/16.01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.md
16.01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.mdmd10KBartifacts-database/by-tag/железо/16.01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.md
01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.mdmd10KBartifacts-database/by-chat/16.01_0774c3a8_Ferinject все добавки/01_Complete Guide to Feriv Iron Sucrose Infusions for Veronika.md
24.01_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.mdmd10KBartifacts-database/by-tag/терапия/24.01_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.md
24.01_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.mdmd10KBartifacts-database/by-tag/лекарства/24.01_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.md
04_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.mdmd10KBartifacts-database/by-chat/24.01_4d85eb65_VNS, кетамин, RFCBT ranking/04_Optimal Transdermal Estradiol Dosing for FHA in a Sensitive Patient.md
18.02_Charité Berlin and Fluoroquinolone Toxicity Research Why FQAD Patients Should Lo.mdmd10KBartifacts-database/by-tag/клиники/18.02_Charité Berlin and Fluoroquinolone Toxicity Research Why FQAD Patients Should Lo.md
02_Charité Berlin and Fluoroquinolone Toxicity Research Why FQAD Patients Should Lo.mdmd10KBartifacts-database/by-chat/18.02_95993d55_Top brain clinics Spain/02_Charité Berlin and Fluoroquinolone Toxicity Research Why FQAD Patients Should Lo.md
107_2026-02-01_iTBS_vs_10Hz_rTMS_Protocol_Selection_for_Rumination_Anhedo.mdmd10KBartifacts-database/pre-extracted-artifacts/107_2026-02-01_iTBS_vs_10Hz_rTMS_Protocol_Selection_for_Rumination_Anhedo.md
05.02_iTBS vs 10Hz rTMS Protocol Selection for Rumination, Anhedonia, and PSSD.mdmd10KBartifacts-database/by-tag/TMS/05.02_iTBS vs 10Hz rTMS Protocol Selection for Rumination, Anhedonia, and PSSD.md
12_iTBS vs 10Hz rTMS Protocol Selection for Rumination, Anhedonia, and PSSD.mdmd10KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/12_iTBS vs 10Hz rTMS Protocol Selection for Rumination, Anhedonia, and PSSD.md
04.01_Gharieni Wellness Devices Marketing Claims Outpace Clinical Evidence.mdmd10KBartifacts-database/by-tag/клиники/04.01_Gharieni Wellness Devices Marketing Claims Outpace Clinical Evidence.md
02_Gharieni Wellness Devices Marketing Claims Outpace Clinical Evidence.mdmd10KBartifacts-database/by-chat/04.01_576fb70a_ZEM Wellness analysis doc/02_Gharieni Wellness Devices Marketing Claims Outpace Clinical Evidence.md
24.01_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.mdmd9KBartifacts-database/by-tag/руминация/24.01_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.md
24.01_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.mdmd9KBartifacts-database/by-tag/терапия/24.01_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.md
02_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.mdmd9KBartifacts-database/by-chat/24.01_e924eae1_Руминация TMS RFCBT/02_SAINT and Accelerated TMS Protocols in Spain Current Options and European Altern.md
59_2026-01-08_.txttxt9KBartifacts-database/chat-transcripts/59_2026-01-08_.txt
03.01_MLX Quartz Bed Separating Evidence from Marketing.mdmd9KBartifacts-database/by-tag/wellness/03.01_MLX Quartz Bed Separating Evidence from Marketing.md
02_MLX Quartz Bed Separating Evidence from Marketing.mdmd9KBartifacts-database/by-chat/03.01_e460ab06_Welnamis MLX Quartz evidence/02_MLX Quartz Bed Separating Evidence from Marketing.md
2026-01-21_unnamed_4.txttxt9KBartifacts-database/chat-uploaded-files/2026-01-21_unnamed_4.txt
70_2026-01-16_Understanding_microbiota_tests.txttxt9KBartifacts-database/chat-transcripts/70_2026-01-16_Understanding_microbiota_tests.txt
036_2025-12-03_NAC_Safety_Assessment_Complex_Clinical_Picture_Requires_Cau.mdmd9KBartifacts-database/pre-extracted-artifacts/036_2025-12-03_NAC_Safety_Assessment_Complex_Clinical_Picture_Requires_Cau.md
080_2026-01-18_Clonazepam_Rumination_and_the_Iron-GABA_Connection_Clinic.mdmd9KBartifacts-database/pre-extracted-artifacts/080_2026-01-18_Clonazepam_Rumination_and_the_Iron-GABA_Connection_Clinic.md
19.01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.mdmd9KBartifacts-database/by-tag/бензо/19.01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.md
19.01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.mdmd9KBartifacts-database/by-tag/руминация/19.01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.md
01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.mdmd9KBartifacts-database/by-chat/19.01_f67d5678_Clonazepam rumination/01_Clonazepam, Rumination, and the Iron-GABA Connection Clinical Analysis.md
27.01_The Estrogen-Depression Connection Mechanism Without Clinical Proof.mdmd9KBartifacts-database/by-tag/гормоны/27.01_The Estrogen-Depression Connection Mechanism Without Clinical Proof.md
27.01_The Estrogen-Depression Connection Mechanism Without Clinical Proof.mdmd9KBartifacts-database/by-tag/железо/27.01_The Estrogen-Depression Connection Mechanism Without Clinical Proof.md
04_The Estrogen-Depression Connection Mechanism Without Clinical Proof.mdmd9KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/04_The Estrogen-Depression Connection Mechanism Without Clinical Proof.md
057_2026-01-06_ZEM_Wellness_Altea_Luxury_Facade_Masks_Troubling_Ownership_.mdmd9KBartifacts-database/pre-extracted-artifacts/057_2026-01-06_ZEM_Wellness_Altea_Luxury_Facade_Masks_Troubling_Ownership_.md
06.01_ZEM Wellness Altea Luxury Facade Masks Troubling Ownership Ties.mdmd9KBartifacts-database/by-tag/клиники/06.01_ZEM Wellness Altea Luxury Facade Masks Troubling Ownership Ties.md
01_ZEM Wellness Altea Luxury Facade Masks Troubling Ownership Ties.mdmd9KBartifacts-database/by-chat/06.01_8973021c_ZEM Altea reviews/01_ZEM Wellness Altea Luxury Facade Masks Troubling Ownership Ties.md
19.12_Nicotine Patch Safety Assessment for Complex FQAD Patient.mdmd9KBartifacts-database/by-tag/FQAD/19.12_Nicotine Patch Safety Assessment for Complex FQAD Patient.md
19.12_Nicotine Patch Safety Assessment for Complex FQAD Patient.mdmd9KBartifacts-database/by-tag/врачи/19.12_Nicotine Patch Safety Assessment for Complex FQAD Patient.md
02_Nicotine Patch Safety Assessment for Complex FQAD Patient.mdmd9KBartifacts-database/by-chat/19.12_3fc5edd6_Анализ программы Pieper/02_Nicotine Patch Safety Assessment for Complex FQAD Patient.md
114_2026-02-01_Yingchi_TMS_FDA-Cleared_Device_Analysis_and_Clinical_Legiti.mdmd9KBartifacts-database/pre-extracted-artifacts/114_2026-02-01_Yingchi_TMS_FDA-Cleared_Device_Analysis_and_Clinical_Legiti.md
05.02_Yingchi TMS FDA-Cleared Device Analysis and Clinical Legitimacy Assessment.mdmd9KBartifacts-database/by-tag/TMS/05.02_Yingchi TMS FDA-Cleared Device Analysis and Clinical Legitimacy Assessment.md
19_Yingchi TMS FDA-Cleared Device Analysis and Clinical Legitimacy Assessment.mdmd9KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/19_Yingchi TMS FDA-Cleared Device Analysis and Clinical Legitimacy Assessment.md
106_2026-02-01_TMS_for_PSSD_Promising_Mechanism_but_No_Direct_Evidence_Exi.mdmd9KBartifacts-database/pre-extracted-artifacts/106_2026-02-01_TMS_for_PSSD_Promising_Mechanism_but_No_Direct_Evidence_Exi.md
05.02_TMS for PSSD Promising Mechanism but No Direct Evidence Exists.mdmd9KBartifacts-database/by-tag/TMS/05.02_TMS for PSSD Promising Mechanism but No Direct Evidence Exists.md
11_TMS for PSSD Promising Mechanism but No Direct Evidence Exists.mdmd9KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/11_TMS for PSSD Promising Mechanism but No Direct Evidence Exists.md
analyses.htmlhtml9KBveronika-health-db/public/analyses.html
analyses.htmlhtml9KBartifacts-database/analyses.html
37_2025-11-03_Veronika_s_new_analysis.txttxt9KBartifacts-database/chat-transcripts/37_2025-11-03_Veronika_s_new_analysis.txt
105_2026-02-01_Benzodiazepines_and_TMS_Efficacy_Conflicting_Evidence_Defie.mdmd9KBartifacts-database/pre-extracted-artifacts/105_2026-02-01_Benzodiazepines_and_TMS_Efficacy_Conflicting_Evidence_Defie.md
05.02_Benzodiazepines and TMS Efficacy Conflicting Evidence Defies Simple Answers.mdmd9KBartifacts-database/by-tag/TMS/05.02_Benzodiazepines and TMS Efficacy Conflicting Evidence Defies Simple Answers.md
10_Benzodiazepines and TMS Efficacy Conflicting Evidence Defies Simple Answers.mdmd9KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/10_Benzodiazepines and TMS Efficacy Conflicting Evidence Defies Simple Answers.md
04-doctors-clinics-v2.mdmd9KBartifacts-database/compiled-docs/04-doctors-clinics-v2.md
PROJECT-LOG.mdmd8KBveronika-health-db/public/PROJECT-LOG.md
85_2026-03-08_.txttxt8KBartifacts-database/chat-transcripts/85_2026-03-08_.txt
ALGORITHMS.mdmd8KBveronika-health-db/ALGORITHMS.md
23.01_TMS and Estrogen Therapy for Hypothalamic Amenorrhea What the Science Says.mdmd8KBartifacts-database/by-tag/гормоны/23.01_TMS and Estrogen Therapy for Hypothalamic Amenorrhea What the Science Says.md
04_TMS and Estrogen Therapy for Hypothalamic Amenorrhea What the Science Says.mdmd8KBartifacts-database/by-chat/23.01_a9dae63c_Эстрогеновые пластыри effects/04_TMS and Estrogen Therapy for Hypothalamic Amenorrhea What the Science Says.md
087_2026-01-21_MyBrain_Barcelona_World-Class_TMS_Expertise_with_Limited_Pr.mdmd8KBartifacts-database/pre-extracted-artifacts/087_2026-01-21_MyBrain_Barcelona_World-Class_TMS_Expertise_with_Limited_Pr.md
21.01_MyBrain Barcelona World-Class TMS Expertise with Limited Protocol Transparency.mdmd8KBartifacts-database/by-tag/TMS/21.01_MyBrain Barcelona World-Class TMS Expertise with Limited Protocol Transparency.md
03_MyBrain Barcelona World-Class TMS Expertise with Limited Protocol Transparency.mdmd8KBartifacts-database/by-chat/21.01_6dcb4cc8_TMS подготовка побочные/03_MyBrain Barcelona World-Class TMS Expertise with Limited Protocol Transparency.md
27.01_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.mdmd8KBartifacts-database/by-tag/гормоны/27.01_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.md
27.01_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.mdmd8KBartifacts-database/by-tag/железо/27.01_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.md
09_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.mdmd8KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/09_Iron-Estrogen Vicious Cycle Theoretical Mechanisms vs Clinical Evidence.md
19.01_Is 8,000 Fair for TMS in Barcelona A Complete Pricing Analysis.mdmd8KBartifacts-database/by-tag/TMS/19.01_Is 8,000 Fair for TMS in Barcelona A Complete Pricing Analysis.md
01_Is 8,000 Fair for TMS in Barcelona A Complete Pricing Analysis.mdmd8KBartifacts-database/by-chat/19.01_f01afa14_SAINT TMS 8k цена/01_Is 8,000 Fair for TMS in Barcelona A Complete Pricing Analysis.md
20.02_Pharmacogenomic Testing at CUN From OneOme to the Genomic Checkup.mdmd8KBartifacts-database/by-tag/анализы/20.02_Pharmacogenomic Testing at CUN From OneOme to the Genomic Checkup.md
05_Pharmacogenomic Testing at CUN From OneOme to the Genomic Checkup.mdmd8KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/05_Pharmacogenomic Testing at CUN From OneOme to the Genomic Checkup.md
15.01_Iron for Depression The Evidence is Weaker Than Often Claimed.mdmd8KBartifacts-database/by-tag/лекарства/15.01_Iron for Depression The Evidence is Weaker Than Often Claimed.md
05_Iron for Depression The Evidence is Weaker Than Often Claimed.mdmd8KBartifacts-database/by-chat/15.01_6221b8ed_Anafranil Brintellix safety/05_Iron for Depression The Evidence is Weaker Than Often Claimed.md
07-notion-content-v3.mdmd8KBartifacts-database/compiled-docs/07-notion-content-v3.md
38_2025-12-01_Cipralex_withdrawal_after_6_weeks.txttxt8KBartifacts-database/chat-transcripts/38_2025-12-01_Cipralex_withdrawal_after_6_weeks.txt
PRODUCT-ARCHITECTURE.mdmd8KBveronika-health-db/PRODUCT-ARCHITECTURE.md
044_2025-12-26_Silexan_for_FQAD_Patients_A_Non-GABAergic_Anxiolytic_Altern.mdmd8KBartifacts-database/pre-extracted-artifacts/044_2025-12-26_Silexan_for_FQAD_Patients_A_Non-GABAergic_Anxiolytic_Altern.md
27.12_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.mdmd8KBartifacts-database/by-tag/клиники/27.12_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.md
27.12_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.mdmd8KBartifacts-database/by-tag/документы/27.12_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.md
01_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.mdmd8KBartifacts-database/by-chat/27.12_dfac065a_Программа восстановления EU/01_Silexan for FQAD Patients A Non-GABAergic Anxiolytic Alternative.md
047_2025-12-27_Quetiapine_Discontinuation_and_Rebound_Insomnia_Clinical_Ev.mdmd8KBartifacts-database/pre-extracted-artifacts/047_2025-12-27_Quetiapine_Discontinuation_and_Rebound_Insomnia_Clinical_Ev.md
23.01_Estrogen Patch Use in Young Women Prevalence, Guidelines, and Treatment Gaps.mdmd8KBartifacts-database/by-tag/гормоны/23.01_Estrogen Patch Use in Young Women Prevalence, Guidelines, and Treatment Gaps.md
03_Estrogen Patch Use in Young Women Prevalence, Guidelines, and Treatment Gaps.mdmd8KBartifacts-database/by-chat/23.01_a9dae63c_Эстрогеновые пластыри effects/03_Estrogen Patch Use in Young Women Prevalence, Guidelines, and Treatment Gaps.md
072_2026-01-14_Russian-Speaking_ERP_Therapists_for_OCD_Treatment_Internati.mdmd8KBartifacts-database/pre-extracted-artifacts/072_2026-01-14_Russian-Speaking_ERP_Therapists_for_OCD_Treatment_Internati.md
14.01_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.mdmd8KBartifacts-database/by-tag/документы/14.01_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.md
14.01_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.mdmd8KBartifacts-database/by-tag/терапия/14.01_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.md
02_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.mdmd8KBartifacts-database/by-chat/14.01_55d3f95d_История на русском (ОКР vs руминация)/02_Russian-Speaking ERP Therapists for OCD Treatment International Options and Veri.md
26.01_Dra. Elena Palomo Lertxundi Integrative Psychiatrist in Spains Basque Country.mdmd8KBartifacts-database/by-tag/врачи/26.01_Dra. Elena Palomo Lertxundi Integrative Psychiatrist in Spains Basque Country.md
01_Dra. Elena Palomo Lertxundi Integrative Psychiatrist in Spains Basque Country.mdmd8KBartifacts-database/by-chat/26.01_c40cc69f_Врач Елена Паломо/01_Dra. Elena Palomo Lertxundi Integrative Psychiatrist in Spains Basque Country.md
17_2025-10-02_Lavender_and_lorazepam_interaction.txttxt7KBartifacts-database/chat-transcripts/17_2025-10-02_Lavender_and_lorazepam_interaction.txt
086_2026-01-21_Stanford_SAINT_Protocol_TMS_Availability_and_Pricing_in_Spa.mdmd7KBartifacts-database/pre-extracted-artifacts/086_2026-01-21_Stanford_SAINT_Protocol_TMS_Availability_and_Pricing_in_Spa.md
21.01_Stanford SAINT Protocol TMS Availability and Pricing in Spain and Europe.mdmd7KBartifacts-database/by-tag/TMS/21.01_Stanford SAINT Protocol TMS Availability and Pricing in Spain and Europe.md
06.03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.mdmd7KBartifacts-database/by-tag/CUN/06.03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.md
06.03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.mdmd7KBartifacts-database/by-tag/кризисы/06.03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.md
03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.mdmd7KBartifacts-database/by-chat/06.03_349efdab_CUN complaint психиатрия/03_CUN Pamplona Direct Contacts Public Phone Numbers, Patient Services, and Navarra.md
02_Stanford SAINT Protocol TMS Availability and Pricing in Spain and Europe.mdmd7KBartifacts-database/by-chat/21.01_6dcb4cc8_TMS подготовка побочные/02_Stanford SAINT Protocol TMS Availability and Pricing in Spain and Europe.md
_INDEX.txttxt7KBartifacts-database/chat-transcripts/_INDEX.txt
27.01_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.mdmd7KBartifacts-database/by-tag/гормоны/27.01_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.md
27.01_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.mdmd7KBartifacts-database/by-tag/железо/27.01_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.md
12_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.mdmd7KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/12_Verification of Iron Deficiency and Psychiatric Symptom Claims Fiani 2025 Meta-A.md
07-notion-content.mdmd7KBartifacts-database/compiled-docs/07-notion-content.md
16.01_IV Iron Infusion Safety Assessment Supplement and Medication Compatibility Analy.mdmd7KBartifacts-database/by-tag/железо/16.01_IV Iron Infusion Safety Assessment Supplement and Medication Compatibility Analy.md
01_IV Iron Infusion Safety Assessment Supplement and Medication Compatibility Analy.mdmd7KBartifacts-database/by-chat/16.01_0970d3a3_Липосомальное железо Feriv/01_IV Iron Infusion Safety Assessment Supplement and Medication Compatibility Analy.md
073_2026-01-14_IV_Iron_Infusion_Options_in_Catalonia_Spain_Private_Clinic_.mdmd7KBartifacts-database/pre-extracted-artifacts/073_2026-01-14_IV_Iron_Infusion_Options_in_Catalonia_Spain_Private_Clinic_.md
14.01_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.mdmd7KBartifacts-database/by-tag/документы/14.01_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.md
14.01_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.mdmd7KBartifacts-database/by-tag/терапия/14.01_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.md
03_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.mdmd7KBartifacts-database/by-chat/14.01_55d3f95d_История на русском (ОКР vs руминация)/03_IV Iron Infusion Options in Catalonia Spain Private Clinic Access and Treatment.md
108_2026-02-01_TMS_Discontinuation_Safety_No_Withdrawal_Risk_When_Stopping.mdmd7KBartifacts-database/pre-extracted-artifacts/108_2026-02-01_TMS_Discontinuation_Safety_No_Withdrawal_Risk_When_Stopping.md
05.02_TMS Discontinuation Safety No Withdrawal Risk When Stopping Treatment Mid-Course.mdmd7KBartifacts-database/by-tag/TMS/05.02_TMS Discontinuation Safety No Withdrawal Risk When Stopping Treatment Mid-Course.md
13_TMS Discontinuation Safety No Withdrawal Risk When Stopping Treatment Mid-Course.mdmd7KBartifacts-database/by-chat/05.02_8be9d9e3_TMS for FQAD (MyBrain)/13_TMS Discontinuation Safety No Withdrawal Risk When Stopping Treatment Mid-Course.md
22.01_Direct Links to Six Diet Protocol Studies Citations, DOIs, and Key Findings.mdmd7KBartifacts-database/by-tag/wellness/22.01_Direct Links to Six Diet Protocol Studies Citations, DOIs, and Key Findings.md
04_Direct Links to Six Diet Protocol Studies Citations, DOIs, and Key Findings.mdmd7KBartifacts-database/by-chat/22.01_b85c581d_30-дневный план детокса/04_Direct Links to Six Diet Protocol Studies Citations, DOIs, and Key Findings.md
068_2026-01-13_Iron_Sucrose_Alternatives_to_Venofer_in_Spain_Only_Two_Prod.mdmd7KBartifacts-database/pre-extracted-artifacts/068_2026-01-13_Iron_Sucrose_Alternatives_to_Venofer_in_Spain_Only_Two_Prod.md
14.01_Iron Sucrose Alternatives to Venofer in Spain Only Two Products Remain.mdmd7KBartifacts-database/by-tag/железо/14.01_Iron Sucrose Alternatives to Venofer in Spain Only Two Products Remain.md
04_Iron Sucrose Alternatives to Venofer in Spain Only Two Products Remain.mdmd7KBartifacts-database/by-chat/14.01_77f07fb7_IV iron Spain (Feriv)/04_Iron Sucrose Alternatives to Venofer in Spain Only Two Products Remain.md
82_2026-02-09_.txttxt7KBartifacts-database/chat-transcripts/82_2026-02-09_.txt
57_2026-01-06_SHA_and_ZEM_comparison_review.txttxt7KBartifacts-database/chat-transcripts/57_2026-01-06_SHA_and_ZEM_comparison_review.txt
27.01_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.mdmd7KBartifacts-database/by-tag/гормоны/27.01_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.md
27.01_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.mdmd7KBartifacts-database/by-tag/железо/27.01_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.md
06_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.mdmd7KBartifacts-database/by-chat/27.01_35a5bd48_Ferritin depression stories/06_No Direct Evidence Links Iron Deficiency to Rumination A Research Gap Analysis.md
29_2025-10-15_Veronika_s_antidepressant_medication_review.txttxt7KBartifacts-database/chat-transcripts/29_2025-10-15_Veronika_s_antidepressant_medication_review.txt
06-decisions-actions-v2.mdmd7KBartifacts-database/compiled-docs/06-decisions-actions-v2.md
26.01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.mdmd6KBartifacts-database/by-tag/FQAD/26.01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.md
26.01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.mdmd6KBartifacts-database/by-tag/лекарства/26.01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.md
01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.mdmd6KBartifacts-database/by-chat/26.01_6b061fa2_Никотиновые пластыри FQ/01_Nicotine Patches for FQAD Strong Theory but No Documented Patient Evidence.md
RESEARCH-AGENT-VISION.mdmd6KBveronika-health-db/RESEARCH-AGENT-VISION.md
65_2026-01-14_.txttxt6KBartifacts-database/chat-transcripts/65_2026-01-14_.txt
36_2025-10-22_Veronika_s_health_overview_and_recommendations.txttxt6KBartifacts-database/chat-transcripts/36_2025-10-22_Veronika_s_health_overview_and_recommendations.txt
04.01_TMS Depression Treatment Prices Spain Leads Europe on Value.mdmd6KBartifacts-database/by-tag/wellness/04.01_TMS Depression Treatment Prices Spain Leads Europe on Value.md
04.01_TMS Depression Treatment Prices Spain Leads Europe on Value.mdmd6KBartifacts-database/by-tag/клиники/04.01_TMS Depression Treatment Prices Spain Leads Europe on Value.md
02_TMS Depression Treatment Prices Spain Leads Europe on Value.mdmd6KBartifacts-database/by-chat/04.01_868ed355_Wellness procedures research trip/02_TMS Depression Treatment Prices Spain Leads Europe on Value.md
33_2025-10-21_Clonazepam_safety_for_Veronika.txttxt6KBartifacts-database/chat-transcripts/33_2025-10-21_Clonazepam_safety_for_Veronika.txt
13.02_Oberberg Fachklinik Berlin Brandenburg Staff Overview and the Charité Connection.mdmd6KBartifacts-database/by-tag/клиники/13.02_Oberberg Fachklinik Berlin Brandenburg Staff Overview and the Charité Connection.md
01_Oberberg Fachklinik Berlin Brandenburg Staff Overview and the Charité Connection.mdmd6KBartifacts-database/by-chat/13.02_f7a1ce19_Oberberg Prof. Röpke/01_Oberberg Fachklinik Berlin Brandenburg Staff Overview and the Charité Connection.md
03-labs.mdmd5KBartifacts-database/compiled-docs/03-labs.md
2026-02-21_unnamed_5.txttxt5KBartifacts-database/chat-uploaded-files/2026-02-21_unnamed_5.txt
14_2025-10-01_Medication_options_for_sleep_and_anxiety.txttxt5KBartifacts-database/chat-transcripts/14_2025-10-01_Medication_options_for_sleep_and_anxiety.txt
03-labs-v2.mdmd5KBartifacts-database/compiled-docs/03-labs-v2.md
35_2025-10-22_Veronika_s_health_assessment_overview.txttxt5KBartifacts-database/chat-transcripts/35_2025-10-22_Veronika_s_health_assessment_overview.txt
20.02_CUN Doctor Campus Locations Madrid vs. Pamplona Assignment Analysis.mdmd4KBartifacts-database/by-tag/анализы/20.02_CUN Doctor Campus Locations Madrid vs. Pamplona Assignment Analysis.md
03_CUN Doctor Campus Locations Madrid vs. Pamplona Assignment Analysis.mdmd4KBartifacts-database/by-chat/20.02_0164d1fa_Нейродиагностика GABA PET/03_CUN Doctor Campus Locations Madrid vs. Pamplona Assignment Analysis.md
50_2025-12-27_Seroquel_discontinuation_and_rebound_insomnia.txttxt4KBartifacts-database/chat-transcripts/50_2025-12-27_Seroquel_discontinuation_and_rebound_insomnia.txt
32_2025-10-18_Healing_hormones_and_mental_health.txttxt4KBartifacts-database/chat-transcripts/32_2025-10-18_Healing_hormones_and_mental_health.txt
46_2025-12-12_Document_translation_request.txttxt4KBartifacts-database/chat-transcripts/46_2025-12-12_Document_translation_request.txt
52_2026-01-04_Veronika_s_history_and_TMS_research.txttxt3KBartifacts-database/chat-transcripts/52_2026-01-04_Veronika_s_history_and_TMS_research.txt
87_2026-03-11_posmotri_vse_chati_pro_veronik_.txttxt3KBartifacts-database/chat-transcripts/87_2026-03-11_posmotri_vse_chati_pro_veronik_.txt
07_2025-09-26_Fluoroquinolones_and_lorazepam_interactions.txttxt3KBartifacts-database/chat-transcripts/07_2025-09-26_Fluoroquinolones_and_lorazepam_interactions.txt
51_2026-01-04_.txttxt3KBartifacts-database/chat-transcripts/51_2026-01-04_.txt
20_2025-10-03_Medication_interaction_safety.txttxt3KBartifacts-database/chat-transcripts/20_2025-10-03_Medication_interaction_safety.txt
58_2026-01-07_100_67.txttxt2KBartifacts-database/chat-transcripts/58_2026-01-07_100_67.txt
42_2025-12-06_Best_IV_iron_treatment_for_Veronika_in_Germany.txttxt2KBartifacts-database/chat-transcripts/42_2025-12-06_Best_IV_iron_treatment_for_Veronika_in_Germany.txt
45_2025-12-11_Translation_to_Russian.txttxt2KBartifacts-database/chat-transcripts/45_2025-12-11_Translation_to_Russian.txt
22_2025-10-04_Trazodone_for_veronika_s_insomnia.txttxt2KBartifacts-database/chat-transcripts/22_2025-10-04_Trazodone_for_veronika_s_insomnia.txt
43_2025-12-06_Functional_medicine_centers_in_Germany_for_Veronika.txttxt2KBartifacts-database/chat-transcripts/43_2025-12-06_Functional_medicine_centers_in_Germany_for_Veronika.txt
03_2025-09-23_today_doctor_gave_a_new_one_fo_.txttxt2KBartifacts-database/chat-transcripts/03_2025-09-23_today_doctor_gave_a_new_one_fo_.txt
15_2025-10-01_Medication_options_for_sleep_and_anxiety.txttxt1KBartifacts-database/chat-transcripts/15_2025-10-01_Medication_options_for_sleep_and_anxiety.txt
08_2025-09-30_can_you_serch_stories_where_pe_.txttxt1KBartifacts-database/chat-transcripts/08_2025-09-30_can_you_serch_stories_where_pe_.txt
02_2025-09-22_last_chat_we_spoke_about_diffe_.txttxt1KBartifacts-database/chat-transcripts/02_2025-09-22_last_chat_we_spoke_about_diffe_.txt
24_2025-10-04_Veronika_s_insomnia_and_mental_health_support.txttxt1KBartifacts-database/chat-transcripts/24_2025-10-04_Veronika_s_insomnia_and_mental_health_support.txt
031_2025-10-22_Task_Limitation_Report_Medical_Data_Compilation_Requires_Di.mdmd1KBartifacts-database/pre-extracted-artifacts/031_2025-10-22_Task_Limitation_Report_Medical_Data_Compilation_Requires_Di.md
22.10_Task Limitation Report Medical Data Compilation Requires Direct Information Acce.mdmd1KBartifacts-database/by-tag/документы/22.10_Task Limitation Report Medical Data Compilation Requires Direct Information Acce.md
01_Task Limitation Report Medical Data Compilation Requires Direct Information Acce.mdmd1KBartifacts-database/by-chat/22.10_18b4c27b_Full overview recommendations/01_Task Limitation Report Medical Data Compilation Requires Direct Information Acce.md
IDEAS-BANK.mdmd1KBveronika-health-db/IDEAS-BANK.md
IDEAS-BANK.mdmd1KBveronika-health-db/public/IDEAS-BANK.md
30_2025-10-16_Veronika_s_morning_anxiety_patterns.txttxt1KBartifacts-database/chat-transcripts/30_2025-10-16_Veronika_s_morning_anxiety_patterns.txt
23_2025-10-04_Trazodone_for_insomnia_treatment.txttxt1KBartifacts-database/chat-transcripts/23_2025-10-04_Trazodone_for_insomnia_treatment.txt
16_2025-10-02_Trittico_medication_timeline.txttxt1KBartifacts-database/chat-transcripts/16_2025-10-02_Trittico_medication_timeline.txt
05_2025-09-26_Lorazepam_for_insomnia_safety.txttxt1KBartifacts-database/chat-transcripts/05_2025-09-26_Lorazepam_for_insomnia_safety.txt
26_2025-10-05_Medication_comparison_for_Veronika.txttxt1KBartifacts-database/chat-transcripts/26_2025-10-05_Medication_comparison_for_Veronika.txt
25_2025-10-04_Veronika_s_mental_health_crisis.txttxt1KBartifacts-database/chat-transcripts/25_2025-10-04_Veronika_s_mental_health_crisis.txt
54_2026-01-06_.txttxt1KBartifacts-database/chat-transcripts/54_2026-01-06_.txt
48_2025-12-23_Veronika_s_comprehensive_health_timeline_and_natural_medicin.txttxt1KBartifacts-database/chat-transcripts/48_2025-12-23_Veronika_s_comprehensive_health_timeline_and_natural_medicin.txt
030_2025-10-22_Claude_System_Limitation_Unable_to_Access_Past_Conversation.mdmd1KBartifacts-database/pre-extracted-artifacts/030_2025-10-22_Claude_System_Limitation_Unable_to_Access_Past_Conversation.md
22.10_Claude System Limitation Unable to Access Past Conversation History for Medical.mdmd1KBartifacts-database/by-tag/анализы/22.10_Claude System Limitation Unable to Access Past Conversation History for Medical.md
01_Claude System Limitation Unable to Access Past Conversation History for Medical.mdmd1KBartifacts-database/by-chat/22.10_a8cc5d8a_Health overview all labs/01_Claude System Limitation Unable to Access Past Conversation History for Medical.md
66_2026-01-14_FloxieHope.txttxt1KBartifacts-database/chat-transcripts/66_2026-01-14_FloxieHope.txt
31_2025-10-18_.txttxt1KBartifacts-database/chat-transcripts/31_2025-10-18_.txt
21_2025-10-04_Trazodone_for_veronika_s_insomnia.txttxt1KBartifacts-database/chat-transcripts/21_2025-10-04_Trazodone_for_veronika_s_insomnia.txt
18_2025-10-02_Anxiety_and_panic_attack_medication_options.txttxt1KBartifacts-database/chat-transcripts/18_2025-10-02_Anxiety_and_panic_attack_medication_options.txt
09_2025-10-01_Wife_s_persistent_sleep_disruption.txttxt1KBartifacts-database/chat-transcripts/09_2025-10-01_Wife_s_persistent_sleep_disruption.txt
12_2025-10-01_Ferinject_alternatives_in_Geneva.txttxt1KBartifacts-database/chat-transcripts/12_2025-10-01_Ferinject_alternatives_in_Geneva.txt
19_2025-10-02_Trazodone_and_lorazepam_medication_timing.txttxt1KBartifacts-database/chat-transcripts/19_2025-10-02_Trazodone_and_lorazepam_medication_timing.txt
11_2025-10-01_Medication_timing_and_prescription_details.txttxt1KBartifacts-database/chat-transcripts/11_2025-10-01_Medication_timing_and_prescription_details.txt
13_2025-10-01_Ferinject_side_effects.txttxt1KBartifacts-database/chat-transcripts/13_2025-10-01_Ferinject_side_effects.txt

📁 MARIACHICC 228 → [[Mariachi Art]]

ФайлТипРазмерПуть
report-audit-v5.htmlhtml5911KBmariachi-organized/03-html-reports/report-audit-v5.html
report-bugs-v4-full.htmlhtml5862KBmariachi-organized/03-html-reports/report-bugs-v4-full.html
report-bugs-v4.htmlhtml3664KBmariachi-organized/03-html-reports/report-bugs-v4.html
home.htmlhtml409KBextracted/home.html
index.htmlhtml361KBsite/index.html
messages.htmlhtml351KBmariachi-organized/09-text-misc/messages.html
google-seo-official-rules.mdmd184KBresearch/deep-research/google-seo-official-rules.md
seo-technical-full.mdmd179KBresearch/deep-research/seo-technical-full.md
social-ai-crawlers-js-rendering.mdmd172KBresearch/deep-research/social-ai-crawlers-js-rendering.md
prerender-risks-analysis.mdmd134KBresearch/deep-research/prerender-risks-analysis.md
style-guide.htmlhtml96KBmariachi-react/client/public/style-guide.html
style-guide-v3.htmlhtml84KBstyle-guide-v3.html
style-guide-v2.htmlhtml60KBstyle-guide-v2.html
style-guide-v2.htmlhtml60KBmariachi-react/client/public/style-guide-v2.html
smm-guide.htmlhtml60KBmariachi-react/client/public/smm-guide.html
roadmap-v1.htmlhtml57KBmariachi-react/docs/reports/roadmap-v1.html
seo-deep-research.htmlhtml57KBseo-deep-research.html
mega-research-v2.htmlhtml56KBmariachi files research/mega-research-v2.html
smm-guide.htmlhtml56KBsmm-guide.html
full_report_v3.htmlhtml54KBfull_report_v3.html
report-full-v3.htmlhtml54KBmariachi-organized/03-html-reports/report-full-v3.html
master_audit.htmlhtml52KBmariachi-organized/03-html-reports/master_audit.html
project-knowledge-base.mdmd51KBresearch/project-knowledge-base.md
report-full-v1.htmlhtml50KBmariachi-organized/03-html-reports/report-full-v1.html
full-strategy-v1.htmlhtml48KBmariachi files research/full-strategy-v1.html
report-audit.htmlhtml48KBmariachi-organized/03-html-reports/report-audit.html
europe-market-mega-v1.htmlhtml48KBmariachi files research/europe-market-mega-v1.html
full_report_v5_pricing.htmlhtml48KBfull_report_v5_pricing.html
full_report_v5.htmlhtml47KBfull_report_v5.html
report-full-v4.htmlhtml45KBmariachi-organized/03-html-reports/report-full-v4.html
mariachi-roadmap-original.htmlhtml45KB.firecrawl/mariachi-roadmap-original.html
mariachi-roadmap.htmlhtml45KBtemp-dscff/mariachi-roadmap.html
mega-research-v1.htmlhtml43KBmariachi files research/mega-research-v1.html
mariachi-art-full-audit.htmlhtml43KBmariachi-art-full-audit.html
mariachi-styleguide.htmlhtml42KBmariachi-react/docs/screenshots/mariachi-styleguide.html
style-guide-v1.htmlhtml42KBmariachi-react/docs/style-guides/style-guide-v1.html
plan-deploy-v2.htmlhtml41KBmariachi-organized/03-html-reports/plan-deploy-v2.html
full_report_v4_pricing.htmlhtml41KBfull_report_v4_pricing.html
roadmap.htmlhtml40KBroadmap.html
pinterest-seo-plan-2026-04-08.mdmd39KBresearch/pinterest-seo-plan-2026-04-08.md
nextjs-migration-plan-v2.mdmd37KBresearch/nextjs-migration-plan-v2.md
mariachi_audit_report.mdmd36KBmariachi-react/docs/research/mariachi_audit_report.md
audit-notes-v1.mdmd36KBmariachi-react/docs/audits/audit-notes-v1.md
mariachi-audit-report-alt.mdmd36KBmariachi-organized/02-docs/audit-reports/mariachi-audit-report-alt.md
plan-deploy-v1.htmlhtml36KBmariachi-organized/03-html-reports/plan-deploy-v1.html
roadmap-client-ru.htmlhtml33KBroadmap-client-ru.html
full_report_v4.htmlhtml33KBfull_report_v4.html
MARIACHI_Daily_2026-04-05.htmlhtml33KBMARIACHI_Daily_2026-04-05.html
roadmap-client.htmlhtml32KBroadmap-client.html
MARIACHI_Daily_2026-04-06.htmlhtml31KBMARIACHI_Daily_2026-04-06.html
tasks-en.htmlhtml30KBmariachi-organized/03-html-reports/tasks-en.html
mariachi-audit-report.mdmd30KBmariachi-organized/02-docs/audit-reports/mariachi-audit-report.md
claude-products-full-guide.mdmd30KBresearch/claude-products-full-guide.md
spain-uk-russia-v1.htmlhtml28KBmariachi files research/spain-uk-russia-v1.html
BOT-IMPROVEMENT-PLAN.mdmd28KBBOT-IMPROVEMENT-PLAN.md
design-system-audit.mdmd28KBresearch/design-system-audit.md
roadmap-masha.htmlhtml28KBroadmap-masha.html
audit-v1.htmlhtml27KBmariachi-react/docs/audits/audit-v1.html
audit-v1.htmlhtml27KBmariachi-organized/03-html-reports/audit-v1.html
roadmap-v2.htmlhtml26KBmariachi-react/docs/reports/roadmap-v2.html
roadmap-standalone-v2.htmlhtml26KBmariachi-organized/03-html-reports/roadmap-standalone-v2.html
mariachi-roadmap-old.htmlhtml26KBtemp-dscff/mariachi-roadmap-old.html
roadmap-masha-v2.htmlhtml25KBroadmap-masha-v2.html
roadmap.htmlhtml25KBmariachi-react/client/public/roadmap.html
report.htmlhtml25KBmariachi-organized/03-html-reports/report.html
compact-006-2026-04-06-session-7.mdmd22KBcompacts/compact-006-2026-04-06-session-7.md
project-status-full.mdmd22KBresearch/project-status-full.md
roadmap-fixes-ru.mdmd21KBmariachi-organized/02-docs/roadmaps/roadmap-fixes-ru.md
research-seo-craft-brands.mdmd21KBresearch/deep-research/research-seo-craft-brands.md
research-geo-aeo-ai-search-optimization.mdmd21KBresearch/deep-research/research-geo-aeo-ai-search-optimization.md
japan-plan-v1.htmlhtml21KBmariachi files research/japan-plan-v1.html
design-system-v1.htmlhtml21KBmariachi-react/docs/design-system/design-system-v1.html
design-system-v1.htmlhtml21KBmariachi-organized/03-html-reports/design-system-v1.html
compact-002-2026-04-04-session-3.mdmd20KBcompacts/compact-002-2026-04-04-session-3.md
git_history.txttxt20KBmariachi-react/docs/research/git_history.txt
compact-010-2026-04-11-session-10.mdmd20KBcompacts/compact-010-2026-04-11-session-10.md
roadmap-masha-v3.htmlhtml19KBroadmap-masha-v3.html
board-changes-v3.htmlhtml18KBmariachi-organized/03-html-reports/board-changes-v3.html
compact-007-2026-04-07-session-8.mdmd17KBcompacts/compact-007-2026-04-07-session-8.md
report-v1.htmlhtml17KBmariachi-react/docs/reports/report-v1.html
report-v1.htmlhtml17KBmariachi-organized/03-html-reports/report-v1.html
roadmap-v1.htmlhtml17KBmariachi-organized/03-html-reports/roadmap-v1.html
email-newsletter-luxury-rug-research-2026-04-07.mdmd17KBresearch/email-newsletter-luxury-rug-research-2026-04-07.md
compact-009-2026-04-08-session-9-part2.mdmd17KBcompacts/compact-009-2026-04-08-session-9-part2.md
tasks-ru-v2.htmlhtml16KBmariachi-organized/03-html-reports/tasks-ru-v2.html
board-changes-v2.htmlhtml16KBmariachi-organized/03-html-reports/board-changes-v2.html
compact-001-2026-04-03-sessions-1-2.mdmd16KBcompacts/compact-001-2026-04-03-sessions-1-2.md
board-changes-v1.htmlhtml16KBmariachi-organized/03-html-reports/board-changes-v1.html
gitlog_full.txttxt15KBmariachi-organized/02-docs/project-history/gitlog_full.txt
asset-catalog-v1.htmlhtml15KBmariachi-react/docs/asset-catalogs/asset-catalog-v1.html
asset-catalog-v1.htmlhtml15KBmariachi-organized/03-html-reports/asset-catalog-v1.html
freelance-rates-europe-2026-verified.mdmd15KBresearch/freelance-rates-europe-2026-verified.md
ahrefs-guide.mdmd15KBmariachi files research/ahrefs-guide.md
fonts-compare.htmlhtml14KBtemp-dscff/mariachitest/fonts-compare.html
full-project-history-ru.mdmd14KBmariachi-organized/02-docs/project-history/full-project-history-ru.md
compact-003-2026-04-04-session-4.mdmd13KBcompacts/compact-003-2026-04-04-session-4.md
mariachi-art-full-audit.mdmd13KBmariachi-organized/02-docs/audit-reports/mariachi-art-full-audit.md
nav-variants.htmlhtml13KBtemp-dscff/mariachitest/nav-variants.html
eu-web-dev-pricing-2026.mdmd12KBresearch/deep-research/eu-web-dev-pricing-2026.md
AUDIT_REPORT_v2.mdmd12KBmariachi-react/docs/AUDIT_REPORT_v2.md
audit-report-v2.mdmd12KBmariachi-organized/02-docs/audit-reports/audit-report-v2.md
mariachi-style-guide.mdmd12KBmariachi-react/docs/research/mariachi-style-guide.md
mariachi-style-guide.mdmd12KBmariachi-organized/02-docs/style-guides/mariachi-style-guide.md
shop-v3-masonry.htmlhtml12KBtemp-dscff/mariachitest/shop-v3-masonry.html
compact-004-2026-04-05-session-5.mdmd12KBcompacts/compact-004-2026-04-05-session-5.md
report-base.htmlhtml12KBmariachi-organized/03-html-reports/report-base.html
rug-v2-essay.htmlhtml11KBtemp-dscff/mariachitest/rug-v2-essay.html
project-stats.htmlhtml11KBproject-stats.html
Comprehensive Audit Report — Mariachi Art Website.mdmd11KBComprehensive Audit Report — Mariachi Art Website.md
COMPREHENSIVE_AUDIT_REPORT.mdmd11KBmariachi-react/docs/COMPREHENSIVE_AUDIT_REPORT.md
audit-comprehensive.mdmd11KBmariachi-organized/02-docs/audit-reports/audit-comprehensive.md
compact-008-2026-04-08-session-9.mdmd11KBcompacts/compact-008-2026-04-08-session-9.md
index.htmlhtml10KBmariachi-organized/01-source-code/entry/index.html
ROADMAP.mdmd10KBmariachi-react/docs/ROADMAP.md
development-roadmap.mdmd10KBmariachi-organized/02-docs/roadmaps/development-roadmap.md
process-hero.htmlhtml10KBtemp-dscff/mariachitest/process-hero.html
inquire-inline.htmlhtml10KBtemp-dscff/mariachitest/inquire-inline.html
messages_clean.txttxt10KBmariachi-organized/09-text-misc/messages_clean.txt
tasks-ru-v1.htmlhtml10KBmariachi-organized/03-html-reports/tasks-ru-v1.html
knowledge-base-extended.mdmd10KBmariachi-organized/02-docs/project-history/knowledge-base-extended.md
shop-v2.htmlhtml10KBtemp-dscff/mariachitest/shop-v2.html
rug-v1-playfair.htmlhtml9KBtemp-dscff/mariachitest/rug-v1-playfair.html
compact-005-2026-04-06-session-6.mdmd9KBcompacts/compact-005-2026-04-06-session-6.md
slogan_variants.htmlhtml9KBmariachi-organized/03-html-reports/slogan_variants.html
skill-definition-v2.mdmd9KBmariachi-organized/05-skills/skill-definition-v2.md
ticker-v2.htmlhtml9KBtemp-dscff/mariachitest/ticker-v2.html
index.htmlhtml8KBtemp-dscff/mariachitest/index.html
mariachi-site-audit.mdmd8KBmariachi-react/docs/research/mariachi-site-audit.md
audit-structure-recommendations-ru.mdmd8KBmariachi-organized/02-docs/audit-reports/audit-structure-recommendations-ru.md
index.htmlhtml8KBmariachi files research/index.html
fade-transitions.htmlhtml8KBtemp-dscff/mariachitest/fade-transitions.html
SESSION-LOG.mdmd7KBSESSION-LOG.md
CLAUDE.mdmd7KBCLAUDE.md
AUDIT_REPORT.mdmd7KBmariachi-react/docs/AUDIT_REPORT.md
audit-pre-deploy.mdmd7KBmariachi-organized/02-docs/audit-reports/audit-pre-deploy.md
TODO-FIXES.mdmd7KBTODO-FIXES.md
2026-04-01_15-55-42_175837_76549.txttxt7KBmariachi-organized/09-text-misc/2026-04-01_15-55-42_175837_76549.txt
rug-v1.htmlhtml7KBtemp-dscff/mariachitest/rug-v1.html
VOICE_AUDIT.mdmd7KBmariachi-react/docs/VOICE_AUDIT.md
voice-audit-1st-vs-3rd-person.mdmd7KBmariachi-organized/02-docs/research/voice-audit-1st-vs-3rd-person.md
NEXTJS-MIGRATION-PLAN.mdmd6KBNEXTJS-MIGRATION-PLAN.md
max-width-research.mdmd6KBmariachi-organized/02-docs/research/max-width-research.md
skill-definition-v1.mdmd6KBmariachi-organized/05-skills/skill-definition-v1.md
pasted_content.txttxt6KBmariachi-organized/09-text-misc/pasted_content.txt
marquee-scroll.htmlhtml6KBtemp-dscff/mariachitest/marquee-scroll.html
changelog-ru.mdmd6KBmariachi-organized/02-docs/project-history/changelog-ru.md
variable-weight.htmlhtml6KBtemp-dscff/mariachitest/variable-weight.html
roadmap-next-steps-ru.mdmd6KBmariachi-organized/02-docs/roadmaps/roadmap-next-steps-ru.md
hero-fullscreen.htmlhtml6KBtemp-dscff/mariachitest/hero-fullscreen.html
market-intelligence-from-mega-v2.mdmd6KBresearch/deep-research/market-intelligence-from-mega-v2.md
STYLEGUIDE.mdmd6KBmariachi-react/STYLEGUIDE.md
style-guide.mdmd6KBmariachi-organized/02-docs/style-guides/style-guide.md
eu-pricing-with-sources.mdmd5KBresearch/deep-research/eu-pricing-with-sources.md
AUDIT-FULL-2026-04-06.mdmd5KBAUDIT-FULL-2026-04-06.md
asset-catalog.mdmd5KBmariachi-organized/02-docs/asset-catalogs/asset-catalog.md
ROADMAP.mdmd5KBROADMAP.md
mariachi-styleguide.htmlhtml5KBmariachi-organized/03-html-reports/mariachi-styleguide.html
mariachi-status-report.mdmd4KBmariachi-react/docs/research/mariachi-status-report.md
audit-execution-report-ru.mdmd4KBmariachi-organized/02-docs/audit-reports/audit-execution-report-ru.md
roadmap-standalone-v1.htmlhtml4KBmariachi-organized/03-html-reports/roadmap-standalone-v1.html
canvas_findings.mdmd4KBmariachi-organized/02-docs/bug-reports/canvas_findings.md
canvas_findings.mdmd4KBmariachi-organized/09-text-misc/canvas_findings.md
live_site.htmlhtml4KBmariachi-organized/03-html-reports/live_site.html
site_notes.mdmd4KBmariachi-react/site_notes.md
site_notes.mdmd4KBmariachi-organized/02-docs/project-history/site_notes.md
photo_catalog.mdmd4KBmariachi-organized/02-docs/asset-catalogs/photo_catalog.md
mariachi-bug-plan.mdmd3KBmariachi-organized/02-docs/bug-reports/mariachi-bug-plan.md
index.htmlhtml3KBmariachi-react/client/index.html
MARIACHI-PROJECT-INDEX.mdmd3KBmariachi-react/docs/research/MARIACHI-PROJECT-INDEX.md
master-index-ru.mdmd3KBmariachi-organized/02-docs/project-history/master-index-ru.md
api-keys.mdmd3KB.credentials/api-keys.md
DEEP_AUDIT_NOTES.mdmd3KBmariachi-react/docs/DEEP_AUDIT_NOTES.md
audit-deep-notes.mdmd3KBmariachi-organized/02-docs/audit-reports/audit-deep-notes.md
knowledge-base.mdmd3KBmariachi-organized/02-docs/project-history/knowledge-base.md
VOICE_CHANGES_REPORT.mdmd3KBmariachi-react/docs/VOICE_CHANGES_REPORT.md
voice-changes-3rd-to-1st-person-ru.mdmd3KBmariachi-organized/02-docs/research/voice-changes-3rd-to-1st-person-ru.md
screenshot_findings.mdmd3KBmariachi-organized/02-docs/bug-reports/screenshot_findings.md
findings.mdmd2KBmariachi-organized/02-docs/bug-reports/findings.md
firecrawl-real-pricing-data.mdmd2KBresearch/deep-research/firecrawl-real-pricing-data.md
deco-placement.mdmd2KBmariachi-organized/02-docs/style-guides/deco-placement.md
BACKLOG.mdmd2KBBACKLOG.md
session-log.mdmd2KBmariachi-react/docs/session-log.md
session-log-v2.mdmd2KBmariachi-organized/02-docs/project-history/session-log-v2.md
RULES.mdmd2KBRULES.md
deep_audit_findings.mdmd2KBmariachi-organized/02-docs/audit-reports/deep_audit_findings.md
llms.txttxt2KBmariachi-react/client/public/llms.txt
preview-welcome-3.htmlhtml2KBmariachi-react/client/public/preview-welcome-3.html
session-log-v1.mdmd2KBmariachi-organized/02-docs/project-history/session-log-v1.md
removed-sections.mdmd2KBmariachi-organized/02-docs/project-history/removed-sections.md
cdn_urls.mdmd2KBmariachi-react/cdn_urls.md
cdn_urls.mdmd2KBmariachi-organized/02-docs/asset-catalogs/cdn_urls.md
CHECKPOINT.mdmd1KBCHECKPOINT.md
preview-welcome-4.htmlhtml1KBmariachi-react/client/public/preview-welcome-4.html
cdn_rugs.mdmd1KBmariachi-organized/02-docs/asset-catalogs/cdn_rugs.md
photo_inventory.mdmd1KBmariachi-organized/02-docs/asset-catalogs/photo_inventory.md
screenshot_map.txttxt1KBmariachi-organized/07-screenshots/misc/screenshot_map.txt
pdf_page_findings.mdmd1KBmariachi-organized/02-docs/bug-reports/pdf_page_findings.md
rules.mdmd1KB.claude/rules.md
preview-welcome-5.htmlhtml1KBmariachi-react/client/public/preview-welcome-5.html
page_status_v3.mdmd1KBmariachi-organized/02-docs/roadmaps/page_status_v3.md
preview-welcome-2.htmlhtml1KBmariachi-react/client/public/preview-welcome-2.html
design_notes.mdmd1KBmariachi-organized/02-docs/style-guides/design_notes.md
cdn_urls_reference.mdmd1KBmariachi-organized/02-docs/asset-catalogs/cdn_urls_reference.md
preview-welcome-6.htmlhtml1KBmariachi-react/client/public/preview-welcome-6.html
nav-research.mdmd1KBmariachi-react/docs/research/nav-research.md
nav-research.mdmd1KBmariachi-organized/02-docs/research/nav-research.md
preview-welcome-7.htmlhtml1KBmariachi-react/client/public/preview-welcome-7.html
deploy-cheatsheet.mdmd1KBmariachi-organized/02-docs/project-history/deploy-cheatsheet.md
preview-welcome-1.htmlhtml1KBmariachi-react/client/public/preview-welcome-1.html
audit-notes-v1.mdmd1KBmariachi-organized/02-docs/audit-reports/audit-notes-v1.md
v3_design_notes.mdmd1KBmariachi-organized/02-docs/style-guides/v3_design_notes.md
bug_findings.mdmd1KBmariachi-organized/02-docs/bug-reports/bug_findings.md
NIGHT-PLAN.mdmd1KBNIGHT-PLAN.md
rug_photo_notes.mdmd1KBmariachi-organized/02-docs/asset-catalogs/rug_photo_notes.md
layout_audit.mdmd1KBmariachi-organized/02-docs/audit-reports/layout_audit.md
README.txttxt1KBmariachi-react/.vercel/README.txt
robots.txttxt1KBmariachi-react/client/public/robots.txt
interior-designers.htmlhtml1KBextracted/interior-designers.html
about.htmlhtml1KBextracted/about.html
workshops.htmlhtml1KBextracted/workshops.html
contact.htmlhtml1KBextracted/contact.html
journal.htmlhtml1KBextracted/journal.html
shop.htmlhtml1KBextracted/shop.html
commissions.htmlhtml1KBextracted/commissions.html
portfolio.htmlhtml1KBextracted/portfolio.html
japan-market-v1.htmlhtml1KBmariachi files research/japan-market-v1.html
robots.txttxt1KBmariachi-organized/01-source-code/config/robots.txt
robots.txttxt1KBsite/robots.txt

📁 LIVE UAE 202 → [[MECLive]]

ФайлТипРазмерПуть
categorized-chat-visualized.htmlhtml3861KBdesign-sandbox/categorized-chat-visualized.html
chat-history-full.txttxt3033KBchat-history-full.txt
conversations.htmlhtml1900KBintranet/conversations.html
full-chat-visualized.htmlhtml1812KBdesign-sandbox/full-chat-visualized.html
chat-history-full.txttxt1394KBdesign-sandbox/chat-history-full.txt
2 qa-report-www.meclive.com.htmlhtml965KBantons/2 qa-report-www.meclive.com.html
all-requests-exhaustive-report.htmlhtml760KBdesign-sandbox/all-requests-exhaustive-report.html
messages.htmlhtml719KBantons/chat_export/ChatExport_2026-03-21 (1)/messages.html
r6-full.htmlhtml718KBintranet/research/r6-full.html
r10-full.htmlhtml717KBintranet/research/r10-full.html
logs.txttxt707KBlogs.txt
no-limits-categorized.htmlhtml530KBdesign-sandbox/no-limits-categorized.html
r2-full.htmlhtml414KBintranet/research/r2-full.html
r17-full.htmlhtml363KBintranet/research/r17-full.html
deep-research-mega-report.htmlhtml346KBdesign-sandbox/deep-research-mega-report.html
r1-full.htmlhtml342KBintranet/research/r1-full.html
r16-full.htmlhtml310KBintranet/research/r16-full.html
research.htmlhtml306KBintranet/research.html
messages2.htmlhtml265KBantons/chat_export/ChatExport_2026-03-21 (1)/messages2.html
r25-full.htmlhtml260KBintranet/research/r25-full.html
r24-full.htmlhtml242KBintranet/research/r24-full.html
r26-full.htmlhtml230KBintranet/research/r26-full.html
r18-full.htmlhtml204KBintranet/research/r18-full.html
r3-full.htmlhtml196KBintranet/research/r3-full.html
r27-full.htmlhtml188KBintranet/research/r27-full.html
r9-full.htmlhtml164KBintranet/research/r9-full.html
r22-full.htmlhtml138KBintranet/research/r22-full.html
r7-full.htmlhtml137KBintranet/research/r7-full.html
r21-full.htmlhtml134KBintranet/research/r21-full.html
r5-full.htmlhtml114KBintranet/research/r5-full.html
r19-full.htmlhtml114KBintranet/research/r19-full.html
r8-full.htmlhtml112KBintranet/research/r8-full.html
r13-full.htmlhtml111KBintranet/research/r13-full.html
report-v1.1.htmlhtml107KBintranet/report-v1.1.html
report-v1.2.htmlhtml107KBintranet/report-v1.2.html
r30-full.htmlhtml105KBintranet/research/r30-full.html
index.htmlhtml104KBintranet/index.html
r12-full.htmlhtml95KBintranet/research/r12-full.html
r28-full.htmlhtml93KBintranet/research/r28-full.html
r11-full.htmlhtml87KBintranet/research/r11-full.html
session-27-chat.mdmd84KBsession-27-chat.md
r4-full.htmlhtml81KBintranet/research/r4-full.html
architecture.htmlhtml79KBintranet/architecture.html
Разговор с Gemini ME CRISIS 31ee6f2c5e5680b796c9dd261c27f7b5.mdmd77KBantons/Разговор с Gemini ME CRISIS 31ee6f2c5e5680b796c9dd261c27f7b5.md
recap.htmlhtml77KBintranet/recap.html
plan.htmlhtml65KBintranet/plan.html
report.htmlhtml65KBintranet/report.html
briefing-15-mar-2026.htmlhtml65KBdata/journal/briefing-15-mar-2026.html
ideas.htmlhtml63KBintranet/ideas.html
index.htmlhtml61KBpublic/light3/index.html
index.htmlhtml60KBpublic/light2/index.html
index-v1.htmlhtml59KBpublic/light/index-v1.html
briefing-14-mar-2026.htmlhtml59KBdata/journal/briefing-14-mar-2026.html
index.htmlhtml58KBpublic/light/index.html
index.htmlhtml56KBarchive/v1-27mar2026/public/index.html
index.htmlhtml56KBpublic/index.html
index.htmlhtml55KBpublic/dark2/index.html
r29-full.htmlhtml55KBintranet/research/r29-full.html
index.htmlhtml52KBindex.html
ai-agents.htmlhtml51KBintranet/ai-agents.html
r31-full.htmlhtml50KBintranet/research/r31-full.html
r14-full.htmlhtml50KBintranet/research/r14-full.html
briefing-11-mar-2026.htmlhtml48KBdata/journal/briefing-11-mar-2026.html
sitrep-demo-11-mar.htmlhtml48KBsitrep-demo-11-mar.html
gemini.htmlhtml47KBintranet/gemini.html
color-palettes.htmlhtml47KBdesign-sandbox/color-palettes.html
meclive-project-recap.htmlhtml47KBmeclive-project-recap.html
report-v1.0.htmlhtml46KBintranet/report-v1.0.html
r20-full.htmlhtml44KBintranet/research/r20-full.html
master-guide.htmlhtml43KBintranet/master-guide.html
index.htmlhtml42KBantons/me-crisis-dashboard/public/index.html
market-model.htmlhtml41KBintranet/market-model.html
agents.htmlhtml40KBintranet/agents.html
agent-writers-guide.htmlhtml38KBintranet/agent-writers-guide.html
index.htmlhtml37KBv0-clean/index.html
index-new.htmlhtml37KBantons/me-crisis-dashboard/public/index-new.html
v3-prototype.htmlhtml32KBdesign-sandbox/v3-prototype.html
briefing-13-mar-2026.htmlhtml30KBdata/journal/briefing-13-mar-2026.html
style-guide.htmlhtml30KBintranet/style-guide.html
the-true-magnum-opus.htmlhtml30KBdesign-sandbox/the-true-magnum-opus.html
v3-light.htmlhtml29KBdesign-sandbox/v3-light.html
gemini-studio-mega-report.htmlhtml28KBdesign-sandbox/gemini-studio-mega-report.html
v0-design-reference.mdmd28KBprompts/v0-design-reference.md
ai-research.htmlhtml27KBintranet/ai-research.html
V0_INSTRUCTION_FINAL.mdmd27KBantons/V0_INSTRUCTION_FINAL.md
index.htmlhtml27KBv2-light/index.html
safety.htmlhtml26KBv2-light/safety.html
r15-full.htmlhtml26KBintranet/research/r15-full.html
Middle_East_Crisis_Report_March_11_2026.htmlhtml25KBantons/Middle_East_Crisis_Report_March_11_2026.html
middle-east-crisis-report-2026-03-09.htmlhtml25KBmiddle-east-crisis-report-2026-03-09.html
gemini-protocol-v3.htmlhtml24KBintranet/gemini-protocol-v3.html
thematic-synthesis.htmlhtml23KBdesign-sandbox/thematic-synthesis.html
the-ultimate-uncut-log.htmlhtml22KBdesign-sandbox/the-ultimate-uncut-log.html
research-report.mdmd22KB.firecrawl/research-report.md
gemini-protocol.htmlhtml21KBintranet/gemini-protocol.html
v3-fresh.htmlhtml20KBdesign-sandbox/v3-fresh.html
briefing-v1.htmlhtml19KBdesign-sandbox/briefing-v1.html
chronology-recap-dark.htmlhtml18KBdesign-sandbox/chronology-recap-dark.html
product-vision-2026.mdmd17KBprompts/product-vision-2026.md
research-dossier.htmlhtml17KBintranet/research-dossier.html
master-encyclopedia-dark.htmlhtml17KBdesign-sandbox/master-encyclopedia-dark.html
r32-full.htmlhtml17KBintranet/research/r32-full.html
uae-live-monitor_full_recap.mdmd17KBuae-live-monitor_full_recap.md
ultimate-structured-recap.htmlhtml17KBdesign-sandbox/ultimate-structured-recap.html
gemini-protocol-v2.htmlhtml17KBintranet/gemini-protocol-v2.html
briefing-02-apr-2026.htmlhtml16KBdata/journal/briefing-02-apr-2026.html
Middle East Crisis Report - March 9 2026.mdmd16KBmiddle/Middle East Crisis Report - March 9 2026.md
briefing-24-mar-2026.htmlhtml16KBdata/journal/briefing-24-mar-2026.html
briefing-05-apr-2026.htmlhtml16KBdata/journal/briefing-05-apr-2026.html
briefing-30-mar-2026.htmlhtml16KBdata/journal/briefing-30-mar-2026.html
briefing-06-apr-2026.htmlhtml16KBdata/journal/briefing-06-apr-2026.html
briefing-23-mar-2026.htmlhtml16KBdata/journal/briefing-23-mar-2026.html
briefing-01-apr-2026.htmlhtml16KBdata/journal/briefing-01-apr-2026.html
briefing-29-mar-2026.htmlhtml16KBdata/journal/briefing-29-mar-2026.html
briefing-26-mar-2026.htmlhtml16KBdata/journal/briefing-26-mar-2026.html
briefing-25-mar-2026.htmlhtml16KBdata/journal/briefing-25-mar-2026.html
briefing-04-apr-2026.htmlhtml16KBdata/journal/briefing-04-apr-2026.html
briefing-20-mar-2026.htmlhtml16KBdata/journal/briefing-20-mar-2026.html
briefing-03-apr-2026.htmlhtml16KBdata/journal/briefing-03-apr-2026.html
briefing-19-mar-2026.htmlhtml16KBdata/journal/briefing-19-mar-2026.html
briefing-18-mar-2026.htmlhtml16KBdata/journal/briefing-18-mar-2026.html
briefing-21-mar-2026.htmlhtml16KBdata/journal/briefing-21-mar-2026.html
briefing-28-mar-2026.htmlhtml16KBdata/journal/briefing-28-mar-2026.html
briefing-27-mar-2026.htmlhtml16KBdata/journal/briefing-27-mar-2026.html
briefing-31-mar-2026.htmlhtml16KBdata/journal/briefing-31-mar-2026.html
briefing-22-mar-2026.htmlhtml16KBdata/journal/briefing-22-mar-2026.html
strikes.htmlhtml16KBv2-light/strikes.html
sample_briefing_mockup.htmlhtml15KBarchive/v1-27mar2026/public/sample_briefing_mockup.html
sample_briefing_mockup.htmlhtml15KBpublic/sample_briefing_mockup.html
research-dossier-ru.htmlhtml15KBintranet/research-dossier-ru.html
.claude_instructions.mdmd15KB.claude_instructions.md
v2-deep-encyclopedia-dark.htmlhtml14KBdesign-sandbox/v2-deep-encyclopedia-dark.html
briefing-17-mar-2026.htmlhtml14KBdata/journal/briefing-17-mar-2026.html
briefing-16-mar-2026.htmlhtml14KBdata/journal/briefing-16-mar-2026.html
meclive-qa-audit.mdmd14KBmeclive-qa-audit.md
map.htmlhtml14KBv2-light/map.html
encyclopedia.htmlhtml13KBdesign-sandbox/encyclopedia.html
AGENTS.mdmd13KBagents/AGENTS.md
Middle-East-Crisis-Report-March-9-2026.mdmd13KBmiddle/Middle-East-Crisis-Report-March-9-2026.md
design-research-brief.mdmd12KBprompts/design-research-brief.md
r23-full.htmlhtml12KBintranet/research/r23-full.html
Middle_East_Crisis_Report_2026-03-09.mdmd12KBmiddle/Middle_East_Crisis_Report_2026-03-09.md
Middle_East_Crisis_Report_March_9_2026.mdmd12KBmiddle/Middle_East_Crisis_Report_March_9_2026.md
social.htmlhtml12KBv2-light/social.html
Middle-East-Crisis-Report-2026-03-09.mdmd12KBmiddle/Middle-East-Crisis-Report-2026-03-09.md
Middle East Crisis Report — March 9 2026.mdmd11KBmiddle/Middle East Crisis Report — March 9 2026.md
docs.htmlhtml11KBintranet/docs.html
site-architecture.mdmd10KBprompts/site-architecture.md
competitor-analysis.mdmd10KBprompts/competitor-analysis.md
plan.htmlhtml9KBintranet-kit-v2/modules/core/plan.html
Middle East Crisis Report — March 9, 2026.mdmd9KBmiddle/Middle East Crisis Report — March 9, 2026.md
design-research.mdmd8KB.firecrawl/design-research.md
ROADMAP.mdmd8KBintranet-kit-v2/ROADMAP.md
ideas.htmlhtml8KBintranet-kit-v2/modules/core/ideas.html
CLAUDE.mdmd8KBCLAUDE.md
atlas-product-kit.mdmd7KBdocs/atlas-product-kit.md
research.htmlhtml7KBintranet-kit-v2/modules/core/research.html
architecture.htmlhtml6KBintranet-kit-v2/modules/core/architecture.html
conversation-log.mdmd6KBconversation-log.md
index.htmlhtml6KBdesign-sandbox/index.html
ai-agents-deep-research.mdmd6KBintranet/research/ai-agents-deep-research.md
docs.htmlhtml6KBintranet-kit-v2/modules/core/docs.html
plan.mdmd5KBplan.md
filter-log.htmlhtml5KBintranet/filter-log.html
design-system-research.mdmd5KBprompts/design-system-research.md
index.htmlhtml5KBintranet-kit-v2/modules/core/index.html
digest.htmlhtml4KBdesign-sandbox/digest.html
ADR-GUIDE.mdmd3KBdocs/templates/ADR-GUIDE.md
ideas.htmlhtml3KBdocs/intranet-kit/template/ideas.html
index.htmlhtml2KBdocs/intranet-kit/template/index.html
ARCHITECTURE.mdmd2KBagents/ARCHITECTURE.md
plan.htmlhtml2KBdocs/intranet-kit/template/plan.html
architecture.htmlhtml2KBdocs/intranet-kit/template/architecture.html
rules.mdmd2KBintranet-kit-v2/claude/rules.md
CLAUDE-INTRANET.mdmd2KBdocs/intranet-kit/CLAUDE-INTRANET.md
claude_handoff.mdmd2KBclaude_handoff.md
research.htmlhtml2KBdocs/intranet-kit/template/research.html
docs.htmlhtml1KBdocs/intranet-kit/template/docs.html
001-express-tailwind-stack.mdmd1KBdocs/decisions/001-express-tailwind-stack.md
015-algorithmic-transliteration.mdmd1KBdocs/decisions/015-algorithmic-transliteration.md
005-strike-haversine-dedup.mdmd1KBdocs/decisions/005-strike-haversine-dedup.md
007-rollback-arabic-rtl.mdmd1KBdocs/decisions/007-rollback-arabic-rtl.md
004-telegram-html-parse-mode.mdmd1KBdocs/decisions/004-telegram-html-parse-mode.md
013-breaking-detection-tiers.mdmd1KBdocs/decisions/013-breaking-detection-tiers.md
010-embedded-agents.mdmd1KBdocs/decisions/010-embedded-agents.md
006-stability-score-design.mdmd1KBdocs/decisions/006-stability-score-design.md
009-atlas-sonnet-not-opus.mdmd1KBdocs/decisions/009-atlas-sonnet-not-opus.md
003-rss-google-news-sources.mdmd1KBdocs/decisions/003-rss-google-news-sources.md
002-remove-gdelt-from-feed.mdmd1KBdocs/decisions/002-remove-gdelt-from-feed.md
011-content-agent-approval.mdmd1KBdocs/decisions/011-content-agent-approval.md
012-image-fallback-chain.mdmd1KBdocs/decisions/012-image-fallback-chain.md
014-atomic-json-writes.mdmd1KBdocs/decisions/014-atomic-json-writes.md
008-rebrand-to-meclive.mdmd1KBdocs/decisions/008-rebrand-to-meclive.md
ADR-TEMPLATE.mdmd1KBdocs/templates/ADR-TEMPLATE.md
ADR-TEMPLATE.mdmd1KBintranet-kit-v2/templates/ADR-TEMPLATE.md
MEMORY.mdmd1KBintranet-kit-v2/claude/memory-template/MEMORY.md
conversation-log.mdmd1KBintranet-kit-v2/claude/memory-template/conversation-log.md
robots.txttxt1KBarchive/v1-27mar2026/public/robots.txt
robots.txttxt1KBpublic/robots.txt
googlea90eecf62aad0876.htmlhtml1KBgooglea90eecf62aad0876.html
googlea90eecf62aad0876.htmlhtml1KBarchive/v1-27mar2026/public/googlea90eecf62aad0876.html
googlea90eecf62aad0876.htmlhtml1KBpublic/googlea90eecf62aad0876.html

📁 LIVE UAE — BACKUP 27MAR2026 180 → [[MECLive (backup)]]

ФайлТипРазмерПуть
categorized-chat-visualized.htmlhtml3861KBdesign-sandbox/categorized-chat-visualized.html
chat-history-full.txttxt3033KBchat-history-full.txt
conversations.htmlhtml1900KBintranet/conversations.html
full-chat-visualized.htmlhtml1812KBdesign-sandbox/full-chat-visualized.html
chat-history-full.txttxt1394KBdesign-sandbox/chat-history-full.txt
2 qa-report-www.meclive.com.htmlhtml965KBantons/2 qa-report-www.meclive.com.html
all-requests-exhaustive-report.htmlhtml760KBdesign-sandbox/all-requests-exhaustive-report.html
messages.htmlhtml719KBantons/chat_export/ChatExport_2026-03-21 (1)/messages.html
r6-full.htmlhtml718KBintranet/research/r6-full.html
r10-full.htmlhtml717KBintranet/research/r10-full.html
logs.txttxt707KBlogs.txt
no-limits-categorized.htmlhtml530KBdesign-sandbox/no-limits-categorized.html
r2-full.htmlhtml414KBintranet/research/r2-full.html
r17-full.htmlhtml363KBintranet/research/r17-full.html
deep-research-mega-report.htmlhtml346KBdesign-sandbox/deep-research-mega-report.html
r1-full.htmlhtml342KBintranet/research/r1-full.html
r16-full.htmlhtml310KBintranet/research/r16-full.html
research.htmlhtml286KBintranet/research.html
messages2.htmlhtml265KBantons/chat_export/ChatExport_2026-03-21 (1)/messages2.html
r25-full.htmlhtml260KBintranet/research/r25-full.html
r24-full.htmlhtml242KBintranet/research/r24-full.html
r26-full.htmlhtml230KBintranet/research/r26-full.html
r18-full.htmlhtml204KBintranet/research/r18-full.html
r3-full.htmlhtml196KBintranet/research/r3-full.html
r27-full.htmlhtml188KBintranet/research/r27-full.html
r9-full.htmlhtml164KBintranet/research/r9-full.html
r22-full.htmlhtml138KBintranet/research/r22-full.html
r7-full.htmlhtml137KBintranet/research/r7-full.html
r21-full.htmlhtml134KBintranet/research/r21-full.html
r5-full.htmlhtml114KBintranet/research/r5-full.html
r19-full.htmlhtml114KBintranet/research/r19-full.html
r8-full.htmlhtml112KBintranet/research/r8-full.html
r13-full.htmlhtml111KBintranet/research/r13-full.html
report-v1.1.htmlhtml107KBintranet/report-v1.1.html
report-v1.2.htmlhtml107KBintranet/report-v1.2.html
r30-full.htmlhtml105KBintranet/research/r30-full.html
index.htmlhtml104KBintranet/index.html
r12-full.htmlhtml95KBintranet/research/r12-full.html
r28-full.htmlhtml93KBintranet/research/r28-full.html
r11-full.htmlhtml87KBintranet/research/r11-full.html
session-27-chat.mdmd84KBsession-27-chat.md
r4-full.htmlhtml81KBintranet/research/r4-full.html
architecture.htmlhtml79KBintranet/architecture.html
Разговор с Gemini ME CRISIS 31ee6f2c5e5680b796c9dd261c27f7b5.mdmd77KBantons/Разговор с Gemini ME CRISIS 31ee6f2c5e5680b796c9dd261c27f7b5.md
recap.htmlhtml77KBintranet/recap.html
plan.htmlhtml65KBintranet/plan.html
report.htmlhtml65KBintranet/report.html
briefing-15-mar-2026.htmlhtml65KBdata/journal/briefing-15-mar-2026.html
ideas.htmlhtml63KBintranet/ideas.html
index.htmlhtml61KBpublic/light3/index.html
index.htmlhtml60KBpublic/light2/index.html
index-v1.htmlhtml59KBpublic/light/index-v1.html
briefing-14-mar-2026.htmlhtml59KBdata/journal/briefing-14-mar-2026.html
index.htmlhtml58KBpublic/light/index.html
index.htmlhtml56KBarchive/v1-27mar2026/public/index.html
index.htmlhtml56KBpublic/index.html
index.htmlhtml55KBpublic/dark2/index.html
r29-full.htmlhtml55KBintranet/research/r29-full.html
index.htmlhtml52KBindex.html
ai-agents.htmlhtml51KBintranet/ai-agents.html
r31-full.htmlhtml50KBintranet/research/r31-full.html
r14-full.htmlhtml50KBintranet/research/r14-full.html
briefing-11-mar-2026.htmlhtml48KBdata/journal/briefing-11-mar-2026.html
sitrep-demo-11-mar.htmlhtml48KBsitrep-demo-11-mar.html
gemini.htmlhtml47KBintranet/gemini.html
color-palettes.htmlhtml47KBdesign-sandbox/color-palettes.html
meclive-project-recap.htmlhtml47KBmeclive-project-recap.html
report-v1.0.htmlhtml46KBintranet/report-v1.0.html
r20-full.htmlhtml44KBintranet/research/r20-full.html
master-guide.htmlhtml43KBintranet/master-guide.html
index.htmlhtml42KBantons/me-crisis-dashboard/public/index.html
market-model.htmlhtml41KBintranet/market-model.html
agents.htmlhtml40KBintranet/agents.html
index.htmlhtml37KBv0-clean/index.html
index-new.htmlhtml37KBantons/me-crisis-dashboard/public/index-new.html
v3-prototype.htmlhtml32KBdesign-sandbox/v3-prototype.html
briefing-13-mar-2026.htmlhtml30KBdata/journal/briefing-13-mar-2026.html
style-guide.htmlhtml30KBintranet/style-guide.html
the-true-magnum-opus.htmlhtml30KBdesign-sandbox/the-true-magnum-opus.html
v3-light.htmlhtml29KBdesign-sandbox/v3-light.html
gemini-studio-mega-report.htmlhtml28KBdesign-sandbox/gemini-studio-mega-report.html
v0-design-reference.mdmd28KBprompts/v0-design-reference.md
ai-research.htmlhtml27KBintranet/ai-research.html
V0_INSTRUCTION_FINAL.mdmd27KBantons/V0_INSTRUCTION_FINAL.md
index.htmlhtml27KBv2-light/index.html
safety.htmlhtml26KBv2-light/safety.html
r15-full.htmlhtml26KBintranet/research/r15-full.html
Middle_East_Crisis_Report_March_11_2026.htmlhtml25KBantons/Middle_East_Crisis_Report_March_11_2026.html
middle-east-crisis-report-2026-03-09.htmlhtml25KBmiddle-east-crisis-report-2026-03-09.html
gemini-protocol-v3.htmlhtml24KBintranet/gemini-protocol-v3.html
thematic-synthesis.htmlhtml23KBdesign-sandbox/thematic-synthesis.html
the-ultimate-uncut-log.htmlhtml22KBdesign-sandbox/the-ultimate-uncut-log.html
research-report.mdmd22KB.firecrawl/research-report.md
gemini-protocol.htmlhtml21KBintranet/gemini-protocol.html
v3-fresh.htmlhtml20KBdesign-sandbox/v3-fresh.html
briefing-v1.htmlhtml19KBdesign-sandbox/briefing-v1.html
chronology-recap-dark.htmlhtml18KBdesign-sandbox/chronology-recap-dark.html
product-vision-2026.mdmd17KBprompts/product-vision-2026.md
research-dossier.htmlhtml17KBintranet/research-dossier.html
master-encyclopedia-dark.htmlhtml17KBdesign-sandbox/master-encyclopedia-dark.html
r32-full.htmlhtml17KBintranet/research/r32-full.html
uae-live-monitor_full_recap.mdmd17KBuae-live-monitor_full_recap.md
ultimate-structured-recap.htmlhtml17KBdesign-sandbox/ultimate-structured-recap.html
gemini-protocol-v2.htmlhtml17KBintranet/gemini-protocol-v2.html
Middle East Crisis Report - March 9 2026.mdmd16KBmiddle/Middle East Crisis Report - March 9 2026.md
briefing-24-mar-2026.htmlhtml16KBdata/journal/briefing-24-mar-2026.html
briefing-23-mar-2026.htmlhtml16KBdata/journal/briefing-23-mar-2026.html
briefing-26-mar-2026.htmlhtml16KBdata/journal/briefing-26-mar-2026.html
briefing-25-mar-2026.htmlhtml16KBdata/journal/briefing-25-mar-2026.html
briefing-20-mar-2026.htmlhtml16KBdata/journal/briefing-20-mar-2026.html
briefing-19-mar-2026.htmlhtml16KBdata/journal/briefing-19-mar-2026.html
briefing-18-mar-2026.htmlhtml16KBdata/journal/briefing-18-mar-2026.html
briefing-21-mar-2026.htmlhtml16KBdata/journal/briefing-21-mar-2026.html
briefing-22-mar-2026.htmlhtml16KBdata/journal/briefing-22-mar-2026.html
strikes.htmlhtml16KBv2-light/strikes.html
briefing-27-mar-2026.htmlhtml16KBdata/journal/briefing-27-mar-2026.html
sample_briefing_mockup.htmlhtml15KBarchive/v1-27mar2026/public/sample_briefing_mockup.html
sample_briefing_mockup.htmlhtml15KBpublic/sample_briefing_mockup.html
research-dossier-ru.htmlhtml15KBintranet/research-dossier-ru.html
.claude_instructions.mdmd15KB.claude_instructions.md
v2-deep-encyclopedia-dark.htmlhtml14KBdesign-sandbox/v2-deep-encyclopedia-dark.html
briefing-17-mar-2026.htmlhtml14KBdata/journal/briefing-17-mar-2026.html
briefing-16-mar-2026.htmlhtml14KBdata/journal/briefing-16-mar-2026.html
meclive-qa-audit.mdmd14KBmeclive-qa-audit.md
map.htmlhtml14KBv2-light/map.html
encyclopedia.htmlhtml13KBdesign-sandbox/encyclopedia.html
AGENTS.mdmd13KBagents/AGENTS.md
Middle-East-Crisis-Report-March-9-2026.mdmd13KBmiddle/Middle-East-Crisis-Report-March-9-2026.md
design-research-brief.mdmd12KBprompts/design-research-brief.md
r23-full.htmlhtml12KBintranet/research/r23-full.html
Middle_East_Crisis_Report_2026-03-09.mdmd12KBmiddle/Middle_East_Crisis_Report_2026-03-09.md
Middle_East_Crisis_Report_March_9_2026.mdmd12KBmiddle/Middle_East_Crisis_Report_March_9_2026.md
social.htmlhtml12KBv2-light/social.html
Middle-East-Crisis-Report-2026-03-09.mdmd12KBmiddle/Middle-East-Crisis-Report-2026-03-09.md
Middle East Crisis Report — March 9 2026.mdmd11KBmiddle/Middle East Crisis Report — March 9 2026.md
docs.htmlhtml11KBintranet/docs.html
site-architecture.mdmd10KBprompts/site-architecture.md
competitor-analysis.mdmd10KBprompts/competitor-analysis.md
Middle East Crisis Report — March 9, 2026.mdmd9KBmiddle/Middle East Crisis Report — March 9, 2026.md
design-research.mdmd8KB.firecrawl/design-research.md
CLAUDE.mdmd8KBCLAUDE.md
atlas-product-kit.mdmd7KBdocs/atlas-product-kit.md
conversation-log.mdmd6KBconversation-log.md
index.htmlhtml6KBdesign-sandbox/index.html
ai-agents-deep-research.mdmd6KBintranet/research/ai-agents-deep-research.md
plan.mdmd5KBplan.md
filter-log.htmlhtml5KBintranet/filter-log.html
design-system-research.mdmd5KBprompts/design-system-research.md
digest.htmlhtml4KBdesign-sandbox/digest.html
ADR-GUIDE.mdmd3KBdocs/templates/ADR-GUIDE.md
ideas.htmlhtml3KBdocs/intranet-kit/template/ideas.html
index.htmlhtml2KBdocs/intranet-kit/template/index.html
ARCHITECTURE.mdmd2KBagents/ARCHITECTURE.md
plan.htmlhtml2KBdocs/intranet-kit/template/plan.html
architecture.htmlhtml2KBdocs/intranet-kit/template/architecture.html
CLAUDE-INTRANET.mdmd2KBdocs/intranet-kit/CLAUDE-INTRANET.md
claude_handoff.mdmd2KBclaude_handoff.md
research.htmlhtml2KBdocs/intranet-kit/template/research.html
docs.htmlhtml1KBdocs/intranet-kit/template/docs.html
001-express-tailwind-stack.mdmd1KBdocs/decisions/001-express-tailwind-stack.md
015-algorithmic-transliteration.mdmd1KBdocs/decisions/015-algorithmic-transliteration.md
005-strike-haversine-dedup.mdmd1KBdocs/decisions/005-strike-haversine-dedup.md
007-rollback-arabic-rtl.mdmd1KBdocs/decisions/007-rollback-arabic-rtl.md
004-telegram-html-parse-mode.mdmd1KBdocs/decisions/004-telegram-html-parse-mode.md
013-breaking-detection-tiers.mdmd1KBdocs/decisions/013-breaking-detection-tiers.md
010-embedded-agents.mdmd1KBdocs/decisions/010-embedded-agents.md
006-stability-score-design.mdmd1KBdocs/decisions/006-stability-score-design.md
009-atlas-sonnet-not-opus.mdmd1KBdocs/decisions/009-atlas-sonnet-not-opus.md
003-rss-google-news-sources.mdmd1KBdocs/decisions/003-rss-google-news-sources.md
002-remove-gdelt-from-feed.mdmd1KBdocs/decisions/002-remove-gdelt-from-feed.md
011-content-agent-approval.mdmd1KBdocs/decisions/011-content-agent-approval.md
012-image-fallback-chain.mdmd1KBdocs/decisions/012-image-fallback-chain.md
014-atomic-json-writes.mdmd1KBdocs/decisions/014-atomic-json-writes.md
008-rebrand-to-meclive.mdmd1KBdocs/decisions/008-rebrand-to-meclive.md
ADR-TEMPLATE.mdmd1KBdocs/templates/ADR-TEMPLATE.md
robots.txttxt1KBarchive/v1-27mar2026/public/robots.txt
robots.txttxt1KBpublic/robots.txt
googlea90eecf62aad0876.htmlhtml1KBgooglea90eecf62aad0876.html
googlea90eecf62aad0876.htmlhtml1KBarchive/v1-27mar2026/public/googlea90eecf62aad0876.html
googlea90eecf62aad0876.htmlhtml1KBpublic/googlea90eecf62aad0876.html

📁 RAZNOEDIF 127

ФайлТипРазмерПуть
_CttoOfvh1I.txttxt322KBbenai_data/_CttoOfvh1I.txt
fisun_v0.htmlhtml154KBfisun_v0.html
inna-fisun-5years.htmlhtml77KBinna-fisun-5years.html
inna-fisun-report.htmlhtml69KBinna-fisun-report.html
roadmap-v1.htmlhtml57KBmariachi-react/docs/reports/roadmap-v1.html
roadmap-v1.htmlhtml57KBdocs/reports/roadmap-v1.html
inna-fisun-audience-full.htmlhtml55KBinna-fisun-audience-full.html
claude-code-architecture.htmlhtml49KBdocs/claude-code-architecture.html
analysis_group2.mdmd47KBbenai_data/analysis_group2.md
BENAI_MEGA_ANALYSIS.mdmd47KBbenai_data/BENAI_MEGA_ANALYSIS.md
FAEKF-nr3D0.txttxt46KBbenai_data/FAEKF-nr3D0.txt
analysis_group4.mdmd45KBbenai_data/analysis_group4.md
mariachi-art-full-audit.htmlhtml43KBmariachi-art-full-audit.html
mariachi-styleguide.htmlhtml42KBmariachi-react/docs/screenshots/mariachi-styleguide.html
style-guide-v1.htmlhtml42KBmariachi-react/docs/style-guides/style-guide-v1.html
mariachi-styleguide.htmlhtml42KBdocs/screenshots/mariachi-styleguide.html
style-guide-v1.htmlhtml42KBdocs/style-guides/style-guide-v1.html
IBT_statement_analysis.htmlhtml41KBIBT_statement_analysis.html
analysis_group3.mdmd41KBbenai_data/analysis_group3.md
analysis_group1.mdmd36KBbenai_data/analysis_group1.md
mariachi_audit_report.mdmd36KBmariachi-react/docs/research/mariachi_audit_report.md
audit-notes-v1.mdmd36KBmariachi-react/docs/audits/audit-notes-v1.md
mariachi_audit_report.mdmd36KBdocs/research/mariachi_audit_report.md
audit-notes-v1.mdmd36KBdocs/audits/audit-notes-v1.md
index.htmlhtml35KBdose-live-app/index.html
inna-fisun-audience.htmlhtml33KBinna-fisun-audience.html
fisun_report.htmlhtml30KBfisun_report.html
inna-fisun-gift-dossier.htmlhtml27KBinna-fisun-gift-dossier.html
audit-v1.htmlhtml27KBmariachi-react/docs/audits/audit-v1.html
audit-v1.htmlhtml27KBdocs/audits/audit-v1.html
COtpdR5Nbho.txttxt27KBbenai_data/COtpdR5Nbho.txt
roadmap-v2.htmlhtml26KBmariachi-react/docs/reports/roadmap-v2.html
roadmap-v2.htmlhtml26KBdocs/reports/roadmap-v2.html
mariachi-art-full-audit.mdmd26KBmariachi-art-full-audit.md
qo4YZvC1q5I.txttxt25KBbenai_data/qo4YZvC1q5I.txt
cosmic-mycelium.htmlhtml24KBcosmic-mycelium.html
HTu1OGWAn5w.txttxt22KBbenai_data/HTu1OGWAn5w.txt
SKILL.mdmd22KBdocs/skills/excel-generator/SKILL.md
openclaw-security-risks-research.mdmd22KBresearch/openclaw-security-risks-research.md
X3uum6W2xEI.txttxt22KBbenai_data/X3uum6W2xEI.txt
design-system-v1.htmlhtml21KBmariachi-react/docs/design-system/design-system-v1.html
design-system-v1.htmlhtml21KBdocs/design-system/design-system-v1.html
git_history.txttxt20KBmariachi-react/docs/research/git_history.txt
git_history.txttxt20KBdocs/research/git_history.txt
A6RbawFHC80.txttxt19KBbenai_data/A6RbawFHC80.txt
XYHqQOX4ivs.txttxt18KBbenai_data/XYHqQOX4ivs.txt
openclaw-hostinger-research.mdmd18KBresearch/openclaw-hostinger-research.md
claude-code-structure.htmlhtml18KBdocs/claude-code-structure.html
3cYusISFc9s.txttxt18KBbenai_data/3cYusISFc9s.txt
Q3HKf8DDiBk.txttxt17KBbenai_data/Q3HKf8DDiBk.txt
report-v1.htmlhtml17KBmariachi-react/docs/reports/report-v1.html
report-v1.htmlhtml17KBdocs/reports/report-v1.html
EqJoui72QrU.txttxt16KBbenai_data/EqJoui72QrU.txt
0T6q4v8Rb_s.txttxt16KBbenai_data/0T6q4v8Rb_s.txt
IBT_to_Santander_cash_matching.htmlhtml16KBIBT_to_Santander_cash_matching.html
stitch_catalog.htmlhtml15KBdose-live-app/stitch_catalog.html
BJuevX91ExM.txttxt15KBbenai_data/BJuevX91ExM.txt
asset-catalog-v1.htmlhtml15KBmariachi-react/docs/asset-catalogs/asset-catalog-v1.html
asset-catalog-v1.htmlhtml15KBdocs/asset-catalogs/asset-catalog-v1.html
CO8EU32b-Y0.txttxt15KBbenai_data/CO8EU32b-Y0.txt
ahrefs-guide.mdmd15KB.claude/skills/ahrefs-guide.md
kGPUBPfywWc.txttxt15KBbenai_data/kGPUBPfywWc.txt
sgSrcSUck7U.txttxt14KBbenai_data/sgSrcSUck7U.txt
catalog.htmlhtml13KBdose-live-app/catalog.html
oleksii-hrankin-deep-research-2026-04-11.mdmd13KBresearch/oleksii-hrankin-deep-research-2026-04-11.md
stitch_cart.htmlhtml13KBdose-live-app/stitch_cart.html
JDjxeB-UEoc.txttxt12KBbenai_data/JDjxeB-UEoc.txt
AUDIT_REPORT_v2.mdmd12KBmariachi-react/docs/AUDIT_REPORT_v2.md
AUDIT_REPORT_v2.mdmd12KBdocs/AUDIT_REPORT_v2.md
mariachi-style-guide.mdmd12KBmariachi-react/docs/research/mariachi-style-guide.md
mariachi-style-guide.mdmd12KBdocs/research/mariachi-style-guide.md
COMPREHENSIVE_AUDIT_REPORT.mdmd11KBmariachi-react/docs/COMPREHENSIVE_AUDIT_REPORT.md
COMPREHENSIVE_AUDIT_REPORT.mdmd11KBdocs/COMPREHENSIVE_AUDIT_REPORT.md
LICENSE.txttxt11KBdocs/skills/skill-creator/LICENSE.txt
stitch_live.htmlhtml10KBdose-live-app/stitch_live.html
ROADMAP.mdmd10KBmariachi-react/docs/ROADMAP.md
ROADMAP.mdmd10KBdocs/ROADMAP.md
IBT_statement_analysis.mdmd10KBIBT_statement_analysis.md
SKILL.mdmd10KBdocs/skills/skill-creator/SKILL.md
stitch_checkout.htmlhtml9KBdose-live-app/stitch_checkout.html
SKILL.mdmd9KBdocs/skills/webdev-design-system/SKILL.md
MTdabgyOxFw.txttxt9KBbenai_data/MTdabgyOxFw.txt
checkout.htmlhtml8KBdose-live-app/checkout.html
TGBY7bGYoJM.txttxt8KBbenai_data/TGBY7bGYoJM.txt
F6T3WkTWYX4.txttxt8KBbenai_data/F6T3WkTWYX4.txt
mariachi-site-audit.mdmd8KBmariachi-react/docs/research/mariachi-site-audit.md
mariachi-site-audit.mdmd8KBdocs/research/mariachi-site-audit.md
home.htmlhtml7KBdose-live-app/home.html
SKILL.mdmd7KBdocs/skills/webdev-qa-testing/SKILL.md
AUDIT_REPORT.mdmd7KBmariachi-react/docs/AUDIT_REPORT.md
AUDIT_REPORT.mdmd7KBdocs/AUDIT_REPORT.md
VOICE_AUDIT.mdmd7KBmariachi-react/docs/VOICE_AUDIT.md
VOICE_AUDIT.mdmd7KBdocs/VOICE_AUDIT.md
cart.htmlhtml7KBdose-live-app/cart.html
SKILL.mdmd6KBdocs/skills/artist-portfolio-webdev/SKILL.md
SKILL.mdmd6KBdocs/skills/webdev-ux-audit/SKILL.md
STYLEGUIDE.mdmd6KBSTYLEGUIDE.md
STYLEGUIDE.mdmd6KBmariachi-react/STYLEGUIDE.md
mariachi-status-report.mdmd4KBmariachi-react/docs/research/mariachi-status-report.md
mariachi-status-report.mdmd4KBdocs/research/mariachi-status-report.md
site_notes.mdmd4KBsite_notes.md
site_notes.mdmd4KBmariachi-react/site_notes.md
compact-001-2026-04-06-session-1.mdmd4KBcompacts/compact-001-2026-04-06-session-1.md
SKILL.mdmd4KBdocs/skills/cdn-asset-management/SKILL.md
MARIACHI-PROJECT-INDEX.mdmd3KBmariachi-react/docs/research/MARIACHI-PROJECT-INDEX.md
MARIACHI-PROJECT-INDEX.mdmd3KBdocs/research/MARIACHI-PROJECT-INDEX.md
cosmic-mycelium-philosophy.mdmd3KBcosmic-mycelium-philosophy.md
SKILL.mdmd3KBdocs/skills/mariachi-brand-reports/SKILL.md
SKILL.mdmd3KBdocs/skills/webdev-project-docs/SKILL.md
index.htmlhtml3KBmariachi-react/client/index.html
index.htmlhtml3KBclient/index.html
DEEP_AUDIT_NOTES.mdmd3KBmariachi-react/docs/DEEP_AUDIT_NOTES.md
DEEP_AUDIT_NOTES.mdmd3KBdocs/DEEP_AUDIT_NOTES.md
VOICE_CHANGES_REPORT.mdmd3KBmariachi-react/docs/VOICE_CHANGES_REPORT.md
VOICE_CHANGES_REPORT.mdmd3KBdocs/VOICE_CHANGES_REPORT.md
SKILL.mdmd2KBdocs/skills/expo-bug-fixer/SKILL.md
SKILL.mdmd2KBdocs/skills/ai-digest/SKILL.md
session-log.mdmd2KBmariachi-react/docs/session-log.md
session-log.mdmd2KBdocs/session-log.md
cdn_urls.mdmd2KBcdn_urls.md
cdn_urls.mdmd2KBmariachi-react/cdn_urls.md
nav-research.mdmd1KBmariachi-react/docs/research/nav-research.md
nav-research.mdmd1KBdocs/research/nav-research.md
researcher.mdmd1KB.claude/agents/researcher.md
index.htmlhtml1KBdose-coffee-app/index.html
robots.txttxt1KBmariachi-react/client/public/robots.txt
robots.txttxt1KBclient/public/robots.txt

📁 TESTER CODEX 121

ФайлТипРазмерПуть
qa-report-www.meclive.com.htmlhtml2854KBreports/qa-report-www.meclive.com.html
2 qa-report-www.meclive.com.htmlhtml965KBreports/2 qa-report-www.meclive.com.html
3qa-report-www.meclive.com.htmlhtml580KBreports/3qa-report-www.meclive.com.html
qa-mega-research-v2.htmlhtml353KBqa-mega-research-v2.html
qa-saas-blueprint.htmlhtml326KBqa-saas-blueprint.html
02-competitive-analysis-raw.txttxt219KBresearch-raw/02-competitive-analysis-raw.txt
07-mega-research-exploration-raw.txttxt218KBresearch-raw/07-mega-research-exploration-raw.txt
11-session2-analysis-raw.txttxt201KBresearch-raw/11-session2-analysis-raw.txt
12-session2-exploration-raw.txttxt199KBresearch-raw/12-session2-exploration-raw.txt
01-ux-research-competitors-raw.txttxt194KBresearch-raw/01-ux-research-competitors-raw.txt
08-local-server-code-raw.txttxt192KBresearch-raw/08-local-server-code-raw.txt
10-session2-research-raw.txttxt178KBresearch-raw/10-session2-research-raw.txt
qa-mega-research-v1.htmlhtml161KBqa-mega-research-v1.html
06-unique-ideas-raw.txttxt117KBresearch-raw/06-unique-ideas-raw.txt
part2-3-tools-istqb.htmlhtml116KBresearch-parts/part2-3-tools-istqb.html
09-auto-audit-frontend-raw.txttxt111KBresearch-raw/09-auto-audit-frontend-raw.txt
13-session2-code-review-raw.txttxt103KBresearch-raw/13-session2-code-review-raw.txt
part1b-tester-workflow-execution.htmlhtml103KBresearch-parts/part1b-tester-workflow-execution.html
04-report-design-raw.txttxt102KBresearch-raw/04-report-design-raw.txt
part4-8-bugs-data-market-plan.htmlhtml95KBresearch-parts/part4-8-bugs-data-market-plan.html
05-monetization-growth-raw.txttxt94KBresearch-raw/05-monetization-growth-raw.txt
03-ai-qa-trends-raw.txttxt82KBresearch-raw/03-ai-qa-trends-raw.txt
qa-deep-research-report.htmlhtml64KBqa-deep-research-report.html
part1-tester-workflow.htmlhtml53KBresearch-parts/part1-tester-workflow.html
qa-checklist-landing.htmlhtml45KBqa-checklist-landing.html
api-catalog.htmlhtml42KBapi-catalog.html
RESEARCH_SCORING_DEEP_DIVE.mdmd39KBdocs/RESEARCH_SCORING_DEEP_DIVE.md
RESEARCH_WEBSITE_CHECKERS_FOR_NON_TECH.mdmd37KBdocs/RESEARCH_WEBSITE_CHECKERS_FOR_NON_TECH.md
conversation-log.mdmd37KBconversation-log.md
FEATURES_GUIDE.mdmd37KBdata/FEATURES_GUIDE.md
qa-market-analysis.htmlhtml36KBqa-market-analysis.html
MASTER_PLAN.mdmd35KBdocs/MASTER_PLAN.md
COMPETITIVE_DEEP_ANALYSIS_2026.mdmd34KBdocs/COMPETITIVE_DEEP_ANALYSIS_2026.md
GEMINI_RAW_AUDITS.mdmd34KBdocs/GEMINI_RAW_AUDITS.md
RESEARCH_COMPETITOR_SCORING.mdmd32KBdocs/RESEARCH_COMPETITOR_SCORING.md
gumroad-instructions.htmlhtml32KBgumroad-instructions.html
CHECKS_CATALOG.mdmd31KBdata/CHECKS_CATALOG.md
presentation.htmlhtml29KBpresentation.html
UX_RESEARCH.mdmd22KBdocs/UX_RESEARCH.md
SPEC_HUMAN_AUDIT_MODULE.mdmd20KBdocs/SPEC_HUMAN_AUDIT_MODULE.md
hub.htmlhtml18KBhub.html
SITE_PROTOTYPE.mdmd18KBdocs/SITE_PROTOTYPE.md
CUSTOMER_GUIDE.mdmd17KBdocs/CUSTOMER_GUIDE.md
FEATURE_SECURITY_OSINT.mdmd17KBdocs/FEATURE_SECURITY_OSINT.md
index.htmlhtml17KBindex.html
UX_REVIEW_CURRENT.mdmd17KBdocs/UX_REVIEW_CURRENT.md
AUDIT_LAYERS_ARCHITECTURE.mdmd16KBdocs/AUDIT_LAYERS_ARCHITECTURE.md
qa-auto-audit.htmlhtml16KBcheckpoints/ui-2026-03-23-pre-claude-simplify/qa-auto-audit.html
qa-auto-audit.htmlhtml16KBcheckpoints/ui-2026-03-22-post-ux/qa-auto-audit.html
api-superplan-additions.htmlhtml16KBapi-superplan-additions.html
SCORING_SYSTEM_DESIGN.mdmd16KBdocs/SCORING_SYSTEM_DESIGN.md
ARCHITECTURE.mdmd15KBdocs/ARCHITECTURE.md
MARKET_SIZE_TAM_SAM_SOM.mdmd14KBdocs/MARKET_SIZE_TAM_SAM_SOM.md
features.htmlhtml14KBfeatures.html
PROJECT_INDEX.mdmd13KBdocs/PROJECT_INDEX.md
AUDIT_LAYERING_BRIEF.mdmd13KBdocs/AUDIT_LAYERING_BRIEF.md
API_CATALOG.mdmd13KBdata/API_CATALOG.md
FEATURE_REPORT_FORMAT.mdmd13KBdocs/FEATURE_REPORT_FORMAT.md
POSITIONING_FINAL.mdmd12KBdocs/POSITIONING_FINAL.md
ROADMAP_DETAILED.mdmd12KBdocs/ROADMAP_DETAILED.md
SCORING_V2_INSTRUCTIONS.mdmd12KBdocs/SCORING_V2_INSTRUCTIONS.md
FEATURE_AI_EXPLORER.mdmd12KBdocs/FEATURE_AI_EXPLORER.md
MINI_TOOLS_COPY.mdmd12KBdocs/MINI_TOOLS_COPY.md
RESEARCH_CODE_AUDIT_MARKET.mdmd11KBdocs/RESEARCH_CODE_AUDIT_MARKET.md
GEMINI_VS_OUR_CHECKS_MAP.mdmd11KBdocs/GEMINI_VS_OUR_CHECKS_MAP.md
COMPETITIVE_HONEST_ANALYSIS.mdmd11KBdocs/COMPETITIVE_HONEST_ANALYSIS.md
qa-auto-audit.htmlhtml11KBqa-auto-audit.html
USER_FLOWS.mdmd10KBdocs/USER_FLOWS.md
POSITIONING_FINAL.mdmd10KBcheckpoints/positioning-2026-03-24-round-2/POSITIONING_FINAL.md
FEATURE_TECH_STACK_AUDIT.mdmd10KBdocs/FEATURE_TECH_STACK_AUDIT.md
LANDING_PAGE_STRUCTURE.mdmd10KBdocs/LANDING_PAGE_STRUCTURE.md
index.htmlhtml9KBdocs/index.html
GEMINI_INSIGHTS_COMPLETE.mdmd9KBdocs/GEMINI_INSIGHTS_COMPLETE.md
RESEARCH_SCORING_ALGORITHMS.mdmd9KBdocs/RESEARCH_SCORING_ALGORITHMS.md
index.htmlhtml9KBsales-package/index.html
FEATURE_SMART_CONTENT_AUDIT.mdmd8KBdocs/FEATURE_SMART_CONTENT_AUDIT.md
SCORING_V2_CALIBRATION_2026-03-24.mdmd8KBdocs/SCORING_V2_CALIBRATION_2026-03-24.md
01-HOMEPAGE.mdmd8KBspecs/01-HOMEPAGE.md
MARKETING_PLAN.mdmd8KBdocs/MARKETING_PLAN.md
ROADMAP_TASKS.mdmd8KBROADMAP_TASKS.md
BUDGET_3_MONTHS.mdmd8KBdocs/BUDGET_3_MONTHS.md
09-ISSUES-LIST.mdmd7KBspecs/09-ISSUES-LIST.md
RESEARCH_UNIQUE_IDEAS.mdmd7KBdocs/RESEARCH_UNIQUE_IDEAS.md
FEATURE_DEEP_TRUST_AUDIT.mdmd7KBdocs/FEATURE_DEEP_TRUST_AUDIT.md
PRICING_PLANS.mdmd7KBdata/PRICING_PLANS.md
FEATURE_ONE_DOLLAR_AUDIT.mdmd6KBdocs/FEATURE_ONE_DOLLAR_AUDIT.md
INDEX.mdmd6KBINDEX.md
GEMINI_METHODOLOGY_FINAL_DECISION.mdmd6KBdocs/GEMINI_METHODOLOGY_FINAL_DECISION.md
08-AUDIT-REPORT.mdmd6KBspecs/08-AUDIT-REPORT.md
index.htmlhtml6KBsaas-foundation/index.html
02-FREE-RESULT.mdmd6KBspecs/02-FREE-RESULT.md
10-AI-ANALYSIS.mdmd5KBspecs/10-AI-ANALYSIS.md
POSITIONING_FINAL.mdmd5KBcheckpoints/positioning-2026-03-24/POSITIONING_FINAL.md
index.htmlhtml4KBresearch-parts/index.html
PROJECT_MAP.mdmd4KBPROJECT_MAP.md
BLUEPRINT_README.txttxt4KBBLUEPRINT_README.txt
14-COMPLIANCE.mdmd4KBspecs/14-COMPLIANCE.md
18-LEGAL.mdmd4KBspecs/18-LEGAL.md
04-HEADER-FOOTER.mdmd4KBspecs/04-HEADER-FOOTER.md
CHECKPOINT_QA_AUDIT_UX_BASELINE.mdmd4KBCHECKPOINT_QA_AUDIT_UX_BASELINE.md
13-PROJECT-DASHBOARD.mdmd3KBspecs/13-PROJECT-DASHBOARD.md
11-MINI-TOOLS.mdmd3KBspecs/11-MINI-TOOLS.md
GUMROAD-LISTING-V2.mdmd3KBsales-package/GUMROAD-LISTING-V2.md
qa-scenario-demo.htmlhtml3KBqa-scenario-demo.html
03-PRICING.mdmd3KBspecs/03-PRICING.md
RESEARCH_REPORT_DESIGN.mdmd3KBdocs/RESEARCH_REPORT_DESIGN.md
06-DASHBOARD.mdmd3KBspecs/06-DASHBOARD.md
15-SETTINGS.mdmd3KBspecs/15-SETTINGS.md
19-PARTNERS.mdmd3KBspecs/19-PARTNERS.md
RESEARCH_AI_TRENDS.mdmd3KBdocs/RESEARCH_AI_TRENDS.md
PROJECT-CONTEXT.mdmd2KB.qa-project/PROJECT-CONTEXT.md
17-BLOG.mdmd2KBspecs/17-BLOG.md
RESEARCH_MONETIZATION.mdmd2KBdocs/RESEARCH_MONETIZATION.md
CLAUDE.mdmd2KBCLAUDE.md
05-AUTH.mdmd2KBspecs/05-AUTH.md
qa-checklist-v3-standalone.htmlhtml2KBqa-checklist-v3-standalone.html
APP_SHELL_SPEC.mdmd2KBsaas-foundation/APP_SHELL_SPEC.md
20-EMBED.mdmd2KBspecs/20-EMBED.md
catalog.htmlhtml1KBsaas-foundation/catalog.html
WHAT-YOU-GET.mdmd1KBsales-package/WHAT-YOU-GET.md
CATALOG_SCHEMA.mdmd1KBdata/CATALOG_SCHEMA.md

📁 mawakover 66

ФайлТипРазмерПуть
.mawa-daily-history.mdmd102KB.mawa-daily-history.md
MARIACHI_Стратегия_Сайта_AI.htmlhtml69KBMARIACHI_Стратегия_Сайта_AI.html
MARIACHI_Глубокая_Стратегия_v5.htmlhtml64KBMARIACHI_Глубокая_Стратегия_v5.html
MARIACHI_Глубокая_Стратегия_v4.htmlhtml59KBMARIACHI_Глубокая_Стратегия_v4.html
MARIACHI_Компании_и_События_Мастер.htmlhtml57KBMARIACHI_Компании_и_События_Мастер.html
MARIACHI_Борд_v3C_CSS_Art_Icons.htmlhtml54KBMARIACHI_Борд_v3C_CSS_Art_Icons.html
MARIACHI_Full_Research_2026-03-12.htmlhtml53KBMARIACHI_Full_Research_2026-03-12.html
MARIACHI_Борд_v3A_SVG_Icons.htmlhtml53KBMARIACHI_Борд_v3A_SVG_Icons.html
MARIACHI_Интерактивный_Борд.htmlhtml47KBMARIACHI_Интерактивный_Борд.html
MARIACHI_MEGA_TOP_v1.htmlhtml47KBMARIACHI_MEGA_TOP_v1.html
MARIACHI_Борд_v3B_Lucide_Icons.htmlhtml46KBMARIACHI_Борд_v3B_Lucide_Icons.html
MARIACHI_Daily_2026-03-19_v2.htmlhtml45KBMARIACHI_Daily_2026-03-19_v2.html
MARIACHI_Интерактивный_Борд_v3.htmlhtml43KBMARIACHI_Интерактивный_Борд_v3.html
MARIACHI_Competitors_B2B_v2.htmlhtml42KBMARIACHI_Competitors_B2B_v2.html
MARIACHI_Daily_2026-03-16.htmlhtml40KBMARIACHI_Daily_2026-03-16.html
MARIACHI_Daily_2026-03-20.htmlhtml39KBMARIACHI_Daily_2026-03-20.html
MARIACHI_Daily_2026-03-24.htmlhtml38KBMARIACHI_Daily_2026-03-24.html
MARIACHI_Artist_Submissions_Deep_Research_v1.htmlhtml38KBMARIACHI_Artist_Submissions_Deep_Research_v1.html
MARIACHI_Hotel_Procurement_Pipeline.htmlhtml38KBMARIACHI_Hotel_Procurement_Pipeline.html
MARIACHI_Daily_2026-03-21.htmlhtml38KBMARIACHI_Daily_2026-03-21.html
MARIACHI_Интерактивный_Борд_v2.htmlhtml37KBMARIACHI_Интерактивный_Борд_v2.html
MARIACHI_Daily_2026-03-30.htmlhtml37KBMARIACHI_Daily_2026-03-30.html
MARIACHI_Daily_2026-03-27.htmlhtml37KBMARIACHI_Daily_2026-03-27.html
MARIACHI_Стратегия_Дашборд.htmlhtml37KBMARIACHI_Стратегия_Дашборд.html
MARIACHI_Daily_2026-03-17.htmlhtml37KBMARIACHI_Daily_2026-03-17.html
MARIACHI_Daily_2026-03-19.htmlhtml36KBMARIACHI_Daily_2026-03-19.html
MARIACHI_Daily_2026-03-11_v2.htmlhtml36KBMARIACHI_Daily_2026-03-11_v2.html
MARIACHI_Daily_2026-03-12.htmlhtml36KBMARIACHI_Daily_2026-03-12.html
MARIACHI_Daily_2026-04-12.htmlhtml36KBMARIACHI_Daily_2026-04-12.html
MARIACHI_Daily_2026-04-08.htmlhtml36KBMARIACHI_Daily_2026-04-08.html
MARIACHI_Daily_2026-04-01.htmlhtml36KBMARIACHI_Daily_2026-04-01.html
MARIACHI_Daily_2026-04-04.htmlhtml36KBMARIACHI_Daily_2026-04-04.html
MARIACHI_Daily_2026-04-11_v2.htmlhtml35KBMARIACHI_Daily_2026-04-11_v2.html
MARIACHI_Daily_2026-04-03.htmlhtml35KBMARIACHI_Daily_2026-04-03.html
MARIACHI_Daily_2026-03-26.htmlhtml34KBMARIACHI_Daily_2026-03-26.html
MARIACHI_Daily_2026-03-23.htmlhtml34KBMARIACHI_Daily_2026-03-23.html
MARIACHI_Daily_2026-03-28.htmlhtml34KBMARIACHI_Daily_2026-03-28.html
MARIACHI_Daily_2026-04-05.htmlhtml33KBMARIACHI_Daily_2026-04-05.html
MARIACHI_Daily_2026-03-12_v4.htmlhtml32KBMARIACHI_Daily_2026-03-12_v4.html
MARIACHI_Daily_2026-03-20_v2.htmlhtml32KBMARIACHI_Daily_2026-03-20_v2.html
MARIACHI_Daily_2026-03-25.htmlhtml32KBMARIACHI_Daily_2026-03-25.html
MARIACHI_Daily_2026-03-12_v3.htmlhtml32KBMARIACHI_Daily_2026-03-12_v3.html
MARIACHI_Daily_2026-04-02.htmlhtml31KBMARIACHI_Daily_2026-04-02.html
MARIACHI_Daily_2026-04-11.htmlhtml31KBMARIACHI_Daily_2026-04-11.html
MARIACHI_Daily_2026-04-06.htmlhtml31KBMARIACHI_Daily_2026-04-06.html
MARIACHI_Исследование_v3.htmlhtml30KBMARIACHI_Исследование_v3.html
MARIACHI_Daily_2026-03-13.htmlhtml30KBMARIACHI_Daily_2026-03-13.html
MARIACHI_Daily_2026-04-09.htmlhtml29KBMARIACHI_Daily_2026-04-09.html
MARIACHI_Daily_2026-03-31.htmlhtml29KBMARIACHI_Daily_2026-03-31.html
MARIACHI_AI_Tools_Guide.htmlhtml28KBMARIACHI_AI_Tools_Guide.html
MARIACHI_Daily_2026-03-22.htmlhtml27KBMARIACHI_Daily_2026-03-22.html
MARIACHI_Daily_2026-03-12_v2.htmlhtml27KBMARIACHI_Daily_2026-03-12_v2.html
MARIACHI_Competitor_Analysis.htmlhtml26KBMARIACHI_Competitor_Analysis.html
MARIACHI_Daily_2026-03-11.htmlhtml26KBMARIACHI_Daily_2026-03-11.html
buyer-personas-artistic-rugs.mdmd21KBbuyer-personas-artistic-rugs.md
MARIACHI_Все_Запросы_Антона_v3.mdmd21KBMARIACHI_Все_Запросы_Антона_v3.md
MARIACHI_Исследование_v3.mdmd19KBMARIACHI_Исследование_v3.md
MARIACHI_Все_Запросы_Антона_v2.mdmd14KBMARIACHI_Все_Запросы_Антона_v2.md
MARIACHI_Daily_Briefing_2026-03-09_v2.mdmd11KBMARIACHI_Daily_Briefing_2026-03-09_v2.md
MARIACHI_Все_Запросы_Антона.mdmd8KBMARIACHI_Все_Запросы_Антона.md
MARIACHI_Daily_Briefing_2026-03-09.mdmd6KBMARIACHI_Daily_Briefing_2026-03-09.md
mawa-daily-2026-03-10.mdmd5KBmawa-daily-2026-03-10.md
MARIACHI_Daily_Briefing_2026-03-11.mdmd4KBMARIACHI_Daily_Briefing_2026-03-11.md
carpet-daily-2026-03-08.mdmd4KBcarpet-daily-2026-03-08.md
MARIACHI_Daily_Briefing_2026-03-09_scheduled.mdmd4KBMARIACHI_Daily_Briefing_2026-03-09_scheduled.md
.mawa-daily-SKILL.mdmd3KB.mawa-daily-SKILL.md

📁 ME NEWS DIGEST 46 → [[MECLive / News]]

ФайлТипРазмерПуть
MECLIVE_MASTER_BRIEF.htmlhtml45KBME SITE DESIGN/MECLIVE_MASTER_BRIEF.html
Middle_East_Crisis_Report_2026-03-30_v2.htmlhtml39KBMiddle_East_Crisis_Report_2026-03-30_v2.html
Middle_East_Crisis_Report_2026-04-08.htmlhtml39KBMiddle_East_Crisis_Report_2026-04-08.html
Middle_East_Crisis_Report_2026-03-19.htmlhtml38KBMiddle_East_Crisis_Report_2026-03-19.html
Middle_East_Crisis_Report_2026-03-30.htmlhtml38KBMiddle_East_Crisis_Report_2026-03-30.html
Middle_East_Crisis_Report_2026-03-19_v2.htmlhtml37KBMiddle_East_Crisis_Report_2026-03-19_v2.html
Middle_East_Crisis_Report_2026-04-12.htmlhtml36KBMiddle_East_Crisis_Report_2026-04-12.html
Middle_East_Crisis_Report_2026-04-07.htmlhtml36KBMiddle_East_Crisis_Report_2026-04-07.html
Middle_East_Crisis_Report_2026-03-23.htmlhtml35KBMiddle_East_Crisis_Report_2026-03-23.html
Middle_East_Crisis_Report_2026-03-24.htmlhtml35KBMiddle_East_Crisis_Report_2026-03-24.html
Middle_East_Crisis_Report_2026-03-27.htmlhtml35KBMiddle_East_Crisis_Report_2026-03-27.html
Middle_East_Crisis_Report_2026-03-22.htmlhtml35KBMiddle_East_Crisis_Report_2026-03-22.html
Middle_East_Crisis_Report_2026-04-05.htmlhtml35KBMiddle_East_Crisis_Report_2026-04-05.html
Middle_East_Crisis_Report_2026-04-01.htmlhtml34KBMiddle_East_Crisis_Report_2026-04-01.html
Middle_East_Crisis_Report_2026-03-17.htmlhtml34KBMiddle_East_Crisis_Report_2026-03-17.html
Middle_East_Crisis_Report_2026-04-09.htmlhtml34KBMiddle_East_Crisis_Report_2026-04-09.html
Middle_East_Crisis_Report_2026-04-03.htmlhtml34KBMiddle_East_Crisis_Report_2026-04-03.html
Middle_East_Crisis_Report_2026-04-04.htmlhtml34KBMiddle_East_Crisis_Report_2026-04-04.html
Middle_East_Crisis_Report_2026-03-21.htmlhtml34KBMiddle_East_Crisis_Report_2026-03-21.html
Middle_East_Crisis_Report_2026-03-25.htmlhtml34KBMiddle_East_Crisis_Report_2026-03-25.html
Middle_East_Crisis_Report_2026-03-16.htmlhtml34KBMiddle_East_Crisis_Report_2026-03-16.html
Middle_East_Crisis_Report_2026-03-20.htmlhtml33KBMiddle_East_Crisis_Report_2026-03-20.html
Middle_East_Crisis_Report_2026-03-31.htmlhtml33KBMiddle_East_Crisis_Report_2026-03-31.html
Middle_East_Crisis_Report_2026-04-02.htmlhtml32KBMiddle_East_Crisis_Report_2026-04-02.html
Middle_East_Crisis_Report_2026-03-28.htmlhtml32KBMiddle_East_Crisis_Report_2026-03-28.html
Middle_East_Crisis_Report_2026-04-11.htmlhtml31KBMiddle_East_Crisis_Report_2026-04-11.html
Middle_East_Crisis_Report_2026-03-26.htmlhtml31KBMiddle_East_Crisis_Report_2026-03-26.html
Middle_East_Crisis_Report_2026-04-10.htmlhtml31KBMiddle_East_Crisis_Report_2026-04-10.html
Middle_East_Crisis_Report_2026-03-12.htmlhtml31KBMiddle_East_Crisis_Report_2026-03-12.html
Middle_East_Crisis_Report_2026-03-13.htmlhtml30KBMiddle_East_Crisis_Report_2026-03-13.html
Middle_East_Crisis_Report_2026-04-06.htmlhtml30KBMiddle_East_Crisis_Report_2026-04-06.html
V0_INSTRUCTION_FINAL.mdmd27KBME SITE DESIGN/V0_INSTRUCTION_FINAL.md
Middle_East_Crisis_Report_March_11_2026.htmlhtml25KBMiddle_East_Crisis_Report_March_11_2026.html
Middle_East_Crisis_Report_March_10_2026.mdmd17KBMiddle_East_Crisis_Report_March_10_2026.md
Middle East Crisis Report - March 9 2026.mdmd16KBMiddle East Crisis Report - March 9 2026.md
middle-east-crisis-report-2026-03-09.htmlhtml16KBmiddle-east-crisis-report-2026-03-09.html
middle-east-crisis-report-2026-03-10.htmlhtml16KBmiddle-east-crisis-report-2026-03-10.html
ME-Crisis-Report-2026-03-09.mdmd15KBME-Crisis-Report-2026-03-09.md
Middle-East-Crisis-Report-March-9-2026.mdmd13KBMiddle-East-Crisis-Report-March-9-2026.md
Middle_East_Crisis_Report_2026-03-09.mdmd12KBMiddle_East_Crisis_Report_2026-03-09.md
Middle_East_Crisis_Report_March_9_2026.mdmd12KBMiddle_East_Crisis_Report_March_9_2026.md
Middle-East-Crisis-Report-2026-03-09.mdmd12KBMiddle-East-Crisis-Report-2026-03-09.md
Middle East Crisis Report — March 9 2026.mdmd11KBMiddle East Crisis Report — March 9 2026.md
FULL_CONVERSATION_LOG.mdmd11KBME SITE DESIGN/FULL_CONVERSATION_LOG.md
Middle East Crisis Report — March 9, 2026.mdmd9KBMiddle East Crisis Report — March 9, 2026.md
MY_PROMPTS_BACKUP.mdmd2KBME SITE DESIGN/MY_PROMPTS_BACKUP.md

📁 tester claude code 38

ФайлТипРазмерПуть
qa-mega-research-v2.htmlhtml353KBqa-mega-research-v2.html
qa-saas-blueprint.htmlhtml326KBqa-saas-blueprint.html
qa-mega-research-v1.htmlhtml161KBqa-mega-research-v1.html
part2-3-tools-istqb.htmlhtml116KBresearch-parts/part2-3-tools-istqb.html
part1b-tester-workflow-execution.htmlhtml103KBresearch-parts/part1b-tester-workflow-execution.html
part4-8-bugs-data-market-plan.htmlhtml95KBresearch-parts/part4-8-bugs-data-market-plan.html
DEEP-RESEARCH-V5.htmlhtml83KBDEEP-RESEARCH-V5.html
QA-Checklist-V3-Product.htmlhtml75KBQA-Checklist-V3-Product.html
qa-saas-mvp-dashboard.htmlhtml67KBqa-saas-mvp-dashboard.html
qa-deep-research-report.htmlhtml64KBqa-deep-research-report.html
part1-tester-workflow.htmlhtml53KBresearch-parts/part1-tester-workflow.html
index.htmlhtml52KBqa-platform/public/index.html
v3-sales-landing.htmlhtml47KBv3-sales-landing.html
qa-checklist-landing.htmlhtml45KBqa-checklist-landing.html
qa-auto-checker.htmlhtml37KBqa-auto-checker.html
qa-market-analysis.htmlhtml36KBqa-market-analysis.html
gumroad-instructions.htmlhtml32KBgumroad-instructions.html
DEEP-RESEARCH-V4.htmlhtml31KBDEEP-RESEARCH-V4.html
MASTER-PLAN.mdmd26KBMASTER-PLAN.md
DEEP-RESEARCH-V4.mdmd20KBDEEP-RESEARCH-V4.md
KNOWLEDGE-BASE.mdmd12KBKNOWLEDGE-BASE.md
SCORING-ALGORITHM.mdmd11KBSCORING-ALGORITHM.md
marketing-kit.mdmd10KBmarketing-kit.md
ROADMAP-SIMPLE-USERS.mdmd10KBROADMAP-SIMPLE-USERS.md
PLAN-SIMPLE-USERS.mdmd9KBPLAN-SIMPLE-USERS.md
INDEX.mdmd6KBINDEX.md
ACTION-LOG.mdmd6KBACTION-LOG.md
PROGRESS-LOG.mdmd6KBPROGRESS-LOG.md
MISTAKES-LOG.mdmd5KBMISTAKES-LOG.md
index.htmlhtml4KBresearch-parts/index.html
BLUEPRINT_README.txttxt4KBBLUEPRINT_README.txt
API_CATALOG.mdmd3KBAPI_CATALOG.md
CHECKS_CATALOG.mdmd3KBCHECKS_CATALOG.md
PROJECT-CONTEXT.mdmd2KB.qa-project/PROJECT-CONTEXT.md
AGENTS.mdmd1KBqa-flow/AGENTS.md
AGENTS.mdmd1KBqa-saas-app/AGENTS.md
CLAUDE.mdmd1KBqa-flow/CLAUDE.md
CLAUDE.mdmd1KBqa-saas-app/CLAUDE.md

📁 qa-flow-project 34

ФайлТипРазмерПуть
qa-mega-research-v2.htmlhtml353KBqa-mega-research-v2.html
qa-saas-blueprint.htmlhtml326KBqa-saas-blueprint.html
qa-mega-research-v1.htmlhtml161KBqa-mega-research-v1.html
part2-3-tools-istqb.htmlhtml116KBresearch-parts/part2-3-tools-istqb.html
part1b-tester-workflow-execution.htmlhtml103KBresearch-parts/part1b-tester-workflow-execution.html
part4-8-bugs-data-market-plan.htmlhtml95KBresearch-parts/part4-8-bugs-data-market-plan.html
DEEP-RESEARCH-V5.htmlhtml83KBDEEP-RESEARCH-V5.html
QA-Checklist-V3-Product.htmlhtml75KBQA-Checklist-V3-Product.html
qa-saas-mvp-dashboard.htmlhtml67KBqa-saas-mvp-dashboard.html
qa-deep-research-report.htmlhtml64KBqa-deep-research-report.html
part1-tester-workflow.htmlhtml53KBresearch-parts/part1-tester-workflow.html
index.htmlhtml52KBqa-platform/public/index.html
v3-sales-landing.htmlhtml47KBv3-sales-landing.html
qa-checklist-landing.htmlhtml45KBqa-checklist-landing.html
qa-auto-checker.htmlhtml37KBqa-auto-checker.html
qa-market-analysis.htmlhtml36KBqa-market-analysis.html
gumroad-instructions.htmlhtml32KBgumroad-instructions.html
DEEP-RESEARCH-V4.htmlhtml31KBDEEP-RESEARCH-V4.html
MASTER-PLAN.mdmd26KBMASTER-PLAN.md
DEEP-RESEARCH-V4.mdmd20KBDEEP-RESEARCH-V4.md
KNOWLEDGE-BASE.mdmd12KBKNOWLEDGE-BASE.md
SCORING-ALGORITHM.mdmd11KBSCORING-ALGORITHM.md
marketing-kit.mdmd10KBmarketing-kit.md
ROADMAP-SIMPLE-USERS.mdmd10KBROADMAP-SIMPLE-USERS.md
PLAN-SIMPLE-USERS.mdmd9KBPLAN-SIMPLE-USERS.md
INDEX.mdmd6KBINDEX.md
ACTION-LOG.mdmd6KBACTION-LOG.md
PROGRESS-LOG.mdmd6KBPROGRESS-LOG.md
MISTAKES-LOG.mdmd5KBMISTAKES-LOG.md
index.htmlhtml4KBresearch-parts/index.html
BLUEPRINT_README.txttxt4KBBLUEPRINT_README.txt
PROJECT-CONTEXT.mdmd2KB.qa-project/PROJECT-CONTEXT.md
AGENTS.mdmd1KBqa-flow/AGENTS.md
CLAUDE.mdmd1KBqa-flow/CLAUDE.md

📁 MARIACHI 33 → [[Mariachi Art]]

ФайлТипРазмерПуть
index.htmlhtml361KBmariachi-live/index.html
roadmap-v1.htmlhtml57KBmariachi-react-zip/docs/reports/roadmap-v1.html
mariachi-styleguide.htmlhtml42KBmariachi-react-zip/docs/screenshots/mariachi-styleguide.html
style-guide-v1.htmlhtml42KBmariachi-react-zip/docs/style-guides/style-guide-v1.html
mariachi_protocol.htmlhtml39KBmariachi_protocol.html
mariachi_audit_report.mdmd36KBmariachi-react-zip/docs/research/mariachi_audit_report.md
audit-notes-v1.mdmd36KBmariachi-react-zip/docs/audits/audit-notes-v1.md
audit-v1.htmlhtml27KBmariachi-react-zip/docs/audits/audit-v1.html
roadmap-v2.htmlhtml26KBmariachi-react-zip/docs/reports/roadmap-v2.html
design-system-v1.htmlhtml21KBmariachi-react-zip/docs/design-system/design-system-v1.html
git_history.txttxt20KBmariachi-react-zip/docs/research/git_history.txt
report-v1.htmlhtml17KBmariachi-react-zip/docs/reports/report-v1.html
asset-catalog-v1.htmlhtml15KBmariachi-react-zip/docs/asset-catalogs/asset-catalog-v1.html
AUDIT_REPORT_v2.mdmd12KBmariachi-react-zip/docs/AUDIT_REPORT_v2.md
mariachi-style-guide.mdmd12KBmariachi-react-zip/docs/research/mariachi-style-guide.md
COMPREHENSIVE_AUDIT_REPORT.mdmd11KBmariachi-react-zip/docs/COMPREHENSIVE_AUDIT_REPORT.md
ROADMAP.mdmd10KBmariachi-react-zip/docs/ROADMAP.md
mariachi-site-audit.mdmd8KBmariachi-react-zip/docs/research/mariachi-site-audit.md
AUDIT_REPORT.mdmd7KBmariachi-react-zip/docs/AUDIT_REPORT.md
VOICE_AUDIT.mdmd7KBmariachi-react-zip/docs/VOICE_AUDIT.md
STYLEGUIDE.mdmd6KBmariachi-react-zip/STYLEGUIDE.md
ideas.mdmd5KBmariachi-react/ideas.md
mariachi-status-report.mdmd4KBmariachi-react-zip/docs/research/mariachi-status-report.md
site_notes.mdmd4KBmariachi-react-zip/site_notes.md
MARIACHI-PROJECT-INDEX.mdmd3KBmariachi-react-zip/docs/research/MARIACHI-PROJECT-INDEX.md
index.htmlhtml3KBmariachi-react-zip/client/index.html
DEEP_AUDIT_NOTES.mdmd3KBmariachi-react-zip/docs/DEEP_AUDIT_NOTES.md
VOICE_CHANGES_REPORT.mdmd3KBmariachi-react-zip/docs/VOICE_CHANGES_REPORT.md
session-log.mdmd2KBmariachi-react-zip/docs/session-log.md
index.htmlhtml2KBmariachi-react/client/index.html
cdn_urls.mdmd2KBmariachi-react-zip/cdn_urls.md
nav-research.mdmd1KBmariachi-react-zip/docs/research/nav-research.md
robots.txttxt1KBmariachi-react-zip/client/public/robots.txt

📁 QXXXII 30 → [[QULTURE XXXIII]]

ФайлТипРазмерПуть
QULTURE XXXIII — Lloret de Mar | Бизнес-план и инвестиционный анализ.htmlhtml359KBQULTURE XXXIII — Lloret de Mar | Бизнес-план и инвестиционный анализ.html
site-html-full.htmlhtml240KBQXXXIII website/site-html-full.html
q33_revenue_streams_v1.htmlhtml68KBq33_revenue_streams_v1.html
FILE_6_SURVIVAL_RATES.htmlhtml54KBFILE_6_SURVIVAL_RATES.html
site-text-full.mdmd25KBQXXXIII website/site-text-full.md
MANUS_UPDATE_GUIDE for money.mdmd18KBMANUS_UPDATE_GUIDE for money.md
QULTURE_XXXIII_Moodboard.htmlhtml16KBQULTURE_XXXIII_Moodboard.html
STYLE-GUIDE.mdmd11KBQXXXIII website/STYLE-GUIDE.md
QULTURE_XXXIII_AI_Prompts.mdmd10KBQULTURE_XXXIII_AI_Prompts.md
05_audit_report_v2.mdmd9KBQXXXIII website/manus_tasks/05_audit_report_v2.md
style-guide-fixes.mdmd8KBQXXXIII website/style-guide-fixes.md
QULTURE_XXXIII_Logo_Brief_for_AI_Designer.mdmd7KBQULTURE_XXXIII_Logo_Brief_for_AI_Designer.md
MANUS_ZAMENI_CIFRY.mdmd6KBMANUS_ZAMENI_CIFRY.md
ideas.mdmd5KBqulture-lloret poslednyaya versiya/ideas.md
ideas.mdmd5KBqulture-lloret v2/ideas.md
ideas.mdmd5KBqulture-lloret 4/ideas.md
02_fix_chart_ux_and_tooltips.mdmd3KBQXXXIII website/manus_tasks/02_fix_chart_ux_and_tooltips.md
Step_05_Final_Polish.mdmd3KBQXXXIII website/manus_tasks/Step_05_Final_Polish.md
Step_01_Finance_and_Charts.mdmd2KBQXXXIII website/manus_tasks/Step_01_Finance_and_Charts.md
01_sync_financial_data.mdmd2KBQXXXIII website/manus_tasks/01_sync_financial_data.md
Step_02_Critical_UI_Fixes.mdmd2KBQXXXIII website/manus_tasks/Step_02_Critical_UI_Fixes.md
Step_03_Zones_and_Nav_Fixes.mdmd2KBQXXXIII website/manus_tasks/Step_03_Zones_and_Nav_Fixes.md
02_fix_font_families.mdmd2KBQXXXIII website/manus_tasks/02_fix_font_families.md
03_fix_font_sizes.mdmd2KBQXXXIII website/manus_tasks/03_fix_font_sizes.md
Step_04_Home_Typography_Fixes.mdmd2KBQXXXIII website/manus_tasks/Step_04_Home_Typography_Fixes.md
04_ui_polish_and_borders.mdmd1KBQXXXIII website/manus_tasks/04_ui_polish_and_borders.md
01_remove_monospace.mdmd1KBQXXXIII website/manus_tasks/01_remove_monospace.md
index.htmlhtml1KBqulture-lloret poslednyaya versiya/client/index.html
index.htmlhtml1KBqulture-lloret v2/client/index.html
index.htmlhtml1KBqulture-lloret 4/client/index.html

📁 test1 30

ФайлТипРазмерПуть
anthropic-best-practices.mdmd44KB.agent/skills/writing-skills/anthropic-best-practices.md
SKILL.mdmd21KB.agent/skills/writing-skills/SKILL.md
testing-skills-with-subagents.mdmd12KB.agent/skills/writing-skills/testing-skills-with-subagents.md
SKILL.mdmd9KB.agent/skills/subagent-driven-development/SKILL.md
SKILL.mdmd9KB.agent/skills/systematic-debugging/SKILL.md
SKILL.mdmd9KB.agent/skills/test-driven-development/SKILL.md
testing-anti-patterns.mdmd8KB.agent/skills/test-driven-development/testing-anti-patterns.md
SKILL.mdmd6KB.agent/skills/receiving-code-review/SKILL.md
SKILL.mdmd5KB.agent/skills/dispatching-parallel-agents/SKILL.md
persuasion-principles.mdmd5KB.agent/skills/writing-skills/persuasion-principles.md
SKILL.mdmd5KB.agent/skills/using-git-worktrees/SKILL.md
root-cause-tracing.mdmd5KB.agent/skills/systematic-debugging/root-cause-tracing.md
SKILL.mdmd4KB.agent/skills/brainstorming/SKILL.md
CREATION-LOG.mdmd4KB.agent/skills/systematic-debugging/CREATION-LOG.md
SKILL.mdmd4KB.agent/skills/finishing-a-development-branch/SKILL.md
SKILL.mdmd4KB.agent/skills/using-superpowers/SKILL.md
SKILL.mdmd4KB.agent/skills/verification-before-completion/SKILL.md
defense-in-depth.mdmd3KB.agent/skills/systematic-debugging/defense-in-depth.md
condition-based-waiting.mdmd3KB.agent/skills/systematic-debugging/condition-based-waiting.md
code-reviewer.mdmd3KB.agent/skills/requesting-code-review/code-reviewer.md
SKILL.mdmd3KB.agent/skills/writing-plans/SKILL.md
SKILL.mdmd2KB.agent/skills/requesting-code-review/SKILL.md
test-pressure-3.mdmd2KB.agent/skills/systematic-debugging/test-pressure-3.md
SKILL.mdmd2KB.agent/skills/executing-plans/SKILL.md
test-pressure-2.mdmd2KB.agent/skills/systematic-debugging/test-pressure-2.md
implementer-prompt.mdmd2KB.agent/skills/subagent-driven-development/implementer-prompt.md
spec-reviewer-prompt.mdmd1KB.agent/skills/subagent-driven-development/spec-reviewer-prompt.md
test-pressure-1.mdmd1KB.agent/skills/systematic-debugging/test-pressure-1.md
test-academic.mdmd1KB.agent/skills/systematic-debugging/test-academic.md
code-quality-reviewer-prompt.mdmd1KB.agent/skills/subagent-driven-development/code-quality-reviewer-prompt.md

📁 AI RESEARCH ED 26 → [[YouTube AI Monitor]]

ФайлТипРазмерПуть
AI_Daily_Intel_20_March_2026_v2.htmlhtml101KBAI_Daily_Intel_20_March_2026_v2.html
AI_Daily_Intel_12_April_2026.htmlhtml96KBAI_Daily_Intel_12_April_2026.html
AI_Daily_Intel_11_April_2026_v2.htmlhtml93KBAI_Daily_Intel_11_April_2026_v2.html
AI_Daily_Intel_10_April_2026.htmlhtml91KBAI_Daily_Intel_10_April_2026.html
AI_Daily_Intel_08_April_2026.htmlhtml91KBAI_Daily_Intel_08_April_2026.html
AI_Daily_Intel_25_March_2026.htmlhtml90KBAI_Daily_Intel_25_March_2026.html
AI_Daily_Intel_07_April_2026.htmlhtml89KBAI_Daily_Intel_07_April_2026.html
AI_Daily_Intel_31_March_2026.htmlhtml87KBAI_Daily_Intel_31_March_2026.html
AI_Daily_Intel_03_April_2026.htmlhtml85KBAI_Daily_Intel_03_April_2026.html
AI_Daily_Intel_05_April_2026.htmlhtml85KBAI_Daily_Intel_05_April_2026.html
AI_Daily_Intel_06_April_2026.htmlhtml84KBAI_Daily_Intel_06_April_2026.html
AI_Daily_Intel_02_April_2026.htmlhtml82KBAI_Daily_Intel_02_April_2026.html
AI_Daily_Intel_26_March_2026.htmlhtml82KBAI_Daily_Intel_26_March_2026.html
AI_Daily_Intel_03_April_2026_v2.htmlhtml82KBAI_Daily_Intel_03_April_2026_v2.html
AI_Daily_Intel_30_March_2026.htmlhtml81KBAI_Daily_Intel_30_March_2026.html
AI_Daily_Intel_04_April_2026.htmlhtml80KBAI_Daily_Intel_04_April_2026.html
AI_Daily_Intel_11_April_2026.htmlhtml79KBAI_Daily_Intel_11_April_2026.html
AI_Daily_Intel_01_April_2026.htmlhtml77KBAI_Daily_Intel_01_April_2026.html
AI_Daily_Intel_24_March_2026.htmlhtml75KBAI_Daily_Intel_24_March_2026.html
AI_Daily_Intel_22_March_2026.htmlhtml73KBAI_Daily_Intel_22_March_2026.html
AI_Daily_Intel_23_March_2026.htmlhtml71KBAI_Daily_Intel_23_March_2026.html
AI_Daily_Intel_21_March_2026.htmlhtml71KBAI_Daily_Intel_21_March_2026.html
AI_Daily_Intel_20_March_2026.htmlhtml68KBAI_Daily_Intel_20_March_2026.html
AI_Daily_Intel_28_March_2026.htmlhtml65KBAI_Daily_Intel_28_March_2026.html
AI_Daily_Intel_27_March_2026.htmlhtml58KBAI_Daily_Intel_27_March_2026.html
SKILL_v2.mdmd15KBSKILL_v2.md

📁 AI RESEARCH ED 2 25 → [[YouTube AI Monitor]]

ФайлТипРазмерПуть
Daily-AI-Intelligence-Briefing-2026-03-28-v1.htmlhtml49KBDaily-AI-Intelligence-Briefing-2026-03-28-v1.html
Daily-AI-Intelligence-Briefing-2026-04-04-v1.htmlhtml47KBDaily-AI-Intelligence-Briefing-2026-04-04-v1.html
Daily-AI-Intelligence-Briefing-2026-04-02-v1.htmlhtml47KBDaily-AI-Intelligence-Briefing-2026-04-02-v1.html
Daily-AI-Intelligence-Briefing-2026-04-12-v1.htmlhtml46KBDaily-AI-Intelligence-Briefing-2026-04-12-v1.html
Daily-AI-Intelligence-Briefing-2026-04-08-v1.htmlhtml46KBDaily-AI-Intelligence-Briefing-2026-04-08-v1.html
Daily-AI-Intelligence-Briefing-2026-03-31-v1.htmlhtml44KBDaily-AI-Intelligence-Briefing-2026-03-31-v1.html
Daily-AI-Intelligence-Briefing-2026-03-24-v1.htmlhtml44KBDaily-AI-Intelligence-Briefing-2026-03-24-v1.html
Daily-AI-Intelligence-Briefing-2026-04-11-v1.htmlhtml43KBDaily-AI-Intelligence-Briefing-2026-04-11-v1.html
Daily-AI-Intelligence-Briefing-2026-04-10-v1.htmlhtml42KBDaily-AI-Intelligence-Briefing-2026-04-10-v1.html
Daily-AI-Intelligence-Briefing-2026-04-01-v1.htmlhtml42KBDaily-AI-Intelligence-Briefing-2026-04-01-v1.html
Daily-AI-Intelligence-Briefing-2026-03-30-v1.htmlhtml40KBDaily-AI-Intelligence-Briefing-2026-03-30-v1.html
Daily-AI-Intelligence-Briefing-2026-04-03-v1.htmlhtml39KBDaily-AI-Intelligence-Briefing-2026-04-03-v1.html
Daily-AI-Intelligence-Briefing-2026-04-09-v1.htmlhtml39KBDaily-AI-Intelligence-Briefing-2026-04-09-v1.html
Daily-AI-Intelligence-Briefing-2026-03-23-v1.htmlhtml38KBDaily-AI-Intelligence-Briefing-2026-03-23-v1.html
Daily-AI-Intelligence-Briefing-2026-03-30-v2.htmlhtml38KBDaily-AI-Intelligence-Briefing-2026-03-30-v2.html
Daily-AI-Intelligence-Briefing-2026-03-20-v2.mdmd38KBDaily-AI-Intelligence-Briefing-2026-03-20-v2.md
Daily-AI-Intelligence-Briefing-2026-03-26-v1.htmlhtml37KBDaily-AI-Intelligence-Briefing-2026-03-26-v1.html
AI-Daily-Briefing-2026-04-07-v1.htmlhtml37KBAI-Daily-Briefing-2026-04-07-v1.html
Daily-AI-Intelligence-Briefing-2026-03-22-v1.htmlhtml33KBDaily-AI-Intelligence-Briefing-2026-03-22-v1.html
Daily-AI-Intelligence-Briefing-2026-03-20-v1.mdmd29KBDaily-AI-Intelligence-Briefing-2026-03-20-v1.md
Daily_AI_Briefing_2026-03-25_v1.mdmd27KBDaily_AI_Briefing_2026-03-25_v1.md
Daily-AI-Intelligence-Briefing-2026-03-22-v1.mdmd26KBDaily-AI-Intelligence-Briefing-2026-03-22-v1.md
Daily-AI-Intelligence-Briefing-2026-03-21-v1.mdmd25KBDaily-AI-Intelligence-Briefing-2026-03-21-v1.md
SKILL-v2.mdmd18KBSKILL-v2.md
SKILL-v3.mdmd13KBSKILL-v3.md

📁 CRYPTO 25 → [[ASIC Miners / Crypto]]

ФайлТипРазмерПуть
about.htmlhtml84KBdashboard/templates/about.html
tao.htmlhtml67KBdashboard/templates/tao.html
SUPER_ALGORITHM_BLUEPRINT.mdmd40KBSUPER_ALGORITHM_BLUEPRINT.md
ADVANCED_METRICS.mdmd33KBADVANCED_METRICS.md
STOCK_TRADER.mdmd32KBbrainstorm/STOCK_TRADER.md
index.htmlhtml32KBdashboard/templates/index.html
HIDDEN_PATTERNS.mdmd31KBHIDDEN_PATTERNS.md
DATA_SCIENTIST.mdmd28KBbrainstorm/DATA_SCIENTIST.md
research.htmlhtml27KBdashboard/templates/research.html
RISK_MANAGER.mdmd27KBbrainstorm/RISK_MANAGER.md
EXOTIC_EDGES.mdmd26KBEXOTIC_EDGES.md
QUANT_TRADER.mdmd23KBbrainstorm/QUANT_TRADER.md
QUANT_STRATEGIES.mdmd22KBQUANT_STRATEGIES.md
COMPETING_BOTS.mdmd20KBCOMPETING_BOTS.md
INSTANT_SIGNAL_STRATEGY.mdmd20KBINSTANT_SIGNAL_STRATEGY.md
PREDICTION_MODELS.mdmd19KBPREDICTION_MODELS.md
NEW_LISTING_PATTERNS.mdmd19KBNEW_LISTING_PATTERNS.md
ML_CRYPTO_MODELS.mdmd18KBML_CRYPTO_MODELS.md
pump-and-dump-research.mdmd16KBpump-and-dump-research.md
PUMP_DUMP_RULES.mdmd15KBPUMP_DUMP_RULES.md
TAO_RESEARCH.mdmd15KBTAO_RESEARCH.md
markets.htmlhtml10KBdashboard/templates/markets.html
conversation-log.mdmd9KBconversation-log.md
OPTIMIZATION_PLAN.mdmd5KBOPTIMIZATION_PLAN.md
requirements.txttxt1KBrequirements.txt

📁 SUPER BOT CREATING 23

ФайлТипРазмерПуть
conversation-history.txttxt1018KBconversation-history.txt
je_test.htmlhtml650KBje_test.html
ev_test.htmlhtml178KBev_test.html
ev_test2.htmlhtml177KBev_test2.html
test_lucasfox.htmlhtml157KBtest_lucasfox.html
style-guide.htmlhtml103KBpackages/landing-generator/output/style-guide.html
ev_curl.htmlhtml80KBev_curl.html
index.htmlhtml54KB.watermark-remover/ui/index.html
Blog_Articles_Spain_Real_Estate.mdmd33KBBlog_Articles_Spain_Real_Estate.md
SCORING-SYSTEM.mdmd32KBpackages/auctions/SCORING-SYSTEM.md
index.htmlhtml19KBcasaviva/index.html
compass_artifact_wf-b70f683f-ce75-41dd-ac8a-6b81207935f8_text_markdown.mdmd18KBcompass_artifact_wf-b70f683f-ce75-41dd-ac8a-6b81207935f8_text_markdown.md
compass_artifact_wf-d7586f28-0300-41d5-99d0-3c8ada26258b_text_markdown.mdmd12KBcompass_artifact_wf-d7586f28-0300-41d5-99d0-3c8ada26258b_text_markdown.md
header.htmlhtml10KBheader.html
PLAN.mdmd7KBpackages/auctions/PLAN.md
CLAUDE.mdmd4KBCLAUDE.md
dewatermark-api-blog.mdmd3KB.firecrawl/dewatermark-api-blog.md
dewatermark-api-docs.mdmd1KB.firecrawl/dewatermark-api-docs.md
dewatermark-api-pricing.mdmd1KB.firecrawl/dewatermark-api-pricing.md
bug_report.mdmd1KB.watermark-remover/.github/ISSUE_TEMPLATE/bug_report.md
requirements.txttxt1KB.watermark-remover/requirements.txt
robots.txttxt1KBpackages/landing-generator/output/robots.txt
pexels_links.txttxt1KBpexels_links.txt

📁 TOPAMB 18 → [[Anton Zinoviev Music]]

ФайлТипРазмерПуть
music-agent-hq-v2.htmlhtml342KBCOWORK/music-agent-hq-v2.html
music-agent-hq-v1.htmlhtml333KBCOWORK/music-agent-hq-v1.html
MASTER-ROADMAP-v2.htmlhtml151KBMASTER-ROADMAP-v2.html
MASTER-ROADMAP.htmlhtml145KBMASTER-ROADMAP.html
action-plan-agent-system.htmlhtml101KBaction-plan-agent-system.html
action-plan-social-media.htmlhtml96KBaction-plan-social-media.html
action-plan-distribution.htmlhtml83KBaction-plan-distribution.html
action-plan-playlists-pr.htmlhtml83KBaction-plan-playlists-pr.html
action-plan-avatar-visuals.htmlhtml79KBaction-plan-avatar-visuals.html
agent-team-blueprint.htmlhtml48KBagent-team-blueprint.html
music-promotion-research-2025-2026.mdmd32KBmusic-promotion-research-2025-2026.md
music-industry-research-2025-2026.mdmd31KBmusic-industry-research-2025-2026.md
multi-agent-research.mdmd19KBCOWORK/multi-agent-research.md
ROADMAP-v2.mdmd14KBCOWORK/ROADMAP-v2.md
ROADMAP-v1.mdmd9KBCOWORK/ROADMAP-v1.md
SCHEDULED-TASKS-v2.mdmd8KBCOWORK/SCHEDULED-TASKS-v2.md
SCHEDULED-TASKS-v1.mdmd6KBCOWORK/SCHEDULED-TASKS-v1.md
CRITICAL-ANALYSIS-v1.mdmd6KBCOWORK/CRITICAL-ANALYSIS-v1.md

📁 TESTER 17

ФайлТипРазмерПуть
qa-mega-research-v2.htmlhtml353KBqa-mega-research-v2.html
qa-saas-blueprint.htmlhtml326KBqa-saas-blueprint.html
qa-mega-research-v1.htmlhtml161KBqa-mega-research-v1.html
part2-3-tools-istqb.htmlhtml116KBresearch-parts/part2-3-tools-istqb.html
part1b-tester-workflow-execution.htmlhtml103KBresearch-parts/part1b-tester-workflow-execution.html
part4-8-bugs-data-market-plan.htmlhtml95KBresearch-parts/part4-8-bugs-data-market-plan.html
qa-deep-research-report.htmlhtml64KBqa-deep-research-report.html
part1-tester-workflow.htmlhtml53KBresearch-parts/part1-tester-workflow.html
qa-checklist-landing.htmlhtml45KBqa-checklist-landing.html
qa-market-analysis.htmlhtml36KBqa-market-analysis.html
gumroad-instructions.htmlhtml32KBgumroad-instructions.html
chat-log.htmlhtml29KB.qa-project/chat-log.html
CONVERSATION-LOG.mdmd10KB.qa-project/CONVERSATION-LOG.md
INDEX.mdmd6KBINDEX.md
index.htmlhtml4KBresearch-parts/index.html
BLUEPRINT_README.txttxt4KBBLUEPRINT_README.txt
PROJECT-CONTEXT.mdmd2KB.qa-project/PROJECT-CONTEXT.md

📁 SISTEMA DOM 12 → [[Home System]]

ФайлТипРазмерПуть
SISTEMA-DOM-Roadmap.htmlhtml104KBSISTEMA-DOM-Roadmap.html
MI_AGENTE_BUSINESS_PLAN.htmlhtml62KBresearch/MI_AGENTE_BUSINESS_PLAN.html
MI_AGENTE_MASTER_PLAN.mdmd41KBresearch/MI_AGENTE_MASTER_PLAN.md
MI_AGENTE_ROADMAP.htmlhtml22KBresearch/MI_AGENTE_ROADMAP.html
knowledge_form.htmlhtml21KBconfig/knowledge_form.html
mi_agente_market_research_2026.mdmd21KBresearch/mi_agente_market_research_2026.md
ARCHITECTURE.mdmd16KBdocs/ARCHITECTURE.md
COMPETITORS.mdmd10KBdocs/COMPETITORS.md
ROADMAP.mdmd8KBdocs/ROADMAP.md
PROJECT_STRUCTURE.mdmd5KBdocs/PROJECT_STRUCTURE.md
conversation-log.mdmd3KBconversation-log.md
requirements.txttxt1KBrequirements.txt

📁 casaradik project-playbook 10

ФайлТипРазмерПуть
01-project-blueprint.mdmd9KB01-project-blueprint.md
02-architecture.mdmd8KB02-architecture.md
08-scripts-reference.mdmd7KB08-scripts-reference.md
06-content-pipeline.mdmd7KB06-content-pipeline.md
09-admin-seo.mdmd6KB09-admin-seo.md
03-design-system.mdmd6KB03-design-system.md
04-scraping-playbook.mdmd6KB04-scraping-playbook.md
07-i18n-guide.mdmd6KB07-i18n-guide.md
05-data-quality.mdmd4KB05-data-quality.md
10-deployment.mdmd3KB10-deployment.md

📁 1st app repeat 9

ФайлТипРазмерПуть
index.htmlhtml47KBacctual-clone/index.html
blog.htmlhtml14KBacctual-clone/blog.html
privacy.htmlhtml13KBacctual-clone/privacy.html
terms.htmlhtml11KBacctual-clone/terms.html
teams.htmlhtml11KBacctual-clone/teams.html
about.htmlhtml10KBacctual-clone/about.html
usdc-invoicing.htmlhtml8KBacctual-clone/usdc-invoicing.html
usdt-invoicing.htmlhtml8KBacctual-clone/usdt-invoicing.html
CLAUDE.mdmd3KBCLAUDE.md

📁 DOSECF 9 → [[Dose Coffee]]

ФайлТипРазмерПуть
dose-capsules-landing_8.htmlhtml48KBSITE VERSIONS/dose-capsules-landing_8.html
drip-bag-manufacturers-europe.htmlhtml39KBdrip-bag-manufacturers-europe.html
dose-awwwards.htmlhtml37KBSITE VERSIONS/dose-awwwards.html
index.htmlhtml23KBSITE COPY/dose-site/index.html
contact.htmlhtml15KBSITE COPY/dose-site/contact.html
about.htmlhtml13KBSITE COPY/dose-site/about.html
product.htmlhtml13KBSITE COPY/dose-site/product.html
collections.htmlhtml10KBSITE COPY/dose-site/collections.html
dose-coffee-deploy-guide.mdmd5KBMDS/dose-coffee-deploy-guide.md

📁 LEGREEN 9 → [[LeGreen Landscaping]]

ФайлТипРазмерПуть
LeGreen_Deep_Dive_Sourced.htmlhtml61KBLeGreen_Deep_Dive_Sourced.html
VerdeCosta_Website.htmlhtml38KBVerdeCosta_Website.html
LeGreen_Agency_Proposal.htmlhtml36KBLeGreen_Agency_Proposal.html
LeGreen_Agency_Proposal_v1.htmlhtml36KBversions/LeGreen_Agency_Proposal_v1.html
LeGreen_Forecast_Dashboard.htmlhtml27KBLeGreen_Forecast_Dashboard.html
LeGreen_Business_Deep_Dive.mdmd23KBLeGreen_Business_Deep_Dive.md
LeGreen_New_Business_Ideas.mdmd15KBLeGreen_New_Business_Ideas.md
Anton_Requests_Log.mdmd6KBAnton_Requests_Log.md
CLAUDE.mdmd4KBCLAUDE.md

📁 AIVIDEOCRAWL 8 → [[YouTube AI Monitor]]

ФайлТипРазмерПуть
ai-daily-digest-2026-04-08.htmlhtml61KBai-daily-digest-2026-04-08.html
ai-daily-digest-2026-04-09.htmlhtml59KBai-daily-digest-2026-04-09.html
ai-daily-digest-2026-04-09-v2.htmlhtml59KBai-daily-digest-2026-04-09-v2.html
ai-daily-digest-2026-04-10.htmlhtml59KBai-daily-digest-2026-04-10.html
ai-daily-digest-2026-04-08-v2.htmlhtml52KBai-daily-digest-2026-04-08-v2.html
ai-daily-digest-2026-04-07-v2.htmlhtml48KBai-daily-digest-2026-04-07-v2.html
ai-daily-digest-2026-04-07.htmlhtml42KBai-daily-digest-2026-04-07.html
ai-daily-digest-2026-04-11.htmlhtml39KBai-daily-digest-2026-04-11.html

📁 Claude 8

ФайлТипРазмерПуть
SKILL.mdmd14KBScheduled/ai-daily-intel/SKILL.md
SKILL.mdmd12KBScheduled/daily-ai-top/SKILL.md
SKILL.mdmd6KBScheduled/obsidian-brain/SKILL.md
SKILL.mdmd6KBScheduled/ai-daily-video-digest/SKILL.md
SKILL.mdmd3KBScheduled/mawa-daily/SKILL.md
SKILL.mdmd2KBScheduled/middle-east-research/SKILL.md
SKILL.mdmd2KBScheduled/daily-middle-east-crisis-report/SKILL.md
SKILL.mdmd2KBScheduled/middle-east-report/SKILL.md

📁 HISTORYSYSTEMLOG 8 → [[Learning Log Tracker]]

ФайлТипРазмерПуть
dashboard.htmlhtml38KBdashboard.html
research-learning-log-systems.mdmd17KBresearch-learning-log-systems.md
ARCHITECTURE.mdmd16KBARCHITECTURE.md
prompt-management-research.mdmd13KBprompt-management-research.md
research-ai-tracking-logging.mdmd12KBresearch-ai-tracking-logging.md
PROMPT-DB-SPEC.mdmd11KBPROMPT-DB-SPEC.md
ROADMAP.mdmd10KBROADMAP.md
TOOLS-AND-INTEGRATIONS.mdmd8KBTOOLS-AND-INTEGRATIONS.md

📁 MARIACHI.com 7 → [[Mariachi Art]]

ФайлТипРазмерПуть
mariachiart_dump.htmlhtml421KBmariachiart_dump.html
index.htmlhtml420KBpublic/index.html
mariachi-styleguide.htmlhtml42KBmariachiart/mariachi-styleguide.html
index.htmlhtml31KBindex.html
ref-dscff-source.htmlhtml29KBref-dscff-source.html
index.htmlhtml1KBmariachiart/index.html
pdf_text.txttxt1KBpdf_text.txt

📁 TESTER CODEX 6

ФайлТипРазмерПуть
RESEARCH_SCORING_DEEP_DIVE_2.mdmd39KBdocs/RESEARCH_SCORING_DEEP_DIVE_2.md
RESEARCH_WEBSITE_CHECKERS_FOR_NON_TECH.mdmd37KBdocs/RESEARCH_WEBSITE_CHECKERS_FOR_NON_TECH.md
COMPETITIVE_DEEP_ANALYSIS_2026.mdmd34KBdocs/COMPETITIVE_DEEP_ANALYSIS_2026.md
RESEARCH_COMPETITOR_SCORING.mdmd32KBdocs/RESEARCH_COMPETITOR_SCORING.md
UX_RESEARCH_QA_AUDIT_TOOLS.mdmd22KBdata/UX_RESEARCH_QA_AUDIT_TOOLS.md
MARKET_SIZE_TAM_SAM_SOM.mdmd14KBdocs/MARKET_SIZE_TAM_SAM_SOM.md

📁 FLOXIE HOPE 5 → [[FQAD]]

ФайлТипРазмерПуть
floxie_hope_archive.mdmd887KBfloxie_hope_archive.md
floxie_hope_research_v3_ru.htmlhtml105KBfloxie_hope_research_v3_ru.html
floxie_hope_research_v3.htmlhtml102KBfloxie_hope_research_v3.html
floxie_hope_research_v2.htmlhtml82KBfloxie_hope_research_v2.html
floxie_hope_research_v1.htmlhtml45KBfloxie_hope_research_v1.html

📁 VERONIKA 4 → [[Veronika]]

ФайлТипРазмерПуть
veronika-research-database-v1.htmlhtml56KBveronika-research-database-v1.html
veronika-mega-report-v1.htmlhtml56KBveronika-mega-report-v1.html
veronika-acute-calming-v1.htmlhtml44KBveronika-acute-calming-v1.html
veronika-clinics-v1.htmlhtml40KBveronika-clinics-v1.html

📁 AUKCIONI AGREGATOR 3 → [[Real Estate Aggregator]]

ФайлТипРазмерПуть
Путеводитель_Аукционы_Испании.htmlhtml50KBПутеводитель_Аукционы_Испании.html
mvp_demo.htmlhtml42KBmvp_demo.html
requirements.txttxt1KBscraper_boe/requirements.txt

📁 AGENTTEAM 2 → [[MECLive]]

ФайлТипРазмерПуть
index.htmlhtml30KBprojects/dosecoffee-landing/index.html
CLAUDE.mdmd2KBCLAUDE.md

📁 Agentic Workflow 2

ФайлТипРазмерПуть
CLAUDE.mdmd3KBCLAUDE.md
requirements.txttxt1KBrequirements.txt

📁 VV DEEP RESEARCH COWORK 2 → [[Deep Research]]

ФайлТипРазмерПуть
Вероника — Полный глубокий анализ ситуации (21.03.2026).mdmd36KBВероника — Полный глубокий анализ ситуации (21.03.2026).md
Veronika-Deep-Analysis-2026-03-21.mdmd36KBVeronika-Deep-Analysis-2026-03-21.md

📁 claude-templates 2

ФайлТипРазмерПуть
CLAUDE.mdmd2KBweb-project/CLAUDE.md
CLAUDE.mdmd1KBdesign-recreation/CLAUDE.md

📁 dose coffee grind 2 → [[Dose Coffee]]

ФайлТипРазмерПуть
index.htmlhtml23KBindex.html
CLAUDE.mdmd1KBCLAUDE.md

📁 1stapp 1

ФайлТипРазмерПуть
index.htmlhtml12KBindex.html

📁 AI AGENT 1 → [[MECLive]]

ФайлТипРазмерПуть
ME_Crisis_Deep_Research_v1.htmlhtml46KBME_Crisis_Deep_Research_v1.html

📁 AntiAgent 1

ФайлТипРазмерПуть
Veronika_Medical_History_Complete.txttxt18KBVeronika_Medical_History_Complete.txt

📁 MYHUB 1

ФайлТипРазмерПуть
README.txttxt1KB.vercel/README.txt

📁 REALSTAT 1 → [[Real Estate Aggregator]]

ФайлТипРазмерПуть
Blog_Articles_Spain_Real_Estate.mdmd33KBBlog_Articles_Spain_Real_Estate.md

📁 SPANISH DOCS 1 → [[Vehicles Spain]]

ФайлТипРазмерПуть
shopify_recovery_codes for dose.txttxt1KBshopify_recovery_codes for dose.txt

📁 TELEGRAM PUSH 1 → [[Telegram Pipeline]]

ФайлТипРазмерПуть
index.htmlhtml32KBpublic/index.html

📁 autoresearch 1 → [[YouTube AI Monitor]]

ФайлТипРазмерПуть
program.mdmd6KBprogram.md

📁 chati na kakoeto vremya iz logov v antigravity 1

ФайлТипРазмерПуть
chat-history-full.txttxt475KBchat-history-full.txt

📁 grind dose 1 → [[Dose Coffee]]

ФайлТипРазмерПуть
capsules.htmlhtml27KBcapsules.html

📁 grind-dose-app 1 → [[Dose Coffee]]

ФайлТипРазмерПуть
index.htmlhtml1KBindex.html

📁 test 1

ФайлТипРазмерПуть
index.htmlhtml1KBindex.html